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Abstract 
This thesis documents the development of serine derived aldehyde 73 and its 
application to natural product synthesis. 
NBn2 
H 1 OTBDPS 
73 
Highly efficient syntheses of the biologically important natural products 
DAB 1 35 and nectrisine 36 from aldehyde 73 are discussed. The synthesis of these 
molecules made use of a highly efficient asymmetric boron mediated syn aldol 
reaction to generate a common intermediate, lactam 114. 
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35 	 36 	 114 
An alternate synthesis of lactam 114, making use of the Sharpless asymmetric 
dihydroxylation reaction is also discussed, along with an extension of the aldol 
reaction methodology which allowed the development of syntheses directed towards 
the C4Me analogue of 35 and the C 3Me analogue of 36. 
Finally the utility of aldehyde 73 towards the synthesis of the potential 
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Introduction 
Chapter 1 : Introduction 
1.0 a-Amino Acids and Their Derivatives 
Chiral, non-racemic natural products including a-amino acids' have been part 
of the organic chemist's repertoire for many years. They have long been utilised as 
building blocks in synthetic strategies. 2 This is due to their presence in peptides and 
proteins and as starting material for the synthesis of naturally occurring biologically 
active compounds. Pertinent examples include the elegant syntheses of cytochalasine 
B 1 3 and (+)-preussin 2, scheme 1. 4 Nearly all the common L-amino acids have been 
employed in synthesis. 2 Such strategies have gained in stature primarily because 
efficient enzymatic processes, asymmetric syntheses, and new separation procedures 
have significantly expanded the number of available non-racemic amino acids. There 
has also been an increasing interest in the synthesis of proteinogenic and non-










Paralleling the interest in the synthesis and uses of a-amino acids has been the 
increased interest in compounds derived from these chiral pool building blocks, 
examples being, amino diols and -hydroxy-a-amino acids, which are frequently 
found as key structural units in bioactive natural products. For instance, D-erythro 
sphingosine 36  and it's derivatives were shown to be inhibitors of protein kinase C 
1 
Introduction 
and (2S,35)--hydroxyleucine 4, scheme 2, is a key constituent of a range of natural 
peptide antibiotics. 7 Amino alcohols in general also play an important role in modern 
organic chemistry as a class of versatile chiral ligands. 8 Indeed, a number of elegant 
processes have benefited from their presence including Sharpless asymmetric 










As chiral building blocks, N-protected amino aldehydes have found numerous 
applications in the synthesis of a wide variety of compounds." In this respect, N-
protected serinal has special importance as the presence of a 3-hydroxy group in the 
side chain affords direct access to y-hydroxy--amino alcohols and, moreover, 
provides a handle for further transformations. 
1.1 Serine Derived Aldehydes 
1.1.1 Serine 
Since the interesting discovery of serine as a component of serecine, a silk 
protein, 12  it has been found in numerous biomolecules and has been employed as a 
building block for peptides and proteins. 
Serine represents an attractive synthetic template for several reasons: (1) It is 
a naturally occurring, chiral amino acid, both enantiomers are readily available as 
economical raw materials; (2) each of the three carbon atoms bear a funtionality that 
can be selectively protected and elaborated upon; (3) many transformations can be 
carried out without adversely affecting optical integrity; (4) the skeleton of the 
corresponding 2-amino-1,3-diol is part of many naturally occurring substances, 
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allowing the exploitation of the synthetic handle serine possesses in the synthesis of 
these substances. 
1.1.2 Protection and Functionalisation Strategies For Serine 
In general, a key aspect of synthetic elaboration is the judicious selection of 
protecting groups. In the protection of serine en route to a serinal derivative the 
synthetic chemist has many choices for each functionality (i.e. the amino group, the 
primary hydroxyl, and the carboxylic acid). The nitrogen terminus is most commonly 
protected as a carbamate (Boc,' 3 Cbz,' 4 or Fmoc 15) using standard chemistry. The 
trityl group has been employed to a lesser extent. 16  More recently, the NN-dibenzyl 
group has been added to the repertoire of N-protecting groups. 17 
A variety of groups have been employed for the protection of the primary 
alcohol in serine, including, benzyl, 18 tert-butyldimethylsilyl (TBS), 19 trityl,2° tert-
buty121 and tetrahydropyran (THP) .22 However, in these cases preprotection of the 
carboxylic acid/or amino group may be necessary. 
Wang and co-workers have reported an interesting preparation of O-benzyl or 
O-tert-butyl serine, scheme 3 18b  Serine is first treated with boron trifluoride to form 
a cyclic oxazaborolidinone. The crude oxazaborolidinone is reacted with either 
isobutylene under acid catalysis or with benzyl trichloroacetimidate/BF3 to form  the 
corresponding 0-protected oxazaborolidinone. Workup with IN sodium hydroxide 
liberates the hydroxyl protected serine, thus circumventing the need to protect the 
























R= tert-Bu, Bn 
Scheme 3 
Simultaneous nitrogen and hydroxyl protection with an isopropylidene 
group 23  or as an oxazolidinone 24 obviates the need for independent hydroxyl 
protection. Both the isopropylidene and oxazolidinone groups can be cleaved under 
relatively mild conditions. 
Protection/activation of the carboxyl group as a suitable ester is most 
common. In the majority of cases the acid functionality is required to be reduced to 
the corresponding alcohol or aldehyde before further elaboration. 
1.1.3 Types of Serine Derived Aldehydes and Their Synthesis 
As can be seen in the preceeding section there are a plethora of protecting 
groups that could be utilised in the synthesis of a serine derived aldehyde. The 
choices made will no doubt, in one way or another, affect additions of nucleophillic 
reagents to the aldehyde (especially protecting groups on the nitrogen atom). They 
may also affect the stereochemical integrity of the a-position. These represent crucial 
choices for the synthetic organic chemist to make when dealing with a-amino 
aldehydes. This section examines the differing types of serine derived aldehydes that 
have been developed and examples of their synthesis. 
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In general, protection of serine's different funtionalities takes place as 
described in section 1.1.2. It could therefore be perceived that many different 
(protected) aldehydes may have been developed, and, indeed, this is the case. In all 
cases the aldehyde group originates from the carboxylic acid funtionality of the 
amino acid. 
Thus, Gamer and co-workers have developed a cyclic oxazolidine aldehyde 
523 scheme 4, while Rapaport reported both an acyclic N-(phenylsulfonyl)-protected 
aldehyde 625  and an N-(9-phenylfiuoren-9-yl) cyclic carbamate 726  There have been 
examples of N-Cbz 827  protection and Reetz has more recently introduced the N,N-
dibenzyl group 9a28 with O-TBS protection. NN-dibenzyl with O-benzyl protection 
9b29 and MOM protection 9c30 have also been reported, along with the more 
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Some major disadvantages are present in the cases of the more classical 
carbamate protected aldehydes. Perhaps the most serious is that they show a 
tendancy to undergo racemization. 3 1  This necessitates their need to be handled in 
cold solvent and subjected to reaction as quickly as possible after their preparation. 
The very bulky 9-phenylfluoren-9-yl protecting group can confer enhanced 
configurational stability. 26 Additionally, NN-dibenzyl amino aldehydes are 
configurationally stable at room temperature and are therefore much easier to 
handle. 28  The Garner aldehyde is also much more resilient to racemisation than its 
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straight chain Boc protected counterparts. 32  Storage for short periods of time, 
therefore, becomes a possibility. Thus, it is these newer types of aldehyde that have 
very much eclipsed the use of the more traditional carbamate protected derivatives. 
The syntheses of these aldehydes in general follows the set pattern of initial 
protection of the nitrogen and primary hydroxyl units. These protective groups are 
easily introduced, be they carbamates (for N-protection) (e.g. Boc, Cbz), 27'3 ' which 
are introduced under basic conditions using CbzCl and Boc20, or benzyl groups (0-
or N-protection), which are also introduced under basic conditions with BnBr. 28 
Silicon protection, 33 MOM protection ,34  THP protection22 and trityl protection 2° 
(examples of 0-protection) are all introduced via standard procedures. This is then 
usually followed by a two step reduction/oxidation protocol, of the carboxylic acid 
(generally as an activated ester). 
The reductions tend to be carried out with lithiumaluminium hydride, 17 
diisobutylaluminium hydride, 35 lithium borohydride36 or sodium borohydride. 37 In 
one or two cases authors have reported the direct reduction of an ester to an aldehyde 
with cold diisobutylaluminium hydride. 38  It has also been noted that conversion to 
the versatile Weinreb amide 39  followed by reduction of the amide with 
lithiumaluminium hydride (which gives exclusively the aldehyde; over reduction of 
the lithium salts is precluded by intramolecular complexation) leads to N-Boc 
protected aldehydes with greater optical purity than has hitherto been observed .31 
Following reductions to the primary alcohol an oxidation is required to 
provide the aldehyde moiety. This is conveniently carried out under Swern 
conditions, 40  or Dess-Martin conditions 41  in excellent yields. The syntheses of 
Gamer's aldehyde 5 23  and Reetz's NN-dibenzyl amino aldehyde 9a28 are shown as 
examples in scheme 5. These are arguably the two most useful serine derived 
aldehydes to date, in terms of ease of synthesis, orthogonal protection, 
configurational stability and their ability to undergo diastereoselective reactions (to 
be discussed in section 1.2). 
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Scheme 5 
The synthesis of Gamer's aldehyde (5) is straight forward, encompassing 
some classical protecting group chemistry, as mentioned in previous sections. Boc 
protection of the nitrogen and esterification followed by isopropylidine formation 
provided an ester with cyclic 0,N-protection, which could be selectively reduced to 
the aldehyde with cold DIBAL-H. The optical purity of the material produced was in 
the range of 93-95% e.e. and the overall yield for the synthesis was in the range of 
4558%.32 Reetz's synthesis began with di-benzylation of the amino functionality 
with concominant benzyl ester formation. The next step was protection of the 
primary hydroxyl as its silyl ether. Reduction of the ester to the primary alcohol 
followed by Swern oxidation provided the aldehyde in 51% overall yield and with an 
optical purity of >99% e.e. 28 
Chromatographic purification of the newly synthesised aldehydes, especially 
with mono-N-substitution is always detrimental and should be avoided unless 
absolutely necessary. 28  This is due, in many cases, to an increased tendency of these 
already unstable aldehydes to racemise under acidic conditions, scheme 6. Here, 
enolisation in the presence of acid causes racemisation. For some aldehydes this can 
occur very quickly during contact with silica gel. 42 
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Scheme 6 
Disturbingly, even the more configurationally stable NN-dibenzylamino 
aldehydes are not immune to problems encountered through chromatography. In 
these cases alongside racemisation, an unusual rearrangement to give aminoketones 
43 12, has been observed for a range of aldehydes, scheme 7. Two different 
mechanisms have been postulated as shown. In the first, a 1,2-R-group shift gives 11, 
followed by a reverse 1,2-hydrogen shift to furnish the rearranged product. In the 
second, enol equilibration allows rearrangement via oxiranium ion 13 and 
aziridinium ion 14 to give 12. The unstable nature of a-amino aldehydes means that 
in nearly all cases of their use they are in a crude isolated form, derived from either 
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1.2 Nucleophilic Additions 
Once suitably protected cc-amino aldehydes are reactive toward a variety of 
classic reagents used for addition to the aldehyde function, and their synthetic 
potential has been amply demonstrated. 
1.2.1 Carbamate Protected a-Amino Aldehydes 
Until about 1987 cc-amino aldehydes were protected at the nitrogen with, in 
general, carbamates (Boc, Cbz). A drawback of their use was the need to handle 
them in cold solvents prior to use because of ease of racemisation (as mentioned in 
section 1.1.3). A further limitation of their use is that in the vast majority of 
nucleophilic additions to them (with Grignard reagents, lithium enolates, KCN/H, 
and sulfur ylides), mixtures of chelation and non-chelation controlled adducts 15 and 
16 respectively, scheme 8, were observed with poor levels of diastereoselection (in 
the range 1:1 to 1).44  
RSSLCHO 	
R 	 + (R)HN 	OH 
15 	 16 
R = CH 2Ph, CR2 CH(CH3)2, 
CH20Ac, CH2cHex 
= CH=CH 2, CH=CC 13 H27 
CHCO2E1; CH2CN, CN 
R!' = Doe or Cbz 
Scheme 8 
Rare cases of high selectivities have been observed. For instance, applying 
reagents which are capable of chelation can drastically enhance addition of 
nucleophiles to give adducts 15 predominantly. Reagents such as the bidentate Lewis 
acids: TiC14, SnC1 1, or M902 have been applied to the addition of allylsilanes, 
enolsilanes, zinc reagents and Me 3 SiCN to a-alkoxy aldehydes 45 with excellent 
stereocontrol. This concept was subsequently applied to the reaction of allylsilane 
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with cc-amino aldehydes, in the presence of SnC1 4 or TiC14 , scheme 9, to give 
chelation controlled adducts 17 with diasereomeric ratios (17:18) in the range 
>90:1 •46 
IFR" 	SnCI4 orTiCl 4 	RUN 	OH 	 R'HNOH 
R" CHO 	 /—SIMe3 	
17 	 + 	 18 
>90 	 : <10 
= Boc or Cbz 
Scheme 9 
However, with limited examples of excellent stereocontrol using reagents that 
promote chelation, combined with the mainly mediocre levels of diastereoselectivity 
achieved with the majority of nucleophiles, this class of aldehyde has been less 
frequently used in synthetic applications of late. 11,44 
Garner's aldehyde 5 is probably the most popular serine derived aldehyde and 
has been used in the synthesis of a wide range of compounds. 47 For example, 
Merino's interesting approach to a,13-diamino  acids utilises Garner's aldehyde as a 
key starting material.47a  Highly stereoselective additions of Grignard reagents to a-
amino nitrone 19 provided a means of generating the desired compounds. Nakagawa 
and co-workers have utilised the aldehyde in a stereoselective preparation of PPMP 
(1-phenyl-2-palmitoylamino-3-morpholino-1-propanol) 20, scheme 10.48  The key 
observation here is the relatively poor selectivity in addition of PhLi to the aldehyde. 
This was, however, rectified by conversion to a ketone followed by a stereoselective 
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Though moderate to good selectivities are generally obtained, the facial 
selectivity in addition of Grignard reagents and other organometallic species to this 
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aldehyde has been shown to be reagent dependent. Moreover, both chelation and 
non-chelation controlled processes can occur concominantly, leading to diminished 
diastereoselectivity or even reversed facial selectivity, scheme 11, such that 
prediction of stereochemical outcome is tenuous. 49 
	
OH 	 OH 
CHO 	
RMgX 11 
O,><NBoc 	 O,><NBoc 	OBoc 
5 
R=Ph 	5 	 : 	I 
R= Pr I : 6 
Scheme 11 
1.2.2 NN-Dibenzylamino Aldehydes 
In the 1990's, Reetz, introduced the idea of protecting group tuning 5° as a 
means of realising high levels of asymmetric control in organometallic additions 
involving NN-dibenzylamino aldehydes. Their configurational stability at room 
temperature and the reliable and predictable high diastereoselectivity (ds >90% is a 
rule) observed with a battery of different organometallics have made them a family 
of extremely useful chiral building blocks. 11,11,12  Curiously, application of N,N-
dibenzylaminoserine aldehyde in asymmetric synthesis has scarcely been reported in 
the literature. 
Non-Chelation Controlled Addition: 
The first reaction of an N,N-dibenzylamino aldehyde to be studied was the 
Grignard addition of phenylmagnesium bromide to alaninal 21a (see scheme 12). 53 
Because similar reactions using a-alkoxy aldehydes such as a-benzyloxy propanal 
had been known to occur non-selectively with formation of 2:1 mixtures of chelation 
and non-chelation controlled adducts, 54  there was little reason to assume that N,N-
dibenzyl a-amino aldehydes would display any sort of diastereoselectivity. However, 
12 
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experimentally only a single diastereomer in the reaction of alaninal 21a with 
phenylmagnesium bromide was observed. It was argued that a tertiary amino group 
would be a better donor ligand for magnesium than an ether moiety (in analogy with 
reactions of a-alkoxy aldehydes) and chelation controlled adducts 22 would 
predominate. However, the product, in fact, turned out to be that of non-chelation 
control 23. 
Bn2N/0 	 RM 	
Bn2N_<OH + Bn2NOH 
21a:R=Me 	 22 	 23 
21b:R=BnOCH2 
9a: R= tert-BuMe 2 SiOCH 2 
Scheme 12 
Moreover, a variety of other organometallic reagents such as MeLi, 
MeTi(O'Pr)3 , "BuCeC12 and MeMgX likewise react to form non-chelation controlled 
products 23. In further experiments it was shown that non-chelation control is quite 
general for a wide variety of organometallic reagents. Table 1 summarises some of 
these additions to alaninal 21a and serine derived aldehydes (21b & 9a). 55 
Table 1 
Entry Aldehyde Reagent R' in 22/23 Yield 22 : 23 
1 21a MeMgI Me 87 5 : 95 
2 21a MeLi Me 91 9:91 
3 21a MeTi(O'Pr)3 Me 78 3 : 97 
4 21a Me2CuLi Me 80 25 : 75 
5 21a PhMgBr Ph 85 3 : 97 
6 21a EtMgBr Et 85 5 : 95 
7 21a tert-BuLi tert-Bu 88 <3 : >97 
8 21a Me3 SiCN/ZnBr2 CN 74 13 : 87 
9 21b EtMgBr Et 71 <5:>95 
10 21b n-C 15H31 MgBr n-C 151-131 79 <5: >95 
11 21b tert-BuLi tert-Bu 54 12 : 88 
12 21b PhMgBr Ph 78 3 : 97 
13 
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13 9a MeMgBr Me 85 <5:>95 
14 9a 'PrMgCl :Pr >88 <5 : >95 
15 9a n-PrMgC1 n-Pr 74 3 : 97 
16 9a n-BuLl n-Bu 30 <5 : >95 
17 9a n-BuLi/CeC1 3 n-Bu 75 <5 : >95 
18 9a n-C 13H27MgBr n-C 13H27 77 6: 94 
19 9a PhMgBr Ph 81 3 : 97 
20 9a CH2=CFIMgBr CH2=CH 65 10: 90 
21 9a c-C3H5Li c-C3 H5 84 10: 90 
22 9a CH2=CHCH2Ti(NEt2)3 CH2CHCH2 83 16: 84 
Chelation Controlled Addition: 
As can be seen in Table 1 there is a distinct propensity for N,N-
dibenzylamino aldehydes to undergo stereoselective non-chelation controlled 
reactions with a multitude of nucleophiles. It can therefore be envisaged that 
difficulties may arise when attempting to generate chelation controlled adducts. The 
reason for this has to do with steric factors arising from the two N-benzyl groups. 
Nevertheless, chelation control has been achieved in several cases. 
In most of the successful cases, a Lewis acid MX was employed in the hope 
of generating intermediates of the type 24, scheme 13. However, it must be 
remembered that such Lewis acids can also form aldehyde adducts of the type 25 














non-chelation control it 	H 
25 
Scheme 13 
Some sporadic success has occurred in chelation controlled additions, for 
example, the highly Lewis acidic MeTiC1 3 leads to excellent stereocontrol in 
additions to NN-dibenzylamino aldehydes. However, diastereoselectivity decreases 
drastically as the size of the R-group increases. The combination of TiC1 4/Me2Zn 
also leads to chelation controlled additions as do SnC14 mediated additions which can 
give good levels of diastereoselectivities. These types of chelation controlled 
additions, however, do not always give good levels of stereocontrol and it appears 
that in the case of Lewis acid mediated reactions several different types of complexes 
with NN-dibenzylamino aldehydes exist and the direction and extent of the 
diastereoselectivity is difficult to predict. 
In a completely different approach, diethylzinc was reacted with N,N-
dibenzylamino aldehydes 21 at 0 °C, scheme 14, to afford chelation controlled 
adducts 22 preferentially, with diastereoselectivities in the range of 88-99% (Table 






Bn2NN_<OH + BrN0H 
21a:RMe 	 22 	 23 
R = CH(CH 3)2 
R= CH2CH(CH3)2 
R = CH2Ph 
21g:R=rPh 
21h: R = CH2OMEM 
Scheme 14 
Table 2 
Entry Aldehyde Yield 22 : 23 
1 21a 95 88:12 
2 21d 64 >99:<l 
3 21e 62 92:8 
4 21f 70 90:10 
5 21g 65 >99:<l 
6 21h 70 95:5 
This reaction was used succesfully by Andres and Pedrosa in the synthesis of 
2-aminopentan-1,3-diol diastereomers, scheme 15. Thus, serinal 9a was transformed 
into the two diastereomeric 3-hydroxynorvinals 28 and 29 en route to the target 
molecules. The key step was addition of ethylmagnesium bromide to the aldehyde to 
give the anti (non-chelation controlled) product 26 or diethylzinc addition to 9a to 
give the syn (chelation controlled) product 27. Both additions were shown to occur in 
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These latter (chelation-controlled) results are unprecedented since all 
previously used organometallics such RLi, RMgX, RIvinX, RCeC1 2, and R2CuLi 
afford opposite diastereomers 23 selectively. The reason for this intriguing difference 
has not yet been pinpointed. However, it has been noted that the addition of 
diethylzinc to N,N-dibenzylamino aldehydes proceeds at unusually high rates. 
Normal aldehydes do not react with diethylzinc without the aid of promoters, such as 
TiC14 , 58 or without the presence of catalysts such as 13-amino alcohols. 59  Thus ligand 
acceleration promoted by the NN-dibenzylamino group appears to be operating, 
perhaps in an autocatalytic fashion. 60  This result is interesting in that if other 
diorganozinc species react in a chelation controlled manner then this would represent 
a general method for preparing chelation controlled adducts from additions to N,N-
dibenzyl amino aldehydes with high diastereoselectivity. 
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1.3 Models For Chelation and Non-Chelation Controlled Additions 
to a-Amino Aldehydes 
1.3.1 Chelation Controlled Reactions: 
Chelation controlled addition to cc-amino aldehydes to give syn-a-amino--
hydroxy compounds can be explained by a Cram chelate model, scheme 1661c  The 
incoming nucleophile adds to the carbonyl through attack at the least hindered face. 
For cc-amino aldehydes complexation with a metal (M) can occur via the carbonyl 
oxygen and the nitrogen atom (e.g. in Et2Zn additions to N,N-
dibenzylaminoaldehydes) or via the carbonyl oxygen and the protecting group on the 
nitrogen (e.g. with Lewis acid promoted additions to Boc protected aldehydes). 
Whatever the complexation nature, the result of nucleophilic attack is the same and 
syn adducts are, in general, the end result. 
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1.3.2 Non-Chelation Controlled Reactions 
Non-Chelation controlled additions to cc-amino aldehydes can be rationalised 
by applying the Felkin-Anh model . 61 Two different conformers (A & B) may be 
predicted, scheme 17. In, for example, the case of NN-dibenzyl amino aldehydes 
which undergo almost exclusively non-chelation controlled additions, conformer (A) 
predicts the observed anti selectivity, with the nucleophile approaching from the less 













conformer (B) competes with conformer (A) and a diminished diastereoselectivity 











Recently there has been increasing interest in a group of hydrophilic plant 
alkaloids due to their potentially useful biological activities. The compounds 
concerned are simple hydroxylated derivatives of the monocyclic and bicyclic 
nitrogen containing ring systems found in piperidine (e.g. deoxynojirimicin, 30), 
pyrrolidine (e.g. DAB1, 31), indolizidine (e.g. castanospermine, 32), pyrrolizidine 
(e.g. australine, 33) and nortropane (e.g. calystegine, 34) alkaloids, scheme 18. 62,63 
Members of the group have been given various generic names in attempts to indicate 
their structural resemblance to sugars: iminosugars, polyhydroxylated alkaloids, 
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The biological activity of these iminosugars in the most part comes from their 
ability to inhibit glycosidases. Glycosidases are a class of enzyme which are 
extremely widespread in organisms.  64  These enzymes catalyze the hydrolysis of 
glycosidic bonds in carbohydrates and glycoconjugates. The net effect is the release 
of low molecular weight monosaccaharides and oligosaccharides. 62 Because 
glycosidases are important in many biochemical systems it is not surprising that 
compounds that inhibit them exhibit biological activity. 
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The enzymatic activity of iminosugars has been attributed to their structural 
resemblance to simple sugars. The extent and specificity of the inhibition was 
thought to be dependent on the position, number and stereochemistry of the hydroxyl 
groups on the molecule. However, experimental data have shown that the chirality of 
the hydroxyl groups on the iminosugars was not sufficient to predict their ability to 
inhibit enzymes. 62 
Some iminosugars inhibit glycosidases involved in glycoprotein processing. 
Glycoproteins belong to a class of glycoconjugates which also includes glycolipids. 
The processing is performed by glycosidase enzymes, which catalyze the trimming 
of saccharide units from the glycoprotein, creating new glycoproteins targetted to 
perform particular biological functions. 
A number of iminosugars have been linked to anti-viral activity. For example, 
castanospermine 32 was found to inhibit AIDS-virus syncytium formation and virus 
replication. Other uses may include anti-cancer agents, 65 insecticides, 66 and plant 
growth regulators. 67 
As a group of compounds the iminosugars have a diverse range of uses: as 
pharmaceutical agents, and as agrochemicals to name but a few. With advances in 
isolation techniques and screening it is possible that more of these compounds will 
be isolated and developed as drugs. 
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1.5 Pyrrolidine Iminosugars 
We, like others, have been interested in the synthesis of polyhydroxylated 
pyrrolidines, not least because of their biological activities. Our interest is focused 
upon the synthesis of the iminosugars DAB1 35 (1,4-dideoxy-1,4-imino-D-
arabinitiol) and nectrisine 36, scheme 19. 
H OH 	 OH 
Hd;; 	 H01q0H 
35 	 36 
Scheme 19 
1.5.1 Previous Syntheses of DAB] 
DAB1 was isolated, almost simultaneously from the fruits of Angylocalyx 
boutiqueanus68 and from Arachniodes standishii. 69 Extensive 1 H NMR studies 
deduced that its structure was that of 35 as shown in scheme 19 (i.e. (2R,3R,4R)-3,4-
dihydroxy-2-hydroxymethyl pyrrolidine). It was found to be a potent inhibitor of 
yeast a-glucosidase, with an 10 5 0 of 1.8 x 10 7M.7° It has also been shown to be a 
potential AIDS-virus replication inhibitor. 71 
There have been several syntheses of DAB 1 from carbohydrate precursors 
since the first by Fleet in 1985.7072  Fleet's original synthesis is highlighted in 
scheme 20. Thus, the acetonide 37, which is readily available from D-xylose was 
esterified with triflic anhydride followed by treatment with sodium azide. 
Methanolysis of the acetonide afforded the D-ribofuranoside 38. Tosylation of the 
primary hydroxyl group and hydrogenation of the azide function gave the bicyclic 
amine 39 (isolated as a carbamate) on heating with sodium acetate. Hydrolysis of 39 
followed by borohydride reduction and removal of the carbamate protecting group 
furnished DAB1, in 15% overall yield as its hydrochloride salt. 
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35 	 39 
(a) (CF3 SO2)20, py, CHCl2 ; (b) NaN3 , DMF, 100 °C; (c) Dowex 50W-8X, MeON; (d) TsCI, py, H 2 , 
Pd black, EtOH!NaOAc; CbzCl, ether, NaHCO 3 (aq.); (e) CF3COOI-llwater; NaBH4, EtOH; H2, Pd 
black, MeCOOH 
Scheme 20 
Other routes to achieve the synthesis of DAB 1 have involved the use of 
aldolases to catalyze aldol condensations, prior to reductive amination and 
cyclisation to the pyrrolidine ring. 73 
There have also been a few interesting syntheses utilising non-carbohydrate 
precursors. For example, Blechert and Huwe developed a racemic synthesis of DAB 1 
from vinyl glycine methyl ester 40, scheme The synthesis relied upon a ring 
closing metathesis reaction to form dehydroprolinol derivative 41. After tritylation of 
the primary hydroxyl group stereoselective epoxidation of the olefin was possible. 
Following epoxidation, a regioselective epoxide ring opening with potassium 
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(a) 4 mol% C12(Pcy3)2Ru=CHCH=CPh 2, Ph; (b) TrCI, Et3N, DMAP, CHCl 2 ; (c) mCPBA, Et20; (d) 
KOH, water, DMSO, 95 °C; (e) HC1, MeOH, AcOMe 
Scheme 21 
Further syntheses have utilised a pyrrolidinone intermediate. A reduction of 
the carbonyl moiety leads to the required pyrrolidine. 75 One such route began with 
D-serine as the initial source of chirality. 751' Formation of known oxazoline 42 from 
D-serine followed by reduction to the aldehyde and subsequent Wittig reaction gave 
E-olefin 43 (along with the separable Z-olefin (variable amounts)). Dihydroxylation 
of this olefin gave a mixture of diastereomeric diols in every case (including the use 
of the Sharpless asymmetric variant), fortunately these were separable. Treatment 
with aqueous hydrochloric acid afforded the pyrrolidin-2-one 44. Finally, borane 
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35 	 44 
(a) DIBAL-H, PhCH 3 ; (b) (Ph)3P=CHCO2Me; (c) 0s0 4 , NMO, acetone/water (4:1); (d) 1.5 N HCI 
(aq.), THF; (e) B 2H6, THF 
Scheme 22 
As can be seen from the above examples the literature is replete with 
examples of DAB1 syntheses. Most of the syntheses undertaken have utilised the 
inherent chirality of carbohydrate precursors. 
1.5.2 Previous Syntheses of Nectrisine 
In 1988 Shibata et al. described the isolation of a metabolite from the fungus 
Nectria lucida named FR-900483. 76 The structure of FR-900483 was shown to be 36 
by extensive NMR studies and a synthesis from D-glucose. 77 The natural product 







Nectrisine 36 has subsequently been shown to be a powerful inhibitor of a-
glucosidases (IC50 = 4.0 x 10 8M; yeast a-glucosidase) 78 and to a slightly lesser 
extent cx-mannosidases (1050 = 3 x 10-6M;  Jack Bean a-mamiosidase). 78 A novel kind 
of biological activity was also reported, in that nectrisine was found to be able to 
inhibit the suppression of lymphocyte production in mice. 77,79 
The first synthesis of nectrisine was by Kayakiri et al .77  from D-glucose and 
served to identify the true structure as depicted in scheme 23. It must be noted that 
whilst nectrisine exists solely in its imine form (by NMR) other stereoisomers do not. 
This is exemplified by 4-epi-nectrisine whose solution structure turns out to be a 
rapidily equilibriating mixture of the imine, amino alcohol and a dimer, scheme 24.80 
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In Kayakiri's synthesis D-glucose was converted to the oxime 45 which was 
hydgrogenated over Raney nickel to provide compound 46 after trifluoroacetate 
protection, scheme Cleavage of the acetal protection with trifluoroacetic acid 
gave 47. Oxidation with sodium periodate followed by hydrogenolysis of the benzyl 
protecting group and alkaline hydrolysis gave nectrisine. 
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36 	 47 
(a) Raney Ni, H2, NH40HIMeOH; (b) (CF 3CO)20, Et3N, CH2C12; (c) TFA, water; (d) Na10 4 , 
THF/water; (e) Pd black, H 2, HCO2H, MeOH; (f) IN NaOH 
Scheme 25 
Through interest in applications of the Vasella reaction, 81 Danishefsky 
devised the synthesis outlined in scheme 26.82  Thus glucal 48, which is readily 
prepared from D-glucal, was reacted with mCPBA. De-silylation and bromination 
afforded 49. Protection of the hydroxyl function and Vasella cleavage provided 50. 
Reduction of the aldehyde gave rise to silyl migration to the primary alcohol. 
Inversion of the secondary alcohol by triflation followed by azidolysis, and 
ozonolysis afforded compound 51. De-silylation and acetylation gave acetate 52. 
Reduction of the azide moiety under hydrogenation conditions followed by 
protection with trifluoracetic anhydride, debenzylation and, finally treatment with IN 
sodium hydroxide and Dowex resin (H form) provided nectrisine 36. 
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(a) mCPBA, MeOH; (b) TBAF, THF; (c) PPh 3 , CBr4; (d) TBSC1, imidazole, DMF; (e) Zn, 
EtOHlwater; (f) NaBH 4; (g) Tf20; (h) NaN 3 , DMF; (i) 03 , DCM; (j)  TBAF; (k) Ac20; (1) Pd/A1 203 , 
142 ; (m) (CF3CO)20; (n) Pd(OH) 2, H2 ; (o) IN NaOH (aq.), Dowex H 
Scheme 26 
An example of a synthesis which does not rely on carbohydrate precursors is 
the synthesis by Kim et al . 78 Their synthetic scheme started with diethyl tartrate 
derived aldehyde 53. The synthesis was centred around the pyrrolidin-2-one 
intermediate 54, which could be reduced to the corresponding amino alcohol 55 
using Super Hydride®.  From here, deprotection under acidic conditions and a 
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(a) LiEt3 BH, THF; (b) 6N HC1, THF; Dowex 1 -X2 (OH) 
Scheme 27 
1.6 Summary of Chapter 1 
This chapter highlights the development and synthesis of cc-amino aldehydes 
and of their reactions with nucleophiles. In particular, it contrasts the differing 
properties of NN-dibenzyl protected aldehydes with their more classically N-
carbamate protected counterparts. Latterly, an introduction to the synthetic targets 
DAB 1 35 and nectrisine 36 was made, along with examples of previous synthetic 
approaches to these natural products. 
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Chapter 2 : Results and Discussion Part 1 
The Synthesis of Nectrisine 
As explained in chapter 1 we have been interested in the synthesis of 
polyhydroxylated pyrrolidines. We have also been interested in the use of NN-
dibenzyl protected serine aldehyde derivatives, of the type developed by Reetz  56, 55 
and of their applications in natural product synthesis. In particular our goal was to 
synthesise the biologically important iminosugars, nectrisine 36 and DAB 1 35, 
scheme 28. 
Underpinning the interest in the syntheses of these natural products was an 
interest in how NN-dibenzyl protected serine aldehydes would behave in Evans type 
boron mediated aldol additions.  83  We wished to apply Evans methodology not only 
to the synthesis of these natural products, but also, to the synthesis of analogues of 
these molecules. In particular we sought to demonstrate the applicability of these 
aldehydes and judiciously selected aldol partners in synthesis. Our initial efforts were 
directed towards the synthesis of C 4Me DAB 1 57 and C3Me nectrisine 58. The 
methodology would then be expanded in order to construct many more analogues of 
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2.1 Retrosynthesis of Nectrisine 
Our initial retrosynthetic analysis of nectrisine is shown in scheme 29. Our 
goal was to generate amino alcohol 59. From here dehydration with concomitant 
deprotection would give nectrisine. 
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Scheme 29 
We envisaged that the cyclic amino alcohol 59 would originate from amino 
aldehyde 60. This amino aldehyde would in turn be generated from Weinreb amide 
61. After debenzylation we were confident that reduction of the amide with DIBAL-
H or lithium aluminium hydride would be straightforward, and would selectively 
give the amino aldehyde with no over reduction. Our confidence was based on the 
fact that Weinreb 84 has shown that additions of nucleophiles to amides of this type 
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give no over addition products. The reason for this is due to the formation of a very 
stable metal chelated intermediate of the type 64, which precludes further attack by 
nucleophiles. Hydrolysis of the intermediate on work-up would generate the desired 
aldehyde, scheme 30. 
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Evans has shown that formation of Weinreb amides from corresponding 
oxazolidin-2-one imides is relatively straightforward and high yielding. 85  A boron 
mediated syn selective aldol reaction between Reetz's NN-dibenzyl amino aldehyde 
56 (derived from D-serine) and Evans type glycolate equivalent 63, with suitable 0-
protection (probably some form of benzyl protecting group to allow deprotection 
concomitantly with the N-benzyl groups) would yield aldol adduct 62. 
2.2 Synthesis of an N,N-dibenzyl Protected Serinal Derivative 
We have been attracted to the NN-dibenzyl protected serine aldehyde 
developed by Reetz for three main reasons. Firstly, Reetz and others have shown that 
additions to this aldehyde occur highly stereoselectively to give anti or Felkin-Anh 
type products, 11,17,22,53,57  in many cases almost exclusively. The aldehyde is stable to 
racemisation, unlike many other types of serine derived aldehyde (chapter 1) and 
can be stored for several days before use. Finally, we wished to address the utility of 
this aldehyde in synthesis, an area which, surprisingly, has not been exploited to date. 
Reetz' s synthesis provides the serine aldehyde in 51% overall yield with 
>99e.e., scheme 555  The least efficient step was benzylation of the amine 
functionality with concomitant benzyl ester formation, which proceeded in mediocre 
yield. We wished to improve upon the overall efficiency of the synthesis thereby 
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making it more attractive for use in synthetic applications. The problem to address 
was, therefore, to increase the yield of nitrogen protection and ester formation. 
We chose to synthesise D-serine methyl ester 65 followed by benzylation of 
the amine to give the desired ester 66. The yield for this two step procedure was 















(a) MeOH, AcC1, reflux; (b) BnBr, K2CO3,  MeCN 
Scheme 31 
We believed that silyl protection for the primary hydroxyl group as used by 
Reetz would offer suitable orthogonality with the benzyl groups, at the same time 
being easily removable at the end of the synthesis. We therefore opted for the tert-
butyldimethylsilyl (TBS) group, which was conveniently introduced using TBSC1 
under basic conditions (imidazole) in DMF,l9,33a  scheme 32. At this stage we decided 
to attempt to reduce the ester functionality directly to the aldehyde moiety using 
DIBAL-H. 23 '35 The reaction was attempted several times with varying temperatures 
in either toluene or THF (Table 3). Whilst aldehyde 68 was formed it was always 
accompanied by significant amounts of the over-reduced alcohol 69 and other 
impurities by t.l.c and 'H NMR. 
4' At the start of this project D-serine methyl ester.hydrochloride was not commercially available 
(unlike its enantiomer) thereby necessitating the need for its synthesis. However, the unnatural 
enantiomer is now available from Aldrich Chemical Company at reasonable cost (and less expensive 
than the natural enantiomer). 
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(a) TBSC1, Imidazole, DMF; (b) DIBAL-H 
Scheme 32 
Table 3 
Attempt Solvent Temp (°C) Aldehyde Over Reduction 
1 Toluene -78 1 1 
2 Toluene -89 1 ¶1 
3 THF -78 1 1 
4 THF -89 1 
5 THF -98 1 1 
Moreover, the aldehyde was extremely unstable to silica gel (a 2D t.l.c 
analysis showed that the aldehyde decomposed to several different compounds after 
being in contact with silica gel for as little as 10 minutes) and it was therefore 
impossible to purify the crude aldehyde further. 
Subsequently we decided to undertake a two step reduction/oxidation protocol 
(this being the method of choice for the majority a-amino aldehyde syntheses). 55 ' 86 
Reduction of the ester functionality to the primary alcohol was envisaged to be 
unproblematic, however, reduction with lithium aluminium hydride at -78 °C did not 
proceed cleanly. The sole impurity turned out to be the desilated meso diol 70, which 
was formed in appreciable quantities (42%). Moreover, reduction with the milder 
DIBAL-H also gave rise to formation of the diol (18%), both reactions being carried 
out at -78 °C scheme 33. 
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NBn2 	 NBa2 	 NBa2 
Me0 ,0TBS 	 . HO,, 2...OTBS 	+ 	HoL.oH 
0 67 	 69 	 70 
Yields 
LIAIH 4 	 48% 	 42% 
DIBAL-H 76% 18% 
Scheme 33 
With the TBS protecting group proving to be too labile for our needs it was 
decided to introduce the less labile tert-butyldiphenylsilyl (TBDPS) group in an 
attempt to overcome these problems. Alcohol 66 was therefore protected as its 
TBDPS ether 71 in quantitative yield .33b  Reduction of the ester using DIBAL-H at - 
78 °C gave the corresponding alcohol 72, within 30 minutes, with excellent chemical 
yield and more importantly with no silyl group cleavage. From here a Swern 
oxidation4° cleanly afforded the desired aldehyde 73 in excellent yield, scheme 34. 
The aldehyde was produced cleanly with no need for silica gel chromatography. This 
was fortunate, as this aldehyde was also extremely unstable to silica gel. The overall 
yield of 86%, from D-serine, means that this route represents a highly efficient 
synthesis of this synthetically important aldehyde. 
NBn2 	 NBn2 
- 	 (a)  
Me0 0H 	 MeO 0TBDPS 
100%  
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H ( 0TBDPS 
73 
(a) TBDPSC1, imidazole, DMF; (b) DIBAL-H, toluene, -78 °C; (c) (Cod) 2, DMSO, Et3N, DCM 
Scheme 34 
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2.2.1 Enantiomeric Excess and Optical Stability ofAldehyde 73 
The enantiomeric excess of the aldehyde was to be measured by chiral HPLC 
(chiracel OD column). However, due to its instability when in contact with silica gel 
we decided to measure it indirectly via alcohol 72. A racemic synthesis of alcohol 72 
provided a means to optimise column conditions [hexane:propan-2-ol (19:1)] to give 
good baseline separation of the two enantiomer peaks. Freshly synthesised chiral 
non-racemic 72 was then analysed by HPLC under the same conditions. The optical 
purity of the alcohol was measured at >98% e.e. 
We were concerned that alcohol 72 might racemise on storage as a result of 
silyl group migration (from C 1 to C3), scheme 35 (a phenomenon reported for a TBS 
protected serine amino alcohol). 37 As a result the enantiomeric excess of 72 was re-
measured after storage (at —20 °C in a freezer) for a period of around one month. 
Gratifyingly, the alcohol's optical purity was still >98% e.e. as measured by chiral 
HPLC. 
lEn2 
- 	 scrambling of 





The alcohol was then oxidised under Swern conditions to give aldehyde 73 in 
quantitative yield, scheme 34. We also wished to confirm that the aldehyde was not 
prone to racemisation. It was, therefore, stored in a refrigerator (4 °C) for a period of 
48 hours, prior to being reduced back to alcohol 72, with the aid of DIBAL-H, 
scheme 36. 





73 	 72 
(a) DIBAL-H, toluene, -78 °C 
Scheme 36 
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The alcohol produced was subjected to chiral HPLC analysis, which showed 
that its optical purity was >98% e.e. Thus we can conclude that aldehyde 73 is stable 
with respect to racemisation, at least over a 48 hour storage period. In practice, 
however, the crude aldehyde was generally used in subsequent manipulations 
immediately following synthesis. 
2.3 Asymmetric Boron Mediated Aldol Reactions 
The venerable aldol reaction involves the reaction of an enolate and an 
aldehyde to form a new carbon-carbon bond. Recent intense and extensive studies on 
the reaction have covered a wide variety of reaction conditions and structural 
modifications, 87,88  and have disclosed that only a few sets of reaction parameters 
bring about high levels of stereoselection. In this regard, the use of chiral boron 
enolate reagents is notably successful, and will be discussed in this section. 
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Scheme 37 
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The aldol reaction creates two new chiral centres producing four possible 
stereoisomers 76a-d, as exemplified for the reaction of a chiral aldehyde (R 2 = Me, 
in 74) and the enolate (R3 = Me in 75) derived from an ethyl ketone, scheme 37. Two 
elements of control are necessary to achieve high stereoselectivity for this process. 
Assuming that the boron mediated aldol reaction proceeds through the accepted chair 
type cyclic transition state (Zimmerman-Traxler model), 89 then under kinetic control 
there are four possible reaction courses: (1) Z-enolate attacks the Re face of the 
aldehyde as shown in scheme 38, 77-*76a, (2) Z-enolate attacks the Si face of the 
aldehyde, 78-*76b, (3) E-enolate attacks Re face of aldehyde, 79-*76c, and (4) E-
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76c 	 76d 
Scheme 38 
K Note: The aldehyde chain adopts a pseudo equatorial position in every case, thereby minimising 1,3-
diaxial interactions 
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From this analogy it can be seen that (a) the enolate geometry directly affects 
the 2,3-stereochemistry of the products (i.e. Z-boron enolates give syn products and 
E-boron enolates give anti products) 83 '9 ' and (b) the direction of enolate approach 
should determine the absolute configuration of the 3-hydroxy group, thereby 
providing control of the relative stereochemistry at the 3,4-positions. 
2.3.1 Control of Enolate Geometry 
As shown above, the relative stereochemistry of the kinetically controlled 
boron mediated aldol reaction is dependant on the geometry of the boron enolate 
(generated in the presence of a tertiary amine base). Thus, if the formation of the 
enolate could be controlled in order to preferentially form Z or E enolates the relative 
stereochemistry of an ensuing aldol reaction could be controlled precisely. 
It turns out that steric requirements of the ligands (L) on the boron atom and 
the R4 group on the enolate, scheme 37, can have a substantial effect on enolate 
geometry. L 2BX (X = leaving group) reagents with a variety of ligands and leaving 
groups have been used to generate either E or Z-boron enolates for a number of 
different substrates. 92  Brown has shown that L2BX reagents with better leaving 
groups (e.g. mesylate or triflate) favour Z-enolates, whereas those with poorer 
leaving groups (e.g. chloride or bromide) favour E-enolates. 93 
Two hypotheses have been postulated in attempts to explain this selectivity. 
The hypothesis by Goodman and Paterson, formulated on the basis of molecular 
orbital calculations performed on R,R 2COBH2X complexes (X = F, Cl), shows that 
an anomeric effect between the uncomplexed lone pair on the carbonyl oxygen and 
the B-X antibonding orbital (cy) exists, causing the B-X bond to eclipse the C0 
bond, scheme 39•9495 
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Scheme 39 
As can be seem in this acetone-boron complexed model, scheme 39, the 
halogen is directed toward one of the protons on the alkyl group to which it is 
adjacent or cis to. This has the effect of inducing a partial negative charge on this a-
carbon, thereby, activating this alkyl group toward deprotonation by an unhindered 
base, such as, triethylamine. Scheme 40 illustrates the formation of Z and E-enolates 







































(a) L2BOTf, 'Pr2NEt; (b) L 2BC1, Et3N 
Scheme 40 
Thus, as can be seen in scheme 40 sterically bulky triflate ligands hinder 
deprotonation of the alkyl group they are adjacent to, thereby allowing, 
deprotonation of the alkyl group which is distal or trans to the triflate group 
providing Z-enolates i.e. 81—*Zenolate. In contrast, when chloride is the ligand, the 
electronic factors as described above mean that deprotonation of the adjacent alkyl 
group protons is now favoured giving E-enolates predominantly i.e. 80 --- E-enolate. 
Corey has proposed an alternate explanation in which the superior leaving 
group ability of the triflate group allows for the formation of a linear intermediate of 
the type 84, scheme 41.96 
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(a) L2BOTf, 'Pr2NEt; (b) L2BCI, Et3N 
Scheme 41 
In this hypothesis, a good leaving group allows deprotonation to give the Z-
enolate via 84. Poorer leaving groups ensure that the bent complex 80 predominates 
and, as above, deprotonation to give E-enolates takes place preferentially. 
2.3.2 Evans Asymmetric Aldol Methodology 
The boron enolate chemistry pioneered by Evans and utilising chiral N-
acyloxazolidin-2-ones has become one of the most popular methods of generating 
aldol adducts, not least, because of the exceptionally high levels of diastereoselection 
that are possible. 83  The original work by Evans involved the pair of chiral 
oxazolidin-2-one auxiliaries 85 and 86 derived from commercially available S-
valinol and (1 S,2R)-norephedrine respectively, scheme 42. 
Ph 	Me 
I-c 
O1NH 	 O1NH 
85 	 86 
Scheme 42 
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These oxazolidin-2-ones are conveniently acylated to give a variety of useful 
chiral acyl equivalents, which when reacted with either lithium amide bases or 
dibutyl boron triflate undergo highly stereoselective enolisation to form, almost 
exclusively, Z-enolates (Z: E selectivities >l00 : 1) . 83 
The corresponding Z-boron enolates, when reacted with achiral aldehydes, 
provide aldol adducts in which the 2,3-syn diastereoisomers are virtually the sole 
products. This is exemplified in the reaction of chiral propionyl equivalents 87 and 
88, which react with a variety of achiral aldehydes to give aldol adducts 89 and 90 as 
the sole products, in these cases enolate formation and the aldol reaction proceed 
with near perfect stereoselection (ca. 500:1), scheme 43. 
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Scheme 43 
The above example serves to illustrate the fact that the easily produced Z-
boron enolates of N-acyl oxazolidin-2-ones react with aldehydes to give syn aldol 
adducts exclusively. The absolute configuration of the two new chiral centres is 
controlled precisely by the chirality of the chiral auxiliary. 
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2.3.3 Double Asymmetric Induction in the Evans A Idol Reaction 
In the above example we have seen that a chiral enolate is able to control the 
stereochemistry of the newly formed chiral centres in the aldol reaction. It is able to 
do this by discriminating between each face of the aldehyde it attacks. For example, 
if we take the Z-enolate derived from 87 and analyse the transition state (91) which 
leads to aldol adduct 89, scheme 44, we can see that the si face of the aldehyde and 
the Co,re face of the enolate react to give the aldol adduct. It is intuitive from 
transition state 92 that the C o, re face of the enolate can not attack the re face of the 
aldehyde, due to unfavourable 1 ,3-diaxial interactions (as mentioned previously). 
Attack from the C o, si face of the enolate to either face of the aldehyde is also 
disfavoured, due to steric crowding over the C o, si face as a result of the substituent at 
the 4-position of the oxazolidin-2-one auxiliary. This selectivity means that N-acyl 
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si face of aldehyde & 
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aldol adduct 89 
Scheme 44 
It follows that a chiral aldehyde should also be able to exert the same kind of 
diastereofacial selectivity. 97  Hence if a chiral enolate and a chiral aldehyde are 
reacted together then we can predict two possible outcomes: (1) the diastereofacial 
selectivity of both chiral partners is the same and aldol adducts with enhanced 
diatereoselectivity result (compared to outcomes from only one of the chiral species 
operating) and (2) the diastereofacial selectivites of the chiral partners is opposite 
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resulting in a diminished diastereoselectivity. The terms 'matched' and 'mismatched' 
pairs (respectively) have been introduced to described the effects of this double 
stereo induction. 
An example which illustrates this effect, and also the power of the Evans 
chiral oxazolin-2-ones in synthesis is shown in scheme 4598  Here the chiral 
aldehyde 93 exerts only a modest level of diastereoinduction, providing aldol adducts 
94 & 95 in a ratio of 1.75:1. The 'matched' reaction is shown directly below 
providing aldol adducts 97 & 98 with a drastically increased diastereomeric ratio of 
660:1. The 'mismatched' reaction gives aldol adducts 99 & 100 in a ratio of 1:400. 
This auxiliary has the opposite sense of stereoinduction compared to the aldehyde, 
but the stereoinductive capability of the chiral oxazolidin-2-one is much greater than 
that of the aldehyde, thus, over turning the inductive capability of the aldehyde to 
give the 'mismatched' diastereomer with an excellent level of diastereoselectivity. 
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Scheme 45 
The chiral auxiliaries can subsequently be removed under a variety of 
conditions, for example, transesterification (LiOBn, 99 Ti(OBn)4 ,' °° BrMgOMe' ° '), 
transamination (Me 2A1N(OR)R), 85 hydrolysis (LiOH' °° or LiOOI-I' °2) or reduction 
(LiBH4). 85 They are then easily recovered and reused. 
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2.4 Application of Evans Aldol Methodology in Nectrisine Synthesis 
As depicted in our retrosynthetic analysis of nectrisine, scheme 29, we 
believed an aldol reaction between the enolate of 101 (= 63, with P = Bn) and our 
N,N-dibenzylamino serine aldehyde 73 would generate the required stereochemistry 
found in 102, as a result of Felkin-Anh type attack by the enolate. Arguments by 
Roush' 03  concerning aldol reactions of cc-methyl chiral aldehydes and achiral 
propionate enolates prompted us to examine the transition states for the ensuing 
reaction between the enolate of 101 and aldehyde 73, scheme 46. Thus transition 
state 103a represents the Felkin-Anh transition state: the medium sized group (taken 
as the CH20TBDPS group) is aligned syn to the carbonyl, and the developing C-C 
bond is anti to the largest substituent (taken as the NBn 2 group) thus giving the 
desired aldol adduct 102. Rotation about a-carbon-carbonyl carbon bond provides 
transtition state 103b which is also somewhat destabilised by steric interactions 
between NBn2 and OBn. Roush's arguments suggest that the interactions shown 
might be serious enough to destabilise this transition state relative to the reaction of 
the enantiomeric enolate of ent-101 and 73 which proceeds through sterically 
favoured transition state 104 to give aldol adduct 105. 
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Scheme 46 
We were therefore concerned that interactions of the type predicted by Roush 
might mean that the aldol reaction to give aldol adduct 102 would be less favourable 
than the reaction between aldehyde 73 and the enolate of ent-101 which leads to 
aldol adduct 105. We feared that diminished yields and/or diastereoselectivities 
might result. Nevertheless, we decided to investigate whether or not these arguments 
would hold in our case. 
The glycolate equivalent 101 has been used by several others' 04  and found to 
be highly effective in subsequent aldol reactions. We were interested in this O-berizyl 
protected glycolate equivalent as we believed that the O-benzyl protecting group 
would be easily removable under the same conditions as the N-benzyl groups, 
thereby, minimising the number of deprotection steps required in the synthesis of 
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nectrisine. In fact, 101 was readily synthesised from L-phenylalanine as shown in 
scheme 47. Thus, the oxazolidinone 106 was synthesised via condensation of diethyl 
carbonate with S-phenyalaninol 107. This was itself derived from L-phenylalanine 
via reduction of the carboxylic acid functionality under conditions described by 
Evans 83d  utilising boranedimethy1sulfide complex or by the method described by 
Meyers' 05  using sodium borohydride. Benzyloxyacetic acid 109 was prepared either 
from glycolic acid, through dibenzylation to give ester 108 followed by 
hydrogenation over ammonium acetate poisoned 10% Pd/C to give the desired acid, 
or by reaction of the sodium salt of benzyl alcohol with bromo acetic acid. Acid 109 
was then condensed with the lithiated oxazolidinone via its unsymmetrical 
anhydride, derived from pivaloyl chloride (trimethylacetyl chloride) to provide 101. 
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Scheme 47 
In our hands, large scale syntheses were best carried out using the Meyers 
reduction route and synthesis of benzyloxy acetic acid via bromoacetic acid. 
With glycolate equivalent 101 in hand we decided to attempt the aldol 
reaction that we believed would give aldol adduct 102. Enolisation of 101 under 
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standard conditions (Bu2BOTf, Et3N; -78 °C-*0 0C)' 04 followed by addition of 
aldehyde 73 gave an aldol adduct (which was tentatively, at this stage, assigned the 
structure 102) as a single diastereomer (by 600 MHz 'H NMR) in excellent yield. 
The 2',3'-syn stereochemistry of the aldol adduct was easily determined via 'H NMR 
coupling constants (the C2 proton was a clear doublet at 5.41 ppm with a coupling 
constant of 2.6 Hz). 
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0 0 	 0 0 OH 
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(a) Et3N, Bu213OTf, DCM, -78 °C-0 °C (1.25 hours), recooled to -78 °C; 73 in DCM, -78 °C 
Scheme 48 
The Weinreb amide 110, scheme 49 was then synthesised using N,O-
dimethylhydroxylamine.hydrochloride and trimethylaluminium. To our surprise, up 
to 40 equivalents of the hydroxylamine salt was required for the reaction to proceed 
to completion. This is in direct contrast to the 3 equivalents quoted by Evans 106  to 
effect the same kind of transformation. The hydroxylamine salt is extremely 
hygroscopic and we hypothesised that the presence of water might be hindering 
completion of the reaction. On thorough drying of the commercially obtained salt 
(several days in a vacuum oven), we subsequently found that only 15 equivalents 
were necessary to carry out the same transformation, in quantitative yield. 
In solution a -hydroxy ketone exists in a chair-like conformation as a result of intramolecular 
hydrogen bonding. The bulk long chain adopts a more favoured equatorial position and the dihedral 
angle between a and 13  protons is --600 for the syn arrangement and --180 0 for the anti arrangement. As 
a result, the Karplus relationship predicts vicinal coupling constants to be —3-5Hz for syn and —7-
12Hz for anti aldol adducts. 
.5-- . 
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Scheme 49 
2.4.1 An Unpredicted Cyclisation 
Our initial synthetic scheme required the removal of the N-benzyl protecting 
groups with, we believed, concomitant O-benzyl deprotection to give the amine 111. 
A DIBAL-H reduction of the Weinreb amide we predicted would give amino 
aldehyde 112 as an intermediate en route to nectrisine, scheme 50. 
Me OBn NBn2 	 Me OH NH2 
YL~
OTBDPS -------------- — MeO (J ( 0Th1)1 ------------- 
0 OH 	 0 OH 
110 111 
OH NH2 
H 	 ODPS 	----------
YY: ---- 




(a) Pd/C, H2; (b) DIBAL-H 
Scheme 50 
However, exposure of Weinreb amide 110 to a hydrogen atmosphere in the 
presence of 10% Pd/C led to formation not of the desired amino diol 111, but to the 
lactam 114, scheme 51. The reaction typically took 3 days to generate 114 in good 
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yield. Furthermore, analysis of the reaction course by t.l.c showed that the starting 
material was consumed within around 24 hours, in conjunction with the formation of 
a new lower Rf spot. Interception of the reaction at this stage provided the 
intermediate 113, the O-benzyl protected lactam. The O-benzyl protecting group then 
took a further 48 hours to undergo complete cleavage to provide the de-benzylated 
lactam 114. This result is somewhat surprising as normally O-benzyl groups should 
be cleaved at a faster rate than N-benzyl groups. °7 Switching to the more active 
Peariman's catalyst (Pd(OH) 2/C) did not affect the reaction time with respect to 0-
benzyl cleavage, however, N-benzyl cleavage was significantly faster, being 
complete within around 8 hours. 
H 	OTBDPS 	 H 	OTBDPS 
Me OBnNBn2 	 0 Nj 	 o N i (a), 89%, 8 hours 	 (a), 80%, 48 hours 
MeO
0D (b), 86%, 24 hours
Bn 0 	OH 	
(b), 76%, 48 ho 
HO 
110 113 	 114 
71%, 56 hours 
65%, 72 hours 
(a) 20% Pd(OH)2/C, H2, MeOH; (b) 10% Pd/C, H 2, MeOH 
Scheme 51 
We were initially surprised by the outcome of this reaction as we hadn't 
expected (MeO)N(Me) to be a particularly good leaving group. However, we 
recognised that the lactam 114 might also represent an important intermediate in the 
synthesis of nectrisine. In fact, by judicious choice of reduction conditions we 
believed it would be possible to access oxidation states corresponding to the amino 
alcohol and the amine. This unexpected cyclisation to give lactam 114, therefore, 
proved to be quite fortuitous. 
Furthermore, an opportunity to verify the stereochemistry of the asymmetric 
centres formed in the aldol reaction became possible at this stage. Thus, lactam 114 
was deprotected in the presence of hydrofluoric acid to afford the known lactam 
11572c,108, scheme 52. 
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(a) HF (48% in H 20), MeCN/THF 
Scheme 52 
A comparison with 'H NMR literature data is shown in Table 4, showing 
good correlation with 115, proving that the correct stereochemistry had been 
assigned to aldol adduct 102. 
Table 4 
Source MHz C3H C4H C5H C6HA C6HB 
Ref72c 300 4.21 3.91 3.36 3.51 3.70 
Ref 108 250 4.33 4.03 3.45-3.50 3.64 3.81 
115 250 4.31 4.00 3.45 3.61 3.79 
Mult. / J (Hz) 
Ref 72c 	 d, 8.0 	t, 8.0 	ddd, 8.0, 5.0, 4.0 	dd, 12.5, 5.0 	dd, 12.5, 4.0 
Ref 108 	 d, 8.0 	dd-t, 7.5 	m 	dd, 12.2, 4.9 	dd, 12.2. 2.8 
115 	 d, 8.0 	dd-1, 8.0 	ddd, 7.9, 4.9, 3.1 	dd, 12.2, 4.9 	dd, 12.2, 3.1 
Note: the data for reference 72c consistently shows a deviation of around 0.1 ppm, compared to 
reference 108 and 115 which is possibly due to a referencing error. 
Furthermore, the optical rotation [(XD]  and melting point (mp) of 115 was also 
in excellent agreement with both literature compounds, Table 5. 
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Table 5 
Source 	 aD 	 mp 
Ref 72c 	+15.2 (c=0.40, H20) 	135-138°C 
Ref 108 	+14.7 (c=0.58, D20) 	130-133 °C 
115 	+14.2 (c=0.40, D20) 	131-133 °C 
With the potential of lactam 114 proving to be very high, we decided to 
attempt to shorten the number of steps required for its synthesis. We therefore, 
attempted a hydrogenation reaction with aldol adduct 102 as the substrate, thus 
potentially circumventing the need for transamination to the Weinreb amide 110. 
Unfortunately, as we feared, the oxazolidin-2-one moiety was a far better leaving 
group than (MeO)N(Me) and cyclisation took place to give a mixture of lactam 116 
along with 113 (essentially a 50:50 mixture). Prolonged reaction times with 20% 
Pd(OH)2/C provided lactam 117 (after 3 days) but never any trace of the desired 
lactam 114 (up to 21 days reaction time), 109 scheme 53. 
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As a result of this we decided to persevere with the two step protocol of 
transamination followed by hydrogenolysis, which was still a very efficient synthesis 
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of this lactam, as opposed to attempting further debenzylation protocols with regard 
to aldol adduct 102. 
2.4.2 Reduction of Lactam to Amino Alcohol 
With recourse to our retrosynthetic analysis of nectrisine it was apparent that 
the next step in our synthesis should be a reduction of this lactam to provide the 
amino alcohol oxidation state 118, as shown in scheme 54. This would then be 
followed by a dehydration step, which ideally might also cause deprotection of the 
silyl ether. A possibility for this transformation might involve the use of concentrated 
hydrochloric acid to enable dehydration, with concomitant silyl deprotection 
(TBDPS deprotection has been achieved in the presence of 6N HCI).' °8 
OTBDPS 
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Scheme 54 
We, therefore, attempted the reduction of lactam 114 with DIBAL-H at -78 
°C, however, no reaction took place. Warming the reaction mixture to 0 °C had no 
effect on the reaction outcome. The same reaction was attempted using the reagent 
lithiumtriethylborohydride (Super Hydride ®) which we thought might be more 
effectual. However, a similar outcome resulted, scheme 55. We did not wish to resort 
to using more powerful reducing agents, such as, lithium aluminium hydride or 
borane as we (section 3.1.1) and others  75  have shown that these are effective in 
reducing such lactams to the corresponding amines. 
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Scheme 55 
We attributed this lack of reactivity to the carbonyl group being of relatively 
low electrophilicity, as a result we believed that increasing the electrophilicity of the 
carbonyl group would allow reduction to the target oxidation state. Several other 
groups have used this strategy to effect similar reductions. 110 The simplest way to 
increase the electrophilicity of the carbonyl group in these cases was to introduce an 
electron-withdrawing protecting group (such as a carbamate) to the nitrogen atom. 
We, initially, attempted to introduce a Boc protecting group on to the nitrogen 
atom of lactam 114. Unfortunately, whilst N-Boc protection in this case was possible, 
using forcing conditions (several equivalents of Boc 2 and Et3N), the more 
nucleophilic hydroxyl groups were preferentially Boc protected. This had the effect 
of increasing the acidity of the proton at the C3 position and as a result the dehydro 
compound 119 was formed in excellent yield, as shown in scheme 56. 
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We therefore surmised that preprotection of the secondary hydroxyl groups 
would be a wise course of action. Strangely, our initial attempts to introduce MOM 
or acetyl protecting groups (under standard conditions)" to the hydroxyl groups 
proved fruitless, with complex mixtures (by t.l.c.) being produced. As a result no 
attempt was made to purify these reaction mixtures further. 
OTBDPS 




(a) MOMCI, 'Pr2NEt, DCM; (b) Ac20, pyridine, DMAP, DCM 
Scheme 57 
Our initial strategy behind introduction of either MOM or acetate protecting 
groups was that they would be easily removable (along with the Boc group and the 
TBDPS group) under the acidic conditions we had chosen to effect the dehydration 
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of the amino alcohol oxidation state to give the imine. Thus as an alternative we next 
attempted to introduce further silicon protection, in the form of TBS groups. 
Reaction of lactam 114 with tert-butyldimethyltrifluoromethanesulfonate (TBSOTf) 
under mildly basic conditions (2,6-lutidine)" 2 cleanly afford the di-TBS protected 
compound 120 in excellent yield. It was now possible to cleanly introduce the 
desired electron-withdrawing Boc group to the molecule to provide 121 in almost 















(a) TBSOTf, 2,6-lutidine, DCM; (b) Boc 20, Et3N, DMAP, DCM 
Scheme 58 
Reduction of compound 121 with Super Hydride ®, proceeded cleanly to 
afford the amino alcohol 122 in excellent chemical yield, scheme 59. Thus, 
introduction of the electron-withdrawing Boc group to the nitrogen atom appears to 
have had the desired effect of increasing the electrophilicity of the carbonyl group 
carbon, thereby, allowing reduction to occur at a much faster rate (only 15 minutes 
required for complete reduction), compared to the attempted reduction of 114. 
2.4.3 Imine Formation 
A solution of 122 in THF was subsequently treated with 6N HC1. After 
heating to 50 °C for 2 hours the protecting groups were readily cleaved. Analysis by 
t.l.c. showed the presence of an extremely polar component, along with several high 
Rf impurities which were easily removed by silica gel colunm chromatography 
(eluent: 5:3:1 CHC13:MeOH:NH3 (28% aqueous)). The polar component was eluted 
along with a large quantity of salts. This compound was not characterised. It was, 
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however, attributed to be intermediate 123, by analogy with a reported synthesis of 
nectrisine, which also utilised an acidic deprotection protocol in the last step of the 
synthesis. 121,  A final purification by ion-exchange chromatography (Dowex 1X2 
(Off form)) provided nectrisine 36 in excellent yield, scheme 59. 
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(a) LiEt3BH, THF, -78 °C, 15 mins; (b) 6N HC1, THF; (c) Dowex 1X2 (Off), eluent = 1120 
Scheme 59 
The correct stereochemistry of the 3 asymmetric centres had already been 
confirmed by the synthesis of lactam 115. However, we wished to further confirm 
the identity 36 was indeed nectrisine by comparison with available literature physical 
data. 77 ' 78 Unfortunately, it appears that literature 'H NMR spectra were run on low 
field instruments and as a result the signals for nectrisine's protons were recorded as 
a multiplet78 or not reported at a11 77 (with the exception of the imino proton) . ' 3C 
NMR data was, however, in very close agreement with compound 36, Table 6, as 
were optical rotations which are shown in Table 7, along with data for the imino 
proton. 
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Table 6 
Source MHz 8c (jpm) 
Ref 77 67.8 171.0 	83.9 	78.8 	77.4 	61.8 
Ref 78 170.7 	83.6 	78.5 	77.0 	61.4 
36 62.9 170.5 	83.4 	78.2 	76.8 	61.2 
Note: Deviations in ppm between all 3 spectra are of a similar magnitude for each signal suggesting 
that the deviation is perhaps due to referencing differences 
Table 7 
Source 	MHz 	Imino proton 	 (XD 
Ref 77 	270 	7.71 (d, J2.0 Hz) 	+22.0 (c=0.6, H20) 
Ref 78 	? 	 7.67 (brs) 	+21.8 (c=0.6, H20) 
36 	600 	7.72 (d, J2.4 Hz) 	+2 1.0 (c=0.4, H20) 
On the basis of the above comparisons and also with literature comparisons of 
lactam 115 we were confident that we had successfully synthesised nectrisine. With 
an overall yield of 31% (12 steps) this represents a highly efficient synthesis of this 
biologically important natural product. 
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2.5 Examination of the Aldol Reaction Leading to Adduct 102 
With the success of the synthesis of nectrisine we wished to take a closer look 
at the aldol reaction which gave adduct 102. In particular we wished to ascertain 
whether this was a 'matched' or a 'mismatched' process. In order to do this we 
surmised that an aldol reaction between a suitable achiral glycolate enolate 
equivalent and our chiral non-racemic aldehyde 73 would provide us with the sense 
and magnitude of the diastereoinduction that aldehyde 73 exerts in the aldol reaction. 
Therefore, the Z-boron enolate of benzyloxy acetic acid methyl ester 124 was 
reacted with aldehyde 73. The ensuing aldol reaction proceeded cleanly to afford a 
syn aldol adduct (the C2 proton was a clear doublet at 4.38 ppm with a syn coupling 
constant of 1.4 Hz) (tentatively assigned as 125) in good yield as a single 
diastereomer, scheme 60. 
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Scheme 60 
Aldol adduct 125 subsequently underwent transamination with N,O-
dimethylhydroxylamine.HC1/A1Me3 to cleanly afford Weinreb amide 110, scheme 
61, in excellent yield within 18 hours. The Weinreb amide was identical in all 
respects (NMR, IR, [aI D, Rf) to the amide synthesised from aldol adduct 102. 
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(a) (MeO)N(Me)H.HCI, A1Me 3 , THF, -30 °C—room temp.—*30 °C, THF; 125, TFIF -30 °C—room 
temp. 
Scheme 61 
This shows that the stereoinductive capability of the aldehyde alone is enough 
to provide the desired Felkin-Anh product. It is therefore probable that since a single 
diastereomer was obtained in the reaction of chiral enolate 101 with 73, then it is 
very likely that this reaction represents a 'matched' case. 
In order to fully confirm that this was the case, the same aldol reaction was 
attempted with the Z-boron enolate of ent-101 (synthesised in an analogous manner 
to 101, from D-phenylalanine). The reaction yielded a mixture of syn aldol adducts 
105 (C2 proton a clear doublet at 5.22 ppm J = 2.4 Hz) and 126 (C2 proton a clear 
doublet at 5.46 ppm J = 1.7 Hz) (with a 9:1 diastereomeric ratio) which were readily 
separable by column chromatography, scheme 62. This, therefore, must represent a 
'mismatched case', with the chiral auxiliary having the opposite sense of 
stereoinduction to the aldehyde. This reaction once again shows the power of the 
Evans N-acyl oxazolidin-2-one chiral auxiliaries, here being able to overturn the 
stereoinductive capability of aldehyde 73 in order to give the aldol adduct 105 
preferentially. 
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Scheme 62 
The aldol adduct 126 was readily transformed into Weinreb amide 110 
(quantitative yield, identical in all respects to the Weinreb amide synthesised from 
102) and aldol adduct 105 was transformed into its Weinreb amide 127, scheme 63. 
The Weinreb amide 127 was subsequently transformed into lactam 128, proving that 
this aldol process would give rise to a different stereoisomeric form of nectrisine, 
although such investigations are beyond the scope of this project. 
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(MeO)N(Me)H.HC1, AIMe 3 , THF, -30'C—room temp.--30 °C; 125, THF -30'C—room temp.; 
Pd(OH)2/C, H2, MeOH 
Scheme 63 
2.5.1 Formation ofAnti and 'Non-Evans' Syn Aldol Adducts 
To obtain such high diastereoselectivities in our aldol process, which gave 
adduct 102, it was necessary to strictly adhere to the published protocol for formation 
of the required syn aldol adducts (1.2 equivalents of dibutylboron triflate and 1.3 
equivalents of base). Although time did not permit its investigation it is worth noting 
the results obtained by Heathcock, 113 who was able to generate anti and 'non-Evans' 
syn aldol adducts by increasing the number of equivalents of Lewis acid used. A 
mechanistic explanation is shown in scheme 64 with the reaction of propionate Z-
enolate 129 and an aldehyde RCHO. The normal 'closed' transition state 
(Zimmerman-Traxier) 130 is shown along with the proposed 'open' transition state 
131 which leads to anti aldol adducts. The open transition state 132 leads to 'non 
Evans' syn aldol adducts and is favoured for smaller Lewis acids (e.g. SnC1 4 or 
TiC!4).' 14 
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Scheme 64 
2.6 Synthesis of a C3Me Analogue of Nectrisine 
In keeping with our initial aims we wished to expand on the synthesis of the 
natural product nectrisine, by synthesising it's C 3Me analogue 58. A retrosynthetic 
analysis using the methodology developed in the synthesis of nectrisine (i.e. 
cyclisation to lactam followed by reduction and dehydration) is shown in scheme 65. 
Thus, we believed that a propionate aldol reaction between aldehyde 73 and the 
chiral propionate equivalent 137 would provide aldol adduct 136 as a single 
diastereomer, in analogy with the highly successful glycolate aldol reaction giving 
102. From then on we believed that the chemistry undertaken for the synthesis of 
nectrisine would be directly applicable to its C3Me analogue. 
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The chiral propionate equivalent 137 was synthesised straightforwardly from 
the lithiated oxazolidin-2-one 106 which was condensed with freshly distilled 
propionyl chloride to provide 137 in virtually quantitative yield. 
As anticipated, the propionate aldol reaction proceeded smoothly to provide 
aldol adduct 136 in excellent yield as a single diastereoisomer. Transamination gave 
the Weinreb amide 135 in virtually quantitative yield, although once again a vast 
excess of the aluminium amide was necessary to drive the reaction to completion. 
Hydrogenation of the Weinreb amide provided the desired lactam 134 in excellent 
yield, within 12 hours. We also attempted hydrogenation of propionate aldol adduct 
136 which as it turned out mirrored the attempt made with the glycolate aldol adduct 
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in that a mixture of the desired lactam 134 and the N-benzyl protected lactam 138 
(approx. 50:50 ratio) was formed. This is summarised in scheme 66. 
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(a) BuLi, THF; C 2H5COC1; (b) Bu 213OTf, Et3N, DCM, 0 °C, (15 mins), cooled to -78 °C; 73 in DCM 
at -78 °C; (c) (MeO)N(Me)H.HCI, A1Me 3, THF, -30 °C–room temp.--30 °C; 132, THF -30 
'C—room temp.; (d) 10% Pd/C, H 2, MeOH 
Scheme 66 
With the lactam 134 in hand we were able to apply the same reaction 
parameters that afforded nectrisine to the synthesis of its C 3Me analogue. Thus, 
protection of the secondary hydroxyl group as its TBS ether and Boc protection of 
the nitrogen atom afforded fully protected lactam 139. From here reduction with 
Super Hydride® provided 133, which was subsequently treated with 6N HC1, thus 
effecting the removal of all of the protecting groups (as observed by t.1.c.). A final 
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ion-exchange purification using Dowex 1 X2 (Off) failed to provide the C3Me 
analogue of nectrisine, no material was recovered from the ion-exchange resin, 
scheme 67, and unfortunately time did not permit further attempts to isolate the 
desired imine. 
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(a) TBSOTf, 2,6-lutidine, DCM; (b) Boc 20, Et3N, DMAP, DCM; (c) LiEt3BH, THF, -78 °C; (d) 6N 
HCl, THF; (e) Dowex 1X2 (Off) 
Scheme 67 
2.6.1 Deprotection of Lactam 134 
It occurred to us that deprotected lactams 115 and 140 might also be of 
biological interest. The deprotection of lactam 114 to give 115 is documented in 
section 2.4.1 through a protocol involving hydrofluoric acid. We, therefore, 
deprotected lactam 134 using tert-butylammoniumfluoride (TBAF) (another 
popular desilylating agent)' 15  which is far less toxic than hydrofluoric acid. The 
deprotection proceeded cleanly affording lactam 140, scheme 68 in excellent yield. 
The deprotection of lactam 114 was also attempted using TBAF, however, purification of the 
deprotected lactam 115 was found to be much more tedious than with the HF protocol. 
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Scheme 68 
2.7 Summary of Chapter 2 
We have successfully completed the synthesis of the natural product 
nectrisine 36 with an excellent overall chemical yield (31%, 12 steps). The aldol 
reaction that generated the desired stereochemical relationships between both the 
hydroxyl and amino groups was thoroughly investigated and found to be the 
'matched' case. The 'mismatched' reaction was found to be capable of generating the 
opposite syn aldol adduct with excellent diastereoselectivity. Finally, the synthesis of 
the C3Me analogue of nectrisine 58 was undertaken. Disappointingly, the synthesis 
failed to provide the desired compound at the final stage. We are confident, however, 
that if more time had been available this situation would have been rectified and the 
synthesis of 58 would have been achieved. 
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Chapter 3 : Results and Discussion Part 2 
The Synthesis of 1,4-Dideoxy-1,4-imino-D-arabinitol (DAB!) 
3.1 Application of Lactam Methodology to DAB1 Synthesis 
As discussed in chapter 2, it soon became clear that lactam 114, was 
potentially, a very useful intermediate in the synthesis of pyrrolidine type 
iminosugars. The powerful aldol methodology used in connection with aldehyde 73 
allowed the construction of this lactam in a highly stereocontrolled manner. 
Subsequent selective reductions of this lactam should, therefore, allow access to 
either the amino alcohol (as in nectrisine synthesis) or to the amine oxidation state. 
Chapter 2 details the reduction of lactam 114 to the amino alcohol oxidation 
state with subsequent elaboration of this amino alcohol to the desired natural product. 
Our attention was then, unsurprisingly, focused on the possibility that reduction of 
lactam 114 to the amine would permit the efficacious synthesis of our second 
synthetic target DAB 1 35. A brief retrosynthetic analysis, scheme 67, shows our 
proposed synthetic strategy, which we also wished to expand to include the synthesis 
of the C4Me analogue of DAB 1 from lactam 134. 
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3.1.1 Forward Synthesis of DAB] and its C 4Me Analogue 
The synthesis of DAB 1 effectively starts from lactam 114, the synthesis of 
which required 8 synthetic steps (50% overall yield) and is discussed in chapter 2. 
We believed that the use of borane75b  or lithium aluminium hydride  75a  would allow 
reduction of the carbonyl group to provide the amine. Reduction of such lactams 
with these reagents has been documented in the literature. 
Treatment of lactam 114 with borane.THF complex provided the 
corresponding amine in quantitative yield. All that remained was a final deprotection. 
This was initially attempted with TBAF in THF; however, it proved impossible to 
purify the natural product, as it appeared to co-run with TBAF on silica gel. Ion-
exchange chromatography was also unsuccessful in purifying the reaction mixture. 
We therefore ventured to deprotect amine 141 using hydrofluoric acid (HF). 
Treatment of 114 with HF" 6 rapidly afforded the deprotected compound. Moreover, 
excess fluoride was removed by treating the concentrated reaction mixture with 
methoxytrimethyl silane (excess fluoride reacts with this reagent to generate 
trimethylsilyifluoride, the boiling point of which is approx. 15 °C, this can then be 
removed conveniently by rotary 17 High Rf impurities were removed 
simply by trituration to give DAB 1 35 as its hydrofluoride salt in quantitative yield. 
This is shown in scheme 69 along with the reaction scheme that afforded the C4Me 
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analogue 57. The HF salts were subjected to ion-exchange chromatography (Dowex 
1 X2 (Off)) to give the free bases of 35 and 57. 
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57 R = Me 
(a) BH3 9THF, THF, reflux; (b) HF (48% aqueous), MeCN; (c) Dowex (Off) 
Scheme 57 
3.1.2 Structure Confirmation 
In order to confirm that we had indeed synthesised DAB 1 a comparison of 
35.HF, with literature physical data for DAB 1 .HC1 from several reports was 
made. 72c75bS  This is summarised in Tables 8 and 9. It can be seen that NMR details 
for the HF salt of 35 are in excellent agreement with those reported for the HC1 salt 
of DAB 1. 
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Table 8 Comparison of'H NMR data with HF salt of 35 
Source Form MHz C2H C3H C4H C5HA C5HB C6HA C6HB 
Ref HC1 salt 300 3.62 4.10 4.34 3.37 3.58 3.84 3.96 
118 
Ref HC1 salt 400 3.65 4.13 4.36 3.39 3.60 3.86 3.98 
72c 
Ref HC1 salt 300 3.55 4.02 4.26 3.29 3.51 3.76 3.88 
75b 
35 HF salt 600 3.61 4.12 4.36 3.38 3.61 3.86 3.98 
Mult. / J (Hz) 
Ref ddd, 8.4, dd, 4. 1, dd, 4.6, dd, dd, dd, dd, 
118 4.6, 4.1 2.5 2.6 12.7, 12.7, 12.3, 12.3, 
2.6 4.6 8.4 4.6 
Ref dt, 8.4, t, 3.4 dd, 4.7, dd, dd, dd, dd, 
72c 4.2 2.8 12.5, 12.6, 12.2, 12.2, 
2.8 4.7 8.3 4.7 
Ref ddd, 8. 1, dd, 3.6, ddd, dd, dd, dd, dd, 
75b 5.7, 3.9 3.3 4.5, 3.3, 12.6, 12.6, 12.3, 12.0, 
2.4 2.4 4.5 8.1 5.7 
35 dt, 8.2, t, 3.7 dd, 5.0, dd, dd, dd, dd, 
4.2 2.7 12.6, 12.6, 12.2, 12.2, 
2.7 5.0 8.2 4.6 
Table 9 Comparison of43C NMR data with HF salt 35 
Source 	Form 	MHz & 
Ref 118 	HClsalt 	100.5 76.4 75.1 67.4 59.7 50.8 
Ref 72c 	HCI salt 	100.5 78.5 77.1 69.4 61.7 52.8 
Ref 75b 	HCI salt 	75 75.7 74.3 66.5 58.9 50.0 
35 	HF salt 	62.9 75.5 74.2 66.6 58.9 49.9 
Note: data for references 118 & 72c show consistent deviations compared with ref 75b and 35, which 
could be due to referencing differences. 
Comparison with data for the free base is shown in Tables 10 and 11. Most 
reports have concentrated on supplying data for the HC1 salt, however, data for the 
free base of 35 correlates well with data from the original paper on DAB l's 
isolation, 68  which served to establish its structure. 
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Table 10 Comparison of'HNMR data with free base of35 
Source 	MHz 	C2H 	C3H C4H 	CSHA 	C5HB 	CSHA 	C6HB 
Ref 68 	400 	2.87 	3.70 4.01 	2.72 	2.99 	3.53 	3.60 
35 	600 	2.99 	3.85 4.16 	2.84 	3.12 	3.67 	3.75 
Mult. / J (Hz) 
Ref 68 	ddd, 6.4, 	dd, 5.3, 3.7 	dd, 5.8, 3.7 	dd, dd, dd, dd, 
5.3,4.9 	 12.1, 12.1, 11.6, 11.6, 
3.8 5.8 6.4 4.9 
35 	 dt6.1, 	dd,5.3,3.9 	dd,5.8,3.9 	dd, dd, dd, dd, 
4.8 	 12.2, 12.2, 11.6, 11.6, 
3.9 5.8 6.4 4.8 
Note: the deviations in chemical shift for each signal are approx. constant. This might be due to 
referencing differences, or, it has come to our attention that the 'H NMR signals for DAB1 are very 
pH dependant and this may also account for these deviations. " 9 
Table 11 Comparison of'3C NMR data with free base of35 
Source MIHz 
Ref 68 	75.4 	79.9 	78.4 	66.4 	62.9 	51.6 
35 	62.9 	79.9 	77.4 	65.0 	62.0 	50.4 
Comparisons with reported optical rotations 70,72b,72c  were also made and are 
summarised in Table 12. 
Table 12 Comparison of Optical Rotation data with 35 
Source Form [a]0 
Ref 70 HC1 salt + 37.9 (c=0.53, H20) 
Ref 70 Free base +7.8 (c=0.46, H20) 
Ref 72b HC1 salt + 34.7 (c=0.78, H20) 
Ref 72b Free base +8.1 (c=0.98,H20) 
Ref 72c HC1 salt + 27.3 (c=0.47, H20) 
35 HF salt + 26.3 (c=0.30, 1120) 
35 Free base +8.2 (c=0.25, H20) 
Thus we were confident that we had indeed synthesised the desired natural 
product DAB1 35. This synthesis represents a highly efficient synthetic route, the 
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target compound being synthesised with an overall yield of 50% (10 steps). Its C4Me 
analogue was also synthesised in a highly efficient manner (65% overall, 10 steps). 
The stereochemical assignment of 57 was made by analogy to the glycolate aldol 
process. 
3.2 Summary of Natural Product Synthesis 
As demonstrated in this and the previous chapter, we have developed highly 
efficient syntheses of the natural products DAB 1 35 and nectrisine 36. Both natural 
products originating from selective reductions of the carbonyl function of lactam 
114. We have also extended this methodology to encompass the synthesis of the 
C4Me analogue of DAB 1 57. Additionally, the precursor to the C 3Me analogue of 
nectrisine 58 was also prepared. Both were accessed by judicious choice of aldol 
partner (glycolate or propionate equivalent) with aldehyde 73. 
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Chapter 4 : Results and Discussion Part 3 
Synthesis of Lactam 114 via Osmium Catalysed Dihydroxylation 
With the success of the boron mediated aldol reaction in generating the 
desired syn-hydroxyl stereochemistry required for the synthesis of DAB 1 and 
nectrisine (via lactam 114), we sought to probe how effective an osmium tetroxide 
dihydroxylation protocol might be in generating lactam 114. 
4.1 Retrosynthetic Analysis of Lactam 114 
Scheme 58 represents a retrosynthesis of lactam 114, encompassing a 
dihydroxylation protocol that would generate the desired syn-diol stereochemistry. 
We believed that E-olefin 144 would be a good candidate for osmium catalysed 
dihydroxylation, since generation of such olefins can conveniently be achieved by 
exploiting the Horner-Wadsworth-Emmons reaction. In this case aldehyde 73 and 
commercially available trimethylphosphonoacetate 145 are required to undergo 
reaction to provide compound 144. From here we believed formation of Weinreb 
amide 142 followed by hydrogenolysis of the N-benzyl protecting groups (vide 
supra) would provide lactam 114. 
77 























0 	 NBn2 
II 
(MeO)2P + 	H.OTBDPS 
CO2Me 	0 
145 	 73 
Scheme 58 
4.2 The Horner-Wadsworth-Emmons Reaction 
The Horner-Wadsworth-Emmons (HWE) reaction, a variant of the Wittig 
reaction, is an extremely versatile method for the formation of a,1 3-unsaturated 
compounds from phosphonates, 148. It has several advantages over the Wittig 
reaction, in that the ylides derived from phosphonates are more reactive than the 
corresponding ylides derived from phosphoranes (Wittig reaction). In addition the 
phosphorus by-product is a phosphate ester and hence soluble in water, unlike, 
triphenylphosphine oxide (the by-product of a Wittig reaction) making purification 
of the reaction mixtures more straightforward. The mechanism of the reaction is 
summarised in scheme 59. The phosphoryl-stabilised carbanion attacks the carbonyl 
in a stepwise manner, to give oxyanion intermediates 147a and b,' 2° which then 
decompose via transient four centred oxyphosphetane intermediates 146a and b' 2 ' to 
yield the olefin. The stereochemistry is determined by a combination of the 
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stereoselectivity in the initial C-C bond forming step, and perhaps, reversibility of 
the intermediates. Several different types of reaction parameters have been developed 
to form predominantly either E or Z olefins. 121 
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4.2.1 Barium Hydroxide Mediated HWE Reaction and Aldehyde 73 
Paterson et. al. found that the use of barium hydroxide as a base in the HWE 
reaction was an extremely mild and effective way of carrying out the reaction. 122  E-
olefins were obtained exclusively and the barium hydroxide caused no epimerisation 
of base sensitive aldehydes. The microcrystalline structure of the barium hydroxide 
was found to be crucial to its activity, and C200 barium hydroxide (produced by 
heating Ba(OH)2.8H20 at 200 °C for 3 hours) 123  was discovered to be the most active 
form. Paterson also found that heating commercial Ba(OH) 2 .8H20 at 100-140 °C for 
2 hours gave good results in HWE reactions. 
We were attracted to these mild conditions, believing that they would be ideal 
for use with aldehyde 73. Thus treatment of trimethylphosphonoacetate 145 with 
barium hydroxide followed by addition of aldehyde 73 lead to the formation of E-
a,-unsaturated ester 144 exclusively, scheme 60, (the E-geometry of the olefin was 
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determined via 'H NMR spectroscopy. The C2H-C3H coupling constant was 
measured at 15.9Hz).' 
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(a) activated Ba(OH) 2, THFIH20 (40:1); 73, THFIH20 (40:1), room temperature 
Scheme 60 
Although the conditions employed in the reaction were mild we decided to 
check that the stereochemical integrity of the cc-position was not being compromised 
by prolonged exposure to barium hydroxide. The aldehyde was thus stirred for 24 
hours (typical length of time for the HWE reaction) in the presence of barium 
hydroxide (in THF/H20 (40:1)) before being reduced to the corresponding alcohol 72 
(as in section 2.2.1). The enantiomeric excess of the alcohol was measured by chiral 
HPLC and was gratifyingly found to be >98%e.e. We were, therefore, confident that 
olefin 144 was being formed without any epimerisation at the C 4 position. 
4.3 Osmium Catalysed Dihydroxylation 
Dihydroxylation of an olefin using osmium tetroxide is a stereospecific 
reaction in which a syn-diol is produced. 124  Classically the osmium tetroxide would 
be used in stoichiometric quantities which would be costly and would cause 
increased exposure to this highly toxic oxidant. Catalytic osmylation utilising sodium 
or potassium chlorate' 25 or hydrogen peroxide 126  to regenerate the osmium tetroxide 
can be useful but frequently results in over oxidation of the newly formed diol to 
provide a-ketols. These problems have been overcome by the development of a 
Vicmal coupling constants for Z-olefins are generally in the range 6-14 Hz (typical iyiO Hz). 
Coupling constants for E-olefins are generally in the range 14-20Hz (typically 16 Hz) 
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catalytic osmylation process, which uses tertiary amine oxides (in particular, N-
methylmorpholine N-oxide (NMO) 149)127  to regenerate the oxidant. This method 
has become the most widely used catalytic osmylation method. The process is 
exemplified in scheme 61. The dihydroxylation of cyclohexene is shown here as an 
example, proceeding through osmate ester intermediate 150. One advantage of 
dihydroxylation using osmium tetroxide is that it is a very general reaction, electron 
rich, electron-deficient, and electronically 'neutral' alkenes will all undergo reaction, 
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The precise mechanism for the formation of osmate ester intermediates of the 
type 150 is a source of contention and is still under debate.  129 Two paths generating 
the same intermediate have been hypothesised and are shown in scheme 62. In the 
first a concerted [3 + 2] cycloaddition in the presence of an amine ligand (L) (known 
to accelerate osmium tetroxide dihydroxylations)' 3° gives the osmate ester. In the 
second proposal a stepwise [2 + 2] cycloaddition provides the same ester. 
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Scheme 61 
4.3.1 Osmium Catalysed Dihydroxylation of 144 
We were initially uncertain as to what the outcome of the osmium catalysed 
dihydroxylation reaction with 144 would be. Others have previously reported low 
facial bias in related reactions of allylic amine derivatives. ' 30' 131 However, Reetz has 
recently performed this reaction on both Boc protected and NN-dibenzyl protected 
allylic amines of the type 151, which are very similar in structure to 144.132  Reetz 
found that depending on the protecting group used, the reaction could be biased 
towards a particular diastereomer (thus demonstrating the concept of protecting 
group tuning), scheme 62. 
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Boc protected derivatives favoured diastereomers of the type 152 with 
diastereoselectivities ranging form 51:49 to 81:19. The use of NN-dibenzyl 
protection resulted in predominant formation of the diastereomers with the opposite 
sense, of the type 153, with slightly better diastereoselectivities, in the range 24:76 to 
8:92. The sense of diastereoselectivity in the Boc protected derivatives is the same as 
in the well studied cases of stereoselective dihydroxylation reactions of allylic 
alcohols and ethers. Reetz has shown that these dihydroxylations are in keeping with 
the Stork-Houk model scheme 63. 
0s04 







R group prefers sterically least 
encumbered position 
Scheme 63 
In the absence of detailed mechanistic studies it is currently difficult to 
explain the results obtained when dihydroxylations were carried out on NN-dibenzyl 
protected derivatives. Nevertheless, it is clear that changing protecting groups can 
have a marked effect on the outcome of the reaction. 
Compound 144 was thus subjected to standard osmium catalysed 
dihydroxylation conditions (0s04, NMO). We found it necessary to employ up to 18 
mol% of 0s04 in order to shorten the reaction time. (1 mol% - 7 days for 100% 
conversion; 18 mol% - 5 hours for 100% conversion). The diastereomeric ratio was 
not affected by the increased amounts of osmium tetroxide. The reaction gave a 
mixture of diastereomers which were readily separable by column chromatography 
in a ratio of 65:35 in favour of diastereomer 154 in moderate overall yield, scheme 
64. 
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(a) Os04, NMO, acetone/water (8:1) 
Scheme 64 
Compound 154 was isolated as a crystalline solid and its structure was 
unambiguously determined by single crystal X-ray diffraction, figure 1. These 
results are, therefore, in keeping with those reported by Reetz. Thus, the 
dihydroxylation reaction has preferentially produced the opposite diastereomer to 
that required for the synthesis of lactam 114. 
Figure 1 x-ray crystal structure of 154 
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We believed that by using the procedure developed by Sharpless, using chiral 
amine ligands, we would, hopefully, be able to effect the outcome of the reaction 
through reagent control. 
4.4 Sharpless Asymmetric Dihydroxylation 
It is well known that prochiral substrates such as aldehydes, ketones, alkenes 
or dienes having at least one stereogenic centre react with achiral reagents or 
catalysts to provide two possible diastereomeric products. Ideally, variation of 
reagents, solvents or reaction conditions should allow access to either diastereomer. 
If the asymmetric induction is poor inspite of such efforts, the principle of double 
stereodifferentiation using chiral reagents or catalysts offers a way out of this 
synthetic dilemma. 97 
The Sharpless asymmetric dihydroxylation (AD) is an extremely efficient way 
of carrying out enantioselective dihydroxylations. Developments in this reaction 133 
by Sharpless pinnacled with the introduction of the pair of chiral amine ligands 155 
and 156 in 1992.134  The ligands are constructed around a phthalazine core ustilising 
dihydroquinidine (DHQD) or dihydroquinine (DHQ), which are both commercially 







Ligand used in AD-mix- Ligand used in AD-mix- a 
Scheme 65 
Dihydroxylations using these ligands are carried out using potassium 
ferricyanide as co-oxidant in conjunction with osmium tetroxide. Mixtures of these 
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components are now commercially available, AD-mix-a (with DHQD ligand) and 
AD-mix-13 (with DHQ ligand), and their use in natural product synthesis has been 
well documented. 135  A full mechanistic understanding of the Sharpless asymmetric 
dihydroxylation process is not yet available and there is still considerable debate over 
certain aspects of the reaction. For instance Corey has recently provided evidence, 
through X-ray crystallographic studies, that a U-shaped enzyme-like binding pocket 
exists and that this is crucial to the enantioselective dihydroxylation of olefins. 136  The 
group of Sharpless has however rejected this model. 137 
A simple pictorial 'working model' for the catalytic site, which at least 
accounts for the experimentally observed selectivity has been developed and is 
shown in scheme 66. The olefin is orientated to minimise steric interactions with the 
catalyst. Once this is achieved the chiral osmium tetroxide catalysts' attack the olefin 
with facial selectivity dependent on which chiral ligand is used. Thus as depicted, 
AD-mix-3 delivers the hydroxyl groups from the top face and AD-mix-(X delivers the 
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Scheme 66 
4.4.1 Sharpless Asymmetric Dihydroxylation 01144 
The use of the chiral dihydroxylation reagents AD-mix-cc and AD-mix-P in 
the dihydroxylation of a,3-unsaturated ester 144 brings about, once again, the 
possibility of having 'matched' and 'mismatched' stereochemical outcomes. Since 
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the dihydroxylation reaction using achiral osmium tetroxide gave predominantly 154, 
scheme 64, then the AD-mix which would also generate this diastereomer would 
clearly represent the 'matched' case and we would therefore expect to obtain higher 
degrees of diasteroselectivity. However, for an efficient synthesis of lactam 114 by 
this dihydroxylation method we would need to generate diastereomer 143 
predominantly. The appropriate AD-mix would be required to override the intrinsic 
diastereoinduction observed in the reaction with achiral osmium tetroxide and this 
would therefore represent a 'mismatched' reaction. 
On subjecting 144 to analysis using the above mnemonic device it is clear that 
AD-mix-a should generate diastereomer 154 and therefore should represent the 
'matched'case. AD-mix-13 should generate diastereomer 143 predominantly and 
accordingly in a 'mismatched' fashion, scheme 67. 
AD-m&.- OH NBn2 
AD-mix- P MeOL1OTBDPS 
0 OH 
143 






The results of the dihydroxylation of 144 with both AD-mixes-a and P are 
summarised in scheme 68 and table 13. When AD-mix-P was used a reversal of 
diastereoselectivity compared with the achiral case was indeed observed (68:32 in 
favour of 143). Surprisingly, AD-mix-a provided no enhancement of the intrinsic 
diastereoselection of the reaction and provided diols 143 and 154 with the same 
diastereoselectivity as was found in the achiral case. Moreover, both reactions were 
frustratingly sluggish and after 7 days reaction time only 28% of 144 had reacted 
(72% of starting material recovered) in the case of AD-mix-a. In the case of AD- 
87 
Results and Discussion III 
mix-n better conversions were observed, however, 25% of 144 still remained 
unreacted after 7 days. (Note: the use of methane sulfonamide in such reactions has 
been shown to increase the rate of osmate ester hydrolysis for non-terminal olefins, 






MeO ,....OTBDPS 	 + 




(a) AD-mix-a or 3, MeS0 2NH2, Acetone/Water (3:1) 
Scheme 68 
Table 13 
AD-mix 	% Conversion 	Yield 	143:154 
a 	 28% 	 65% 	34:66 
75% 	 68% 	68:32 
'Yields based on recovered starting material 
As can be seen the Sharpless asymmetric dihydroxylation was of moderate 
use in generating desired diol 143. The reasons for the sluggish reactions, and lower 
than expected diastereoselectivity in the case of AD-mix-a, are difficult to explain 
and might possibly be due to steric complications. Electronic factors may also have 
some part to play, as it is well known that electronically rich olefins react at a faster 
rate than electron poor olefins, with 0s04. Indeed, in a brief examination of the 
achiral dihydroxylation reaction (0s0 4, NMO) involving the coresponding allylic 
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alcohol of 144, scheme 69, we observed much faster rates for the reaction compared 
with the a,3 unsaturated ester (completion of reaction within 24 hours with only 1 
mol% 0s04). Hence, removal of the deactivating ester functionality appears to 
drastically improve the rate of reaction. 
NBn2 
HO ,-,.OTBDPS 
(obtained from LiAIH 4 






Approx. 3:1 mixture of inseparable 
diastereomers 
(a) 0s04, NMO, acetone/water (8:1) 
Scheme 69 
There have been similar reports of poorer than expected levels of 
diastereoselectivity and conversions in AD-mix catalysed dihydroxylations.75b It is 
perhaps worth noting that in the achiral dihydroxylation of 144 the addition of more 
osmium tetroxide increased the rate of the reaction considerably. It may be possible 
to optimise conditions for the asymmetric variant in order to gain increased olefin 
conversion via increasing the amount of osmium tetroxide and of course chiral ligand 
present in each AD-mix. 138 Time, however, did not permit further investigations into 
this reaction. 
4.5 Formation of Lactams 114 and 128 From Diols 143 and 154 
Synthesis of lactams 114 and 128 was expected to proceed without incident 
and indeed this was the case. Formation of Weinreb amides 142 and 157 under 
previously described conditions proceeded with excellent yields over a 24 hour 
reaction period. The Weinreb amides were subsequently subjected to hydrogenolysis 
conditions (Pd(OH)2/C) which lead to spontaneous cyclisation and generation of the 
desired lactams, scheme 70. 
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154 	 157 	 128 
(a) (MeO)N(Me)H.HC1, A1Me 3, THF, -30 °C-room temp.-*30 °C; 143/154, THF -30 'C—room 
temp; (b) Pd(OH) 2/C, H2, MeOH 
Scheme 70 
Since the crystal structure of 154 has been determined it is now very clear that 
this stereochemical arrangement gives rise to lactam 128 and by default the 
stereochemical arrangement in 143 and therefore aldol adduct 102 must give rise to 
lactam 114. Thus providing further evidence that the correct stereochemistry was 
indeed assigned to lactam 114 and hence aldol adduct 102. 
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Chapter 5 : Results and Discussion Part 4 
Further Applications of Serine Aldehyde 73 to Natural Product 
Synthesis 
5.1 Application to Hydantocidin Analogue Synthesis 
During our initial synthetic work on the synthesis of nectrisine 36 we had 
focused on generating amino aldehyde intermediate 112. In order to do this we had 
envisaged the aldehyde moiety coming from either a reductive protocol (from the 
corresponding Weinreb amide) or, perhaps, an oxidative protocol (from the 
corresponding primary alcohol), scheme 71. Eventually, the synthesis of nectrisine 
as discussed in chapter 2 turned out to the most successful method of generating the 
natural product. However, the failings of our studies directed toward the synthesis of 
amino aldehyde 112 led to the interesting discovery that hydantocidin analogues 
could be synthesised via aldehyde 73. 
Me OP NBn2 
N 	-L OThDPS 
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Hydantocidin 158, scheme 72, was isolated from the fermentation broth of 
Streptomyces hygrocopicus and provided the first example of a spirohydantoin 
nucleus at the anomeric position of a sugar. 139  Because of the potent herbicidal and 
plant growth regulatory activity 140 considerable interest has been shown in the 
synthesis hydantocidin and its stereoisomers by aldol,' 4 ' dihydroxylation,' 42 and 
other procedures. 143  Various deoxyhydantocidins have also been described.
144  As yet 
no proposal has been made for the mode of action of hydantocidin. 




5.1.1 Attempts to Generate Nectrisine via a Reductive Protocol 
We have learned in chapter 2 that deberizylation of Weinreb amide 110 to 
yield the free amine was impossible due to spontaneous lactamisation. We therefore, 
ventured that reduction of the Weinreb amide moiety to the aldehyde functionality 
followed by hydrogenolysis of the benzyl protecting groups might be more effectual 
in generating nectrisine via intermediate amino aldehyde 112. We believed that the 
amino aldehyde would be reactive enough to cyclise rapidly on generation. This 
would therefore provide the corresponding lactol 118. We were, however, unsure 
how stable this lactol would be. If dehydration occurred under the hydrogenation 
conditions then the likelihood would be that further reduction of the resulting imine 
would occur, thus yielding the corresponding amine 141. If this did happen, 
however, all would not have been lost, as this would still represent an attractive route 
toward the synthesis of our second natural product target, DAB1 35. These initial 
thoughts are summarised in scheme 73. 
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Reduction of Weinreb amides to aldehydes was discussed in chapter 2, 
section 2.1. Thus, treatment of Weinreb amide 110 with DIBAL-H at -78 °C led to 
the smooth formation of the desired aldehyde 159 in excellent yield, scheme 74. The 
aldehyde was slightly unstable to silica gel, in that heating a sample of the aldehyde 
on a t.l.c. plate with the aid of a heat gun led to the sample quickly turning brown on 
the plate. Column chromatography was carried out as quickly as possible and the 
aldehyde was isolated as a single diastereomer. The optical integrity of the a-
position was, however, of some concern. A sample of the aldehyde was left in acidic 
deuterochioroform for a period of ca. 72 hours. Re-examination of the 'H NMR 
spectrum showed that the sample was now a mixture of inseparable diastereomers 
(approximately 92:8 ratio). The aldehyde could, however, be stored at -20 °C for at 
least one month without showing any signs of epimerisation. 
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The hydrogenation reaction (in the presence of 20% Pd(OH)2/C) scheme 75, 
was, however, extremely disappointing. The starting material slowly reacted to give 
a multi-component reaction mixture, by t.l.c. None of the desired product(s) could be 






(a) Pd(OH) 2/C, H2, MeOH 
Scheme 75 
5.1.2 Attempts to Generate Nectrisine via an Oxidative Protocol 
A retrosynthetic analysis of nectrisine showing our proposed route, 
encompassing an oxidative method of generating desired amino aldehyde 112 is 
shown in scheme 76. We believed that aldol adduct 161 would be more useful in this 
synthetic scheme than adduct 102. This reasoning was due to the fact that we were 
sure we could remove the p-methoxybenzyl (PMB) group from this aldol adduct and 
replace it with a TBS ether, at the same time protecting the neighbouring free 
hydroxyl group. Reduction of aldol adduct 162 to yield a primary hydroxyl group, 
followed by debenzylation would provide compound 163 (we believed that O-benzyl 
protecting groups would also be cleaved under these conditions and would 
subsequently present problems in the oxidation step, hence replacement with the 
TBS group). Oxidation of the primary hydroxyl and cyclisation would provide, after 
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dehydration, imine 164. The silyl ether protecting groups could then be removed in 
one step to afford nectrisine. 










TBSO 	NBn2 	 Debenzylation 	TBSO 	NH2 
	
HO ,lOTBDPS < 	HO JOTBDPS 





TBSO NBn2 	 PMBO NBn2 
Remove PMB 
01N (' (K 
OTBDPS Re-protected as>TBS o
oTBDPs 
162 	 161 
Ph 
OPMB 
O1NJ + 73 
160 
Scheme 76 
The PMB protected chiral glycolate equivalent 160 was synthesised in an 
analogous manner to equivalent 101. Thus, bromoacetic acid was condensed with the 
sodium salt of p-methoxybenzylalcohol to provide p-methoxybenzyloxyacetic acid 
165. Conversion of 165 to the unsymmetrical anhydride derived from 
pivaloylchloride and reaction with lithiated 106 provided 160 in excellent yield, 
scheme 77. 104b 
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(a) NaH, PMBOH, THF, reflux; (b) 165, pivaloylchloride, Et3N, THF, -78 °C (c) 106, BuLi, THF, -78 
oc 
Scheme 77 
The ensuing aldol reaction between 160 and 73 (scheme 78) provided the 
desired syn aldol adduct 161 in good yield as a single diastereomer (the relative C2-
C3 syn stereochemistry was assigned, as before, on the basis of 1 1-1 NMR coupling 
constants; the C2 proton was a clear doublet at 5.37 ppm, J = 2.7 Hz). The Felkin-
Anh selectivity was made on the basis of precedent (chapter 2). It is worth noting 
that this aldol reaction had to be performed within very strict reaction parameters. 145 
The reaction was performed in toluene (no aldol adduct was detected when DCM 
was the solvent) and enolisation temperatures had to be maintained between -30 and 
-50 °C to obtain good yields of the aldol adduct 161. 
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Ph 	 Ph 
J •Sj 




0 0 0 0 OH 
160 	 161 
(a) Bu2BOTf, Et3N, toluene, -50 °C--30 °C—'-78 °C; 73 in toluene at -78 °C 
Scheme 78 
5.1.3 Attempted Removal ofp-Methoxybenzyl Protection 
The next course of action was to be removal of the PMB protecting group. 
Initially we believed that this would be a straightforward process. The literature is 
replete with examples of oxidative removal of PMB groups utilising the reagent 
DDQ (2,3-dichloro-5,6-dicyano-1,4-benzoquinone). 831 Reaction of aldol adduct 161 
with 1.3 equivalents of DDQ did not, however, provide any of the de-protected 
product. The reaction was quenched after 1 hour, and t.l.c. showed that the reaction 
mixture was essentially starting material, however, two other components were 
apparent. Separation of these components was easily achieved by column 
chromatography to provide recovered starting material, oxazolidin-2-one 106 and 
aldehyde 166. In a separate experiment conducted under the same conditions but 
over a 24 hour period no aldehyde was detected and t.l.c. analysis showed that 
several other components were now present. NMR and IR suggested that oxidation 
of the N-benzyl protecting groups was now occurring along with oxidation of the 
aldehyde to the carboxylic acid functionality, scheme 79. At present we are unable to 
explain these results. 
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(a) DDQ, DCMIH20 (9: 1 ), 1-24 hours 
Scheme 79 
Aldehyde 166 could also be generated via reduction of Weinreb amide 167 
using DIBAL-H at -78 °C, scheme 80. The aldehyde obtained was identical in all 
respects to the aldehyde synthesised from aldol adduct 161 (vide supra). 
Me OPMBNBn2 	 OPMBNBn2 





0 OH 0 OH 
167 	 166 
(a) (MeO)N(Me)H.HC1, A1Me 3 , -30 'C—room temp.--30 °C; 161, -30 °C–room temp. (b) DIBAL-
H, toluene, -78 °C, 15 mins 
Scheme 80 
5.1.4 Retention of PMB Group in the Synthesis of an Hydantocidin Analogue 
With the apparent failure in removing the PMB group from aldol adduct 161 
we decided to continue with our synthetic plan, however, retaining the PMB group. 
TBS protection of the free secondary hydroxyl group was undertaken utilising 
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TBSOTf in the presence of 2,6-lutidine to provide the protected aldol adduct 168 in 
quantitative yield. It is worth noting that prolonged reaction times (24 hours) 
generated small traces (ca. 5%) of the PMB de-protected compound 170 (presumably 
caused by the presence of triflic acid from hydrolysed TBSOTO. Short reaction times 
(3 hours) completely prevented this. Reductive cleavage of the oxazolidin-2-one 
chiral auxiliary using lithium borohydride, as described by Evans, 85b  proceeded 
without incident to afford alcohol 169 in excellent yield (scheme 81) along with 




o 0 OTBS 
170 
(a), 24 hours 
Ca. 5% 
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(a) TBSOTf, 2,6-lutidme, DCM; (b) LiBH 4, THF, MeOH 
Scheme 81 
We had initially believed that debenzylation of the N-benzyl groups, under 
hydrogenolysis conditions, would also cleave any O-benzyl protecting groups 
(including OPMB) (hence our earlier attempt to remove the PMB group in order to 
replace it with a TBS ether). However, we decided to continue with the 
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hydrogenolysis protocol and address any issues regarding oxidation of the primary 
hydroxyl in the presence of a secondary hydroxyl group at a later date, if required. 
As it turned out exposure of 169 to a hydrogen atmosphere in the presence of 
Peariman's catalyst effectively removed the N-benzyl protecting groups without 
cleaving the p-methoxybenzyl group to give 171 in excellent yield, scheme 82. This 
result was slightly surprising but fortunate as it meant we no longer had to address 
the issue of oxidising a primary hydroxyl group in the presence of both a secondary 
alcohol and a secondary amine. 





HO 	 OTBDPS 
OTBS 
171 
(a) Pd(OH)2/C, H2, MeOH 
Scheme 82 
5.1.5 IBX Oxidation ofAmino Alcohol 171 
There has been considerable interest, during the last decade or so, in 
hypervalent iodine derivatives due to their recognised versatility in preparative 
organic synthesis. 41,146  Of the various iodo-based reagents, the Dess-Martin 
periodinane (DMP) 172 (scheme 83) has attracted particular attention because it is 
one of the mildest reagents available for the oxidation of alcohols to carbonyls. 
Recently, the iodinane oxides 173 (o-IodoxyBenzoic Acid (IBX))' 47 and 174148  have 
been used to convert alcohols to aldehydes. These iodinane oxides seem to share 
some oxidising properties with DMP, for example, they all oxidise primary alcohols 
to aldehydes without over oxidation to carboxylic acids. In fact, it has also been 
claimed 148  that 174 is the actual oxidant in aged but still effective batches of DMP. 
However IBX differs from DMP in the oxidation of 1,2-diols. DMP cleaves the 
glycol bond whereas IBX oxidises them to ct-ketols or a-diketones without cleavage 
of the 1,2-diol bond. 
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Scheme 83 
IBX has been utilised to a much lesser extent than DMP due, in the most part, 
to its insolubility in common organic solvents. However, the discovery that IBX was 
readily soluble in DMSO and that THF could be used as a co-solvent for DMSO 
insoluble compounds has led to an increase in use of this oxidant, and it is now seen 
an extremely important addition to the repertoire of oxidising agents presently 
available. 
IBX was synthesised by Garnet Howells according to the published procedure 






(a) KBr03 , H2SO4  (0.7 M), 70 °C, 3.5 hours 
Scheme 84 
We were attracted to the use of IBX in the oxidation of the primary hydroxyl 
group of amino alcohol 171 as a result of a report that showed it to selectively 
oxidise primary alcohols in the presence of primary, secondary and tertiary 
amines. 150 Thus to a clear solution of one equivalent of IBX in DMSO (the IBX 
solubilises after Ca. 15 minutes) was added a solution of 171 in THE After 
approximately 15 minutes t.l.c. showed that the starting material had been 
completely consumed and a new spot had appeared. Careful analysis of this 
compound showed that it was not the desired lactol, which would have been formed 
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via oxidation of the primary hydroxyl, but the cyclic sugar 176a present as a 3:2 
mixture of anomers. Thus, contrary to literature precedent oxidation of the amine has 
occurred. The resulting imine 175 was presumably then trapped by the primary 
hydroxyl group to afford 176a, scheme 85, (in a very clean reaction no other 
oxidation products were observed). 
Although one might expect hydrolysis of amine 176a to occur in the presence 
of water, 151  evidence for the retention of the nitrogen atom can be seem in the high 
resolution mass spectrum (176a-C3 5H52NO5 Si2 [M+H]' within 0.12 ppm vs 
C35H5006Si2 [M], with 38 ppm deviation). Whilst the 13C NMR signal for the 
anomeric carbon atom is perhaps higher than might be anticipated, similar stable 
anomeric amines have been observed by Fleet,' 52a  through reduction of azide 
precursors. Furthermore, the facile oxidation of secondary amines to imines using a 
hypervalent iodine species has previously been reported. 152b 
Further evidence for the trapping of imine intermediates can also be seen in 
the work of Fleet towards the synthesis of 5-epihydantocidin 153 and other analogues 
of hydantocidin.' 54 In these examples the imine intermediates were generated by 
azide disproportionation in the presence of TPAP' 53 and by NBS oxidation of an 
amine, 154 respectively. 
To confirm that 176a was indeed the proposed anomeric amine a small 
portion of the compound was reacted with phenyl isocyanate. After flash column 
chromatography the urea 176b was isolated in a pure form. The stereochemical 
relationship at the anomeric position was assigned on the basis of 'H NMR nOe 
experiments. Signals for the urea NH protons were clearly visible in the 'H NMR 
spectrum (at 7.71 and 5.17 ppm), the formation of the urea was further confirmed by 
JR and HRMS. A 'H NMR of the crude reaction mixture also showed the presence of 
the diastereomeric urea, however, this could not be isolated in a pure form. 
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(a) IBX, DMSO, TFIF; (b) PhNCO, THF 
Scheme 85 
Although this result was disappointing from the point of view that nectrisine 
could not be synthesised in this manner, it is clear that 176b is structurally similar to 
the sugar core of hydantocidin 158. Formation of the hydantoin ring would, 
therefore, provide us with an analogue of hydantocidin 177 that might be of 
biological interest. This, therefore, turned out to be a most useful discovery. 
Unfortunately, further studies into the formation of the hydantoin ring and 
completion of the synthesis of the analogue was not possible due to time constraints. 
However, this chemistry is at present being actively pursued within the Hulme group, 
along with the synthesis of other analogues of hydantocidin. 
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5.2 Use of Propionate Aldol Adduct 136 to Provide Another 
Potential Hydantocidin Analogue 
The chemistry developed in the above example was expanded to include the 
propionate aldol adduct 136. The same chemistry was utilised and is shown in 
scheme 86. Due to time constraints the synthesis of amino alcohol 180 was not 
optimised and full characterisation of 180 and 181 was not possible, however, NMR 
data strongly supported their synthesis. 
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(a) TBSOTf, 2,6-lutidine, DCM; (b) LiBH 4, THF, MeOH; (c) Pd(OH) 2/C, H2, MeOH; (d) IBX, 
DMSO, 180, THF 
Scheme 86 
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5.3 Use of an Asymmetric Chromium Mediated Reformatsky 
Reaction in the Synthesis of a Lactacystin Analogue 
Lactacystin 182 is a microbial product first isolated by Omura et. al.  152  and 
found to be a remarkably selective and potent inactivator of the 20S proteosome. 
Because of this and the scarcity of naturally derived 182 there has been intense 
interest in the synthesis of 182 and its analogues.  153  Corey subsequently found that 
the gem-dimethyl analogue 183 was an even more potent inhibitor. 154 
HO2C NHAc 





We believed that the methodology which allowed for the formation of lactams 
114 and 134 would be useful in a synthetic strategy directed toward lactacystin 
analogues of the type 183. Directing our synthesis, initially, towards this gem-
dimethyl analogue would negate the need to control the relative stereochemistry 
between the C6 and C 7 substituents (synthesis of 182 would require an anti aldol type 
reaction to generate the required stereochemistry). However, in order to generate the 
required anti-Felkin-Anh stereochemical relationship between substituents at the C 5 
and C6 positions a 'mismatched' aldol type process would be required. Our initial 
goal was, therefore, to efficiently generate lactam 184, scheme 88. 
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The above retrosynthetic analysis highlights the chemistry which we believed 
would generate the desired lactam 184. As before, hydrogenolysis of Weinreb amide 
185 should lead to the desired lactam which, it was thought, would be attainable 
from aldol adduct 186. The synthesis of 186 would be achieved via an asymmetric 
chromium mediated Reformatsky reaction, between the chromium enolate of 187 and 
ent-73. 
5.3.1 The Asymmetric Chromium Mediated Reformatsky Reaction 
The introduction of a quaternary centre in the asymmetric Evans boron 
mediated aldol reaction has been shown to be problematic, in that ring opening of the 
oxazolidin-2-one as shown in scheme 89 is known to occur generating oxazinediones 
of the type 188. 155  
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(a) (i) Bu 2BOTf, Et3N, (ii) PhCHO 
Scheme 89 
Utilising other types of auxiliaries, for example, imidazolidin-2-ones, 156 can 
prevent this. However, we wished to continue utilising the Evans type oxazolidin-2-
ones, and instead, overcome this problem by generating the desired aldol adduct via 
an asymmetric chromium mediated Reformatsky reaction, recently developed by 
Wessjohann.' 57 
The Reformatsky reaction, scheme 90, like the aldol reaction, can be regarded 
as a two step reaction with formation of an enolate (traditionally using Zn) 189 and 
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Wessjohann recently reported that the reaction of a-bromo ester 191 with 
isobutyraldehyde or benzaldehyde in the presence of CrC1 2 and Lil gave good yields 
of -hydroxy esters 192 and 193, scheme 91 (this has now been greatly expanded 
upon to include many other types of bromo compounds and reaction partners). 160d 
The traditional Reformatsky reaction using zinc, in general, suffers from low 
reactivity of the zinc species (use of activated zinc can be useful) 158  and poor 
reproducibility. The chromium mediated Reformatsky reaction was, on the other 
hand, found to be capable of generating aldol adducts with reproducible yields, 
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excellent chemoselectivity, and also, without any retro-reaction, 1601' which is a 
drawback of many base catalysed aldolisations. 






191 	 192 	 193 R = Pr or Ph 
(a) CrC12, LII, THF 
Scheme 91 
Additionally, the reaction produced predominantly anti aldol adducts 192, 
with relatively low selectivities. This was explained by invoking the Zimmerman-
Traxler model 194, scheme 92, in which a slight preference for the E-enolate exists, 
providing anti diastereomers 192. 
1,3-pseudo diaxial interaction 







Wessjohann has subsequently shown that it is possible, under these 
conditions, to introduce quaternary centres to aldol adducts in an asymmetric fashion. 
Using Evans oxazolidin-2-one chiral equivalent ent-187, 160 ' the corresponding aldol 
adduct 195 was generated as a single diastereomer, scheme 93, with the absolute 
stereocontrol being determined by the chirality of the auxiliary, in the same manner 
as the previously discussed boron mediated aldol reaction, chapter 2. However, the 
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problem associated in generating such aldol adducts with asymmetric boron-enolate 
chemistry (ring opening of oxazolidin-2-one, described above) was not observed. 
0 0 	 0 0 OH OMe 
MeO 	o 	(a) 
OMe ON Bt + 	
76% \- 
' I 
Ph 	 Ph 
ent-187 	 195 
(a) CrC12, Lii, TI-IF 
Scheme 93 
5.3.2 Asymmetric Chromium Mediated Reformatsky Reaction with Aldehyde 73 
We believed that the high levels of stereoselectivity observed for the 
'mismatched' boron mediated aldol reaction (scheme 62) between the boron-enolate 
of ent-101 and 73 might also be observed in the chromium mediated Reformatsky 
reaction. For the correct absolute stereochemistry (generating 186) this would require 
a reaction between the chromium-enolate of 187 and ent-73 (a 'mismatched' 
reaction, by analogy with the boron aldol process). 
Initially, however, we chose to perform the reaction with the chromium-
enolate of 187 and aldehyde 73, which we believed would give the Felkin-Anh type 
product and represent the 'matched' reaction. This was in order to ascertain whether 
the chromium Reformatsky reaction would be compatible with aldehyde 73, and if 
so, how selective it would be compared with the 'matched' boron mediated aldol 
process. 
The reaction of lithiated 106 and 2-bromo-2-methylpropionylbromide 196 
provided chiral component 187 in excellent yield, scheme 94. 
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(a) BuLi, THF, -78'C; 196 
Scheme 94 
Reaction between 187 and 73 in the presence of CrC12 and LiI in THF 
cleanly afforded the desired aldol adduct as a single diastereomer in good yield. The 
Felkin-Anh stereochemistry was assigned by analogy to the previously described 
boron mediated aldol process. The quality of the CrC12 was found to be crucial. Aged 
samples, inevitably, contained some of the oxidised Cr(III) species which resulted in 
lower isolated yields of the desired adduct. As a result all manipulations involving 
chromium (II) chloride were carried out in a glove bag under an argon atmosphere. 
Good supplies of chromium (II) chloride resulted in reproducibly good yields for the 
reaction, scheme 95. 
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0 0 OH 
186 
187 
(a) CrC12, Lii, 73, THF, room temperature 
Scheme 95 
Addition of lithium iodide results in clean reactions and higher yields. The effect of its addition 
includes general Lewis acid and nucleophilic iodide catalysis. However, the main influence of its 
addition is thought to be through its ability to solubilise and modify the nature of the chromium 
dichloride. The active species has been proposed by Wessjohann to be a Li 2[CrX4L2] species or 
similar complex. 
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Attempts to generate Weinreb amide 185 under the usual transamination 
conditions (A1Me3/(MeO)N(Me)H.HC1) was unsuccessful. Formed in quantitative 
yield, the product from the reaction was discovered to be oxazine-2,4-dione 197. 
This must have been the result of attack from the secondary hydroxyl group onto the 
A1Me3 activated oxazolidin-2-one carbonyl group, as shown in scheme 96. This 

















(a) (Me0)N(Me)H.HC1, A1Me 3 , THF, -30'C—room temp.--30 °C; 186, THF, -30'C—room temp. 
Scheme 96 
As a result of this we decided to investigate whether lactamisation (to 
generate the desired lactam 184) would be possible through debenzylation of aldol 
adduct 186. We believed that the hindered exo-cyclic carbonyl group would allow for 
the removal of both benzyl protecting groups before cyclisation could take place. 
However, exposure of 186 to a hydrogen atmosphere in the presence of Pearlman's 
catalyst, disappointingly, afforded only the N-benzyl protected lactam 198 in good 
yield, scheme 97. Once again, prolonged exposure to hydrogen under these 
conditions did not result in the desired deprotected lactam being formed. 
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(a) Pd(OH) 2/C, H2, MeOH 
Scheme 97 
Clearly the failing of this route was due to the unsuitability of the Evans chiral 
oxazolidin-2-one. The formation of oxazinediones is documented in boron mediated 
aldol reactions of Evans oxazolidin-2-ones, as described at the beginning of this 
section. However, circumvention of this problem via the successful use of a 
chromium mediated Reformatsky reaction inevitably proved futile, with formation of 
the undesired oxazine-2,4-dione 197 taking place in the next stage of the synthesis. 
We believe that the use of alternative chiral auxiliaries, for example, 
imidazolidin-2-ones, of the type 199 (mentioned previously) or the 'SuperQuat' type 
auxiliaries 200 developed by Davies'  59  might prove to be more successful, scheme 
98. The carbonyl group of these auxiliaries is more resistant to nucleophilic attack, 
compared with Evans type oxazolidin-2-ones, as a result of electronic (increased 
deactivation of carbonyl by N-Me moiety in 199) and steric (5,5-dimethyl substituent 
of SuperQuats hinders approach of nucleophile) factors respectively. Unfortunately, 
time did not permit further investigations. 
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Chapter 6 : Experimental 
6.1 General Experimental 
'H nuclear magnetic resonance (NMR) spectra were recorded using an internal 
deuterium lock for the indicated reference at ambient probe temperatures on Varian 
Gemini 200 (200 MHz), Bruker AC250 (250 MHz), Bruker AM360 (360 MHz) or 
Varian Inova 600 (600 MHz) Fourier transform instruments. The data is presented as 
follows: chemical shift (in ppm on the ö scale relative to 6 Tms = 0), integration, 
multiplicity (s = singlet, d = doublet, t = triplet, q = quartet, qn = quintet, m = 
multiplet, br = broad), coupling constant and the interpretation. ' 3C NMR spectra 
were recorded using an internal deuterium lock for the indicated reference at ambient 
probe temperatures on Varian Gemini 200 (50.3 MHz), Bruker AC250 (62.9 MHz) 
or Bruker AM360 (90.6 MHz) instruments and are reported in ppm on the 5 scale. 
Infra-red spectra were recorded on a Biorad FTS-7 or a Perkin Elmer Paragon 
1000 FT-JR instrument using 5 mm sodium chloride plates, or 0.1 mm sodium 
chloride solution cells. The wavelengths of maximum absorbance (V.,) are quoted in 
cm 1 . 
Fast atom bombardment (FAB) mass spectra were performed on a Kratos 
MS50TC mass spectrometer. Electron impact (El) mass spectra were performed on a 
Finnigan 4500 mass spectrometer. The parent ion or relevant fragment are quoted, 
followed by significant fragments and their relative intensities. 
Optical rotations were measured on an AA-1000 polarimeter with a path 
length of 1.0 dm at the sodium D line (589 run) and are reported as follows: [a]D, 
concentration (c in gIlOO cm'), and solvent. All optical rotations were measured at a 
temperature of 23 °C. 
Elemental analysis was carried out on a Perkin Elmer 2400 CNN Elemental 
analyser. T.l.c. was performed on Merck 60F 254 (0.25 mm) glass backed silica plates 
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and visualised by ultraviolet (UV) light and/or ammonium molybdate stain. 9 Flash 
column chromatography was carried out on Merck Kieselgel 60 (Merck 9385) under 
positive pressure by means of a hand pump. Eluent compositions are quoted as v/v 
ratios. Chiral high performance liquid chromatography (HPLC) was carried out on a 
Waters 786 instrument with a Chiracel OD column (internal diameter 4.6 mm) 
equipped with a UV detector. A standard flow rate of 0.5 cm3/min was used. All 
HPLC samples were filtered through 0.45 tm nylon syringe filters prior to analysis. 
All solvents used for HPLC analysis were vacuum filtered and degassed prior to use. 
Reagents were purified by standard means. 163  Dichioromethane (DCM), 
dimethylformamide (DMF), triethylamine, diisoproylethylamine and 2,6-lutidine 
were distilled from calcium hydride and stored over calcium hydride under an argon 
atmosphere. Tetrahydrofuran (THF) was distilled from sodium metallbenzophenone 
ketyl and stored under an argon atmosphere. Acetyl and propionyl chloride were 
distilled immediately prior to use. All other reagents were used as supplied. 
All experiments were performed in an inert atmosphere of argon under 
anhydrous conditions using oven dried apparatus cooled in a desiccator or flame 
dried under argon prior to use. Standard techniques for the handling of air-sensitive 
materials were employed. 161 
11 Ammonium molybdate dip prepared as follows: to water (950 cm') was added concentrated sulfuric 
acid (50 cm') followed by ammomium molybdate (50 g) and ceric sulfate (3 g). The mixture was 
stirred until all solid material had disappeared and a bright yellow solution remained. 
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Methyl (2R)-2-amino-3-hydroxypropanoate.hydrochloride 65 
NH2 HCI 
MeO,, 3 OH 
Acetyl chloride (56.1 g, 50.8 cm3, 0.71 mol) was added dropwise to methanol (300 
cm') at 0 °C. The mixture was stirred for Ca. 15 mins and D-Serine (25.0 g, 0.24 mol) 
was then added portionwise to the solution. The resulting mixture was heated to 
reflux and held at reflux for 3 hours. Concentration under reduced pressure provided 
the title compound (36.2 g, 98%) as a solid. Recrystallisation from methanol 
provided an analytical sample, mp 164-166 °C; [cx] -8.9 (c 0.64, MeOH) [lit., 
(Aldrich) mp 163-166 °C, [aID  -4.0 (c 4.0, EtOH)]; 8H  (200 MHz, D 20) 4.13 (111, t, J 
3.8, CA,  3.95 (1H, dd, J 12.7, 4. 1, C3HAHB), 3.83 (1H, dd, J 12.7, 3.5, C3HAHB), 
3.70 (3H, s, OMe); & (50.3 MHz) 168.6, 58.8, 54.3, 53.3; (Found : C, 30.57; H, 
6.33; N, 8.79. C4H9NO3 .HC1 requires C, 30.87; H, 6.43; N, 9.00%). 
Methyl (2S)-2-amino-3-hydroxypropanoate.hydrochloride ent-65 
Synthesised in an analogous manner to the (R)-isomer, from L-serine. Thus, acetyl 
chloride (4.1 cm', 57.6 mmol), methanol (25 cm') and L-serine (2.0 g, 18.9 mmol) 
gave the title compound (2.8 g, 95%) as a colourless crystalline solid, mp 163 °C 




Methyl (2R)-2-dibenzylamino-3-hydroxypropanoate 66 
NBn2 
Me0 3 0H 
To a solution of D-serine methylester.hydrochloride (15.0 g, 96.5 mmol) in 
anhydrous acetonitrile (240 cm) was added potassium carbonate (66.6 g, 0.48 mol) 
followed by benzyl bromide (41.1 g, 28.6cm3, 0.24 mol). The mixture was stirred for 
24 hours. Water (3 00cm3) was added and the aqueous phase was extracted with 
EtOAc (3 x 300 CM)  . The combined organic extracts were dried and concentrated 
under reduced pressure. The remaining residue was chromatographed on silica gel 
[hexane:EtOAc (4:1)] to give the title compound (27.5 g, 95%) as an oil, Rf 
[hexane:EtOAc (5:1)] 0.23; [aID  +174.6 (c 0.8, CHC13); Vm (neat)/cm' 3455, 3061, 
3028, 2950, 2844, 1731, 1491, 1453; oH (200 MHz, CDC13) 7.39-7.21 (1011, m, 
ArH), 3.92 (2H, d, J 13.4, NCHAHBPh x 2) 3.80 (311, s, OMe), 3.80-3.69 (2H, m, C2H 
+ CHXHYOH), 3.69 (211, d, J 13.4, NCHAHBPh x 2), 3.59 (1H, dd, J 15.0, 7.5, 
CHXHYOH), 2.58 (111, brs, 011); O (50.3 MHz) 171.1, 138.6 (2C), 128.9 (4C), 128.4 
(4C), 127.3 (2C), 61.6, 59.2, 54.6 (2C), 51.2; m/z (FAB) 299 ([M+H], 59%), 268 
(100), 240 (96), 181 (41), 92 (41); HRMS (FAB) (C 18H21NO3 requires 299.1521, 
found 299.1576). 
Methyl (2S)-2-dibenzylamino-3-hydroxypropanoate ent-66 
Synthesised in analogous manner to the (R)-isomer from ent-65. Thus, ent-65 (2.21 
g, 14.6 mmol), potassium carbonate (9.75 g, 70.5 mmol) and benzyl bromide (4.2 
cm3, 35.4 mmol) in acetonitrile (45 cm) gave the title compound (4.08 g, 94%) as a 
colourless oil, [a]D  -127.7 (c 1. 1, CHC13). 
117 
Experimental 
Methyl (2R)-3-t-butyldimethylsilyloxy-2-dibenzylaminopropanoate 67 
NBn2 
MeO 3 OTBS 
0 	j 
To a solution of ester 66 (3.86 g, 12.8 mmol) and tert-butyldimethyilsilyl chloride 
(3.85 g, 25.6 mmol) in anhydrous DMF (20 cm') was added imidazole (3.50 g, 51.2 
mmol). The mixture was stirred for 18 hours. Brine (150 cm') was added and the 
aqueous phase was extracted with DCM (3 x 150cm). The combined organic 
extracts were dried and concentrated under reduced pressure. The residue was 
chromatographed on silica gel [hexane:EtOAc (5:1)] to give the title compound (5.21 
g, 99%) as a colourless oil, R f [hexane:EtOAc (4:1)] 0.83; [aID +49.6 (c 1.35, 
CHC13); Vm (neat)/cm' 1737, 1602, 1585, 1494; oH (200 MHz, CDC13) 7.42-7.19 
(10H, m, ArH), 4.00 (1H, dd, J 9.8, 6.6, CHAHBOTBS), 3.97 (2H, d, J 13.9, 
NCHXHYPh x 2), 3.88 (1H, dd, J 9.7, 6.2, CHAHBOTBS), 3.75 (3H, s, OMe), 3.67 
(2H, d, J 14.0, NCHXHYPII x 2), 3.56 (1H, dd-t, J6.1, C21]), 0.86 (9H, s, tBu),  0.00 
(6H, s, Me x 2); O (50.3 MHz) 172.0, 139.8 (2C), 128.6 (4C), 128.1 (4C), 126.8 
(2C), 62.8, 62.5, 55.3 (2C), 50.9, 25.6 (3C), 17.9, -5.8 (2C); mlz (FAB) 413 
([M+H], 11%), 354 (29), 268 (26), 91(100), 73 (72); HRMS (FAB) (C 24H35NO3 Si 
requires 413.2386, found 413.2421). 
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Attempted synthesis of Aldehyde 68 via DIBAL-H reduction of Ester 67 
NBn2 
H 1 ,,OTBS 
General Procedure: 
To a solution of ester 67 in toluene or THF at either -78, -89, or -98 °C was added 
diisobutylaluminium hydride (1 equivalent (1.0 Min toluene)). The resulting solution 
was stirred until the starting material had been consumed (by t.l.c.). The reaction was 
quenched at the reaction temperature by addition of methanol and allowed to warm to 
room temperature. The resulting mixture was then poured onto a rapidly stirred 
biphasic mixture of saturated aqueous sodium potassium tartrate solution and DCM 
and stirred for 1 hour. In each case t.l.c. and 'H NMR showed that the aldehyde was 
not formed as the sole product. It was also discovered that the aldehyde was 
extremely unstable to silica gel and as a result the reaction mixtures were not purified 
further. 
(2S)-2-Dibenzylamino-3-lert-butyldimethylsilyloxypropan-1-ol 69 and 2-
Dibenzylaminopropan-1,3-diol 70 from reduction of TBS ester 67 
NBn2 	 NBn2 
HO... OTBS 
LIA1H4 Procedure: 
To a suspension of lithium aluminium hydride (20 mg, 0.53 mmol) in THF (4 cm3) at 
-78 °C was added ester 67 (100 mg, 0.24 mmol) in THF (4 cm 3) at -78 °C. The 
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resulting mixture was stirred at -78 °C for 3 hours. The reaction was quenched by 
sequential addition of water (1 cm'), 15% aqueous sodium hydroxide solution (1 
cm3) and finally, water (1 CM)  . The organic phase was separated and the aqueous 
phase was extracted with diethyl ether (3 x 10 CM)  . The combined organic extracts 
were dried and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (5:1)—*(1:1)] to elute first the desired 
alcohol 69 (45 mg, 48%) as a colourless oil, followed by the undesired meso diol 
impurity 70 (28 mg, 42%) as a colourless solid. 
DIBAL-H Procedure: 
To a solution of ester 67 (100 mg, 0.24 mmol) in toluene (3 cm') at -78 °C was added 
diisobutylaluminium hydride (0.53 cm', (1.0 M in toluene), 0.53 mmol). The reaction 
mixture was stirred at -78 °C for 40 minutes. The reaction was quenched by addition 
of methanol (0.5 cm3) and allowed to warm to room temperature before being diluted 
with DCM (10 CM)  . A saturated aqueous solution of sodium potassium tartrate (10 
cm 3)  was added and the resulting mixture was stirred vigorously for 3 hours. The 
organic phase was separated and the aqueous phase was extracted with DCM (3 x 10 
cm3). The combined organic extracts were dried and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
(5:1 )-(1:1)] to elute first the desired alcohol 69 (67 mg, 76%) followed by the meso 
diol 70 (12 mg, 18%). 
Data for alcohol 69: 
Obtained as colourless oil, 
Rf [hexane:EtOAc (5:1)] 0.38; [aID  —66.8 (c 0.6, CHC13); V m  (neat)/cm' 3451, 1601, 
1492; 6H  (200 MHz, CDC13) 7.27-7.10 (10H, m, ArH), 3.82 (2H, d, J 13.2, 
NCHAHBPh x 2), 3.77 (1H, dd, J 10.6, 5.9, CHX HY OTBS), 3.64 (1H, dd, J 10.6, 5.9, 
CHXHY OTBS), 3.57 (2H, d, J 13.5, NCHAHBPh x 2), 3.50-3.45 (2H, m, CH20H), 
2.98-2.89 (1H, m, CA,  2.84 (1H, brs, OH), 0.84 (9H, s, tBu),  0.00 (6H, 5, Me x 2); 
120 
Experimental 
c (50.3 MHz) 139.5 (2C), 128.8 (4C), 128.3 (4C), 127.0 (2C), 60.8, 59.6, 59.4, 53.9 
(2C), 25.7 (3C), 18.0, -5.7 (2C); mlz (FAB) 386 ([M+H], 57%), 354 (49), 296 (17), 
240 (55), 91(100), 73 (93); HRMS (FAB) (C 23H35NO2Si requires 386.2515, found 
386.2515). 
Data for diol 70: 
Obtained as a colourless solid, 
Rf [hexane:EtOAc(1:1)] 0.24; mp 83-85 °C; Vm (neat)/cm' 3324, 1602, 1584,1493; 
c (200 MHz, CDC1 3) 7.40-7.11 (1 OH, m, ArH), 3.78 (4H, s, NCH2Ph x 2), 3.74 (2H, 
dd, J 11.0, 7.7, CHXHYOH x 2), 3.61 (2H, dd, J 11.0, 5.7, CHXHYOH x 2), 3.00 (1H, 
ft, J 7.7, 5.8, C21]), 2.69 (2H, brs, OH x 2); 3 (50.3 MHz) 139.2 (2C), 128.9 (4C), 
128.4 (4C), 127.2 (2C), 59.9, 59.7 (2C), 53.9 (2C); mlz (FAB) 272 ([M+H]F,  60%), 
240 (55), 182 (18), 105 (17), 91(100), 73 (23); HRMS (FAB) (C I7H2INO2 requires 
272.165 1, found 272.1650). 
Methyl (2R)-3-tert-butyldiphenylsilyloxy-2-dibenzylaminopropanoate 71 
NBn2 
MeO OTBDPS 
To a solution of ester 66 (11.4 g, 37.8 mmol) and tert-butyldiphenylsilyl chloride 
(20.8 g, 19.7 cm', 75.6 mmol) in anhydrous DMF (60 cm) was added imidazole 
(10.5 g, 151.2 mmol). The mixture was stirred for 18 hours. Brine (150 cm) was 
added and the aqueous phase was extracted with DCM (3 x 150cm). The combined 
organic extracts were dried and concentrated under reduced pressure. The residue 
was chromatographed on silica gel [hexane:EtOAc (15:1)] to give the title compound 
(20.42 g, 100%) as a colourless oil, Rf [hexane:EtOAc (10:1)] 0.77; [a] 1, +30.9 (c 
2.22, CHCL3); Vm  (neat)/cm' 3060, 2948, 1734, 1592, 1455; 8H(200 MHz, CDC13) 
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7.67-7.22 (20H, m, ArH), 4.06 (1H, dd, J 10.2, 6.2, CHAHBOTBDPS), 4.03 (2H, d, J 
14.3, NCHXHYPh x 2), 4.00 (1H, dd, 10.2, 6.2, CH AHBOTBDPS), 3.77 (2H, d, J 14.3, 
NCHXHYPh x 2), 3.76 (3H, s, OMe), 3.70 (1H, t, J6.2, CA,  1.05 (9H, s, tBu) ; 
(62.9 MHz) 171.8, 139.6 (2C), 135.4 (4C), 133.0 (2C), 129.5 (2C), 128.5 (4C), 128.1 
(4C), 127.5 (4C), 126.8 (2C), 63.2, 62.8, 55.3 (2C), 51.0, 26.5 (3C), 19.0, mlz (FAB) 
537 (Mt, 100%), 478 (40), 268 (35), 135 (25); HRMS (FAB) (C 34H39NO3 Si requires 
537.2699, found 537.2721). 
Methyl (28)-3-tert-butyldiphenylsilyloxy-2-dibenzylaminopropanoate ent-71 
Synthesised in an analogous manner to the (R)-isomer from ent-66. Thus, ent-66 
(2.11 g, 6.86 mmol), tert-butyldiphenylsilyichioride (3.77 g, 1.37 mmol) and 
imida.zole (1.87 g, 2.74 mmol) in DMF (11 cm') gave the title compound (3.75 g, 




To a solution of ester 71 (3.0g, 5.6 mmol) in anhydrous toluene (20 cm 3) at -78 °C 
was added diisobutylaluminium hydride (14.0 cm3 , ( 1.OM in toluene), 14.0 mmol). 
The mixture was stirred at -78 °C for 30 minutes then quenched by dropwise addition 
of methanol (ca. 10 cm'). The resulting mixture was allowed to warm to room 
temperature and diluted with DCM (100 cm'). A saturated aqueous solution of 
sodium potassium tartrate (75 cm) was added and the biphasic mixture was stirred 
vigorously for 3 hours by which time two clear phases were apparent. The organic 
phase was separated and the aqueous phase was extracted with DCM (3 x 100 CM). 
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The combined organic extracts were dried and concentrated under reduced pressure. 
The remaining residue was chromatographed on silica gel [hexane:EtOAc (5:1)], to 
give the title compound (2.64 g, 93%) as a colourless oil, Rf [hexane:EtOAc (5:1)] 
0.38; [a]D  -58.4 (c 1.15, CHC13); Vm (neat)/cm' 3451, 3061, 3028, 2933, 2858, 
1593, 1456; 6H (200 MHz, CDC1 3) 7.74-7.19 (20H, m, An]), 3.90 (1H, dd, J 10.7, 
6.0, CHAHBOTBDPS), 3.88 (2H, d, J 13.4, NCHXHYPh x 2), 3.75 (1H, dd, J 10.7, 
6.0, CHAHBOTBDPS), 3.61 (2H, d, J 13.4, NCHXHYPh x 2), 3.58 (2H, d, J 7.5 
C 1 H2), 3.10 (in, ddd, J7.4, 6.0, 6.0, C2H), 2.92 (1H, brs, OH), 1.10 (9H, s, tBu); & 
(62.9 MHz) 139.4 (2C), 135.5 (4C), 132.9 (2C), 129.8 (2C), 129.7 (2C), 128.8 (4C), 
128.3 (4C), 127.7 (4C), 61.3, 59.9, 59.4, 53.9 (2C), 26.7 (3C), 19.0; mlz (FAB) 510 
([M+H], 91%), 480 (92), 240 (99), 197 (100), 77 (50); HRMS (FAB) (C 33H4ONO2Si 
requires 510.2828, found 510.2829). 
(2R)-3-tert-Butyldiphenylsilyloxy-2-dibenzylaminopropan-1-ol ent- 72 
Synthesised in an analogous manner to the (5)-isomer from ent-71. Thus, ent-71 
(1.02 g, 1.88 mmol) and diisobutylaluminium hydride (3.95 cm', (1.5 Min toluene), 
5.63 mmol) in toluene (4.0 cm) gave the title compound (878 mg, 91 %) as a 
colourless oil, [a] D  +45.2 (c 1.06, CHCI3). 
Via Reduction of Aldehyde 73: 
To a solution of aldehyde 73 (78 mg, 0.15 mmol) in toluene (1 cm 3) at -78 °C was 
added diisobutylaluminium hydride (0.21 cm', (1.0 M in toluene), 0.21 mmol). The 
mixture was stirred at -78 °C for 5 mins. The reaction was quenched by the sequential 
addition of water (50 itl), aqueous sodium hydroxide (50 tl, 1.0 Al) and water (1 
cm3). The resulting mixture was allowed to warm to room temperature and extracted 
with DCM (3 x 2 CM)  . The combined organic extracts were dried and concentrated 
under reduced pressure. The remaining residue was chromatographed on silica gel 
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[hexane:EtOAc (5:1)] to give alcohol 72 (70 mg, 90%) as a colourless oil, HPLC 
[hexane:propan-2-ol (19:1)] (S enantiomer) R = 5.2 minutes, (R enantiomer) R = 6.2 
minutes, >98% e.e. 
(2R)-3-tert-Butyldiphenylsilyloxy-2-dibenzylaminopropanal 73 
NBn2 
H 3 OTBDPS 
To a solution of oxalyl chloride (0.45 g, 0.31 cm3, 3.6 mmol) in anhydrous DCM 
(15 cm3) at -78 °C was added a solution of DMSO (0.57 g, 0.43 cm3 , 4.5 mmol) in 
DCM (0.5 cm3) dropwise. The mixture was stirred for ca. 5 minutes when it became 
cloudy. A solution of the alcohol 72 (1.57 g, 3.08 mmol) in DCM (5.0 cm3) at -78 °C 
was introduced via caimula. The resulting clear solution was stirred at -78 °C for 1 
hour. Triethylamine (1.20 g, 1.63 cm 3 , 11.72 mmol) was added and the resulting 
cloudy solution was allowed to warm to room temperature over ca. 15 minutes. 
Water (10 cm) was added producing two clear phases. The organic phase was 
separated and the aqueous phase was extracted with DCM (3 x 10 CM)  . The 
combined organic extracts were washed sequentially with 1% HC1 (20 CM),  water 
(20 CM)  , a saturated aqueous solution of sodium bicarbonate (20 cm 3) and brine (20 
cm 3),  then dried and concentrated under reduced pressure to give the title compound 
(1.56 g, 100%) as a very pale yellow oil which was used in subsequent stages 
without further purification, R f [hexane:EtOAc (5:1)] 0.66; Vm  (neat)/cm-1 3068, 
3028, 2930, 2856, 2711, 1731, 1427,1112; 8. (200 MHz, CDC13) 9.80 (1H, s, COIl), 
7.76-7.26 (20H, m, ArH), 4.16 (1H, dd, J 11.0, 5.6, CHAHBOTBDPS), 4.09 (1H, dd, 
J 11.0, 5.6, CHAHBOTBDPS), 3.98 (2H, d, J 13.9, NCHXHYPh x 2), 3.90 (2H, d, J 
13.9, NCHXHYPh x 2), 3.52 (1H, t, J 5.8, C2H), oc  (50.3 MHz) 202.8, 139.3 (2C), 
135.6 (2C), 135.5 (2C), 132.8, 132.7, 129.8 (2C), 128.6 (4C), 128.3 (4C), 127.7 (4C), 








To a mixture of L-phenylalanine (80.0 g, 0.48 mol) and sodium borohydride (43.7 g, 
1.15 mol) in sodium dried THF (750 cm3) at 0 °C was added a solution of iodine (122 
g, 0.48 mol) in sodium dried THF (250 CM)  . After gas evolution had ceased the 
resulting mixture was heated to reflux and held at reflux for 18 hours. The mixture 
was cooled to 0 °C and the remaining sodium borohydride was quenched by careful 
addition of methanol (-80 CM)  . The resulting clear solution was stirred for 30 mins 
before being concentrated under reduced pressure to a colourless paste. This paste 
was taken up into 20% aqueous potassium hydroxide solution (1.0 L) and stirred at 
room temperature for 18 hours. The mixture was extracted with DCM (3 x 750 cm) 
and the combined organic extracts were dried and concentrated under reduced 
pressure to a colourless solid which was recrystallised from toluene to give the title 
compound (60.8 g, 84%) as a colourless crystalline solid, mp 91-93 °C; [aID  -22.9 (c 
1.2, EtOH) [lit.,83d  mp 89.5-91.5 °C, [aID  -24.7 (c 1.03, EtOH)]; Vm (CHC13 
soln.)/cm 1 3679, 3623, 3368, 1580, 1520, 1498; oH (200 MHz, CDCI3) 7.33-7.09 
(5H, m, ArR), 3.59 (1H, dd, J 10.6, 3.5, C IHAHB), 3.37 (1H, dd, J 10.6, 7.3, C I HAHB), 
3.09 (1H, dddd, J 8.8, 7.3, 5.0, 3.5, CA,  2.77 (1H, dd, J 13.6, 5.0, C3HH), 2.63 
(2H, brs, NH2), 2.49 (1H, dd, J 13.6, 8.8, C3HHy); 8c(50.3 MHz) 138.5, 128.9 (2C), 
128.3 (2C), 126.2, 65.6, 53.9, 40.2, mlz (FAB) 152 ([M+H], 100%), 91(40), 77 (5). 




To a solution of L-phenylalanine (5.0 g, 30.3 mmol) in THF (15 cm') was added 
borontrifluoridesetherate (3.73 cm', 30.3 mmol). The mixture was heated to reflux 
and held at reflux for 1 hour, by which time all solid material had dissolved. The 
temperature of the reaction mixture was then lowered to just below reflux and 
borane.dimethylsulfide (30.3 cm 3, ( 1.0 M in DCM), 30.3 mmol) was added 
dropwise. Hydrogen evolution was observed and dimethylsulfide was allowed to 
distil off as it was liberated. The solution was then heated to reflux and held at reflux 
for 6 hours. The reaction mixture was cooled to 0 °C and the remaing borane was 
quenched by careful addition of THF/water (1:1) (10 CM)  . Aqueous sodium 
hydroxide (25 cm3 , 5.0 M) was added and the reaction mixture was heated to reflux 
and held at reflux for 16 hours. Concentration under reduced pressure removed THF 
and the remaining aqueous mother liquor was extracted with DCM (5 x 20 cm'). The 
combined organic extracts were dried and concentrated under reduced pressure to 
give a solid which was recrystallised from EtOAc to give the title compound (3.05 g, 
67%) as colourless needles, mp 92-94 °C; all spectroscopic data was identical to the 





Synthesised in an analogous manner to (2S)-2-amino-3-phenylmethylpropan-1-ol 
from D-phenylalanine. Thus D-phenylalanine (20.0 g, 0.12 mol), sodium 
borohydride (10.93 g, 0.29 mol) and iodine (30.5g, 0.12 mol) in THF (250 cm') gave 
after recrystallisation from toluene the title compound (13.9 g, 76%) as a colourless 
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crystalline solid, mp 87-89 °C, [aID  +22.3 (c 1.0, EtOH) [lit., 165 mp 88-89 °C, [aID 
+22.1 (c 1.5, EtOH)]. 
Evans Route: 
Synthesised in an analogous manner from D-phenylalanine (5.0 g, 30.3 mmol), 
borontrifluoride.etherate (3.73 cm 3, 30.3 mmol) and borane.dimethylsulfide (30.3 
cm 3,  (1.0 Min DCM), 30.3 mmol) in THF (15 cm) to give the title compound (2.91 





A dry 1L 3-necked flask equipped with a thermometer and a 45 cm Vigreaux 
distillation column was charged with S-phenylalaninol 107 (48.5 g, 0.32 mol), 
potassium carbonate (4.4 g, 0.032 mol) and diethyl carbonate (79.0 cm 3 , 0.65 mol). 
The mixture was carefully heated to 135-140 °C and ethanol was allowed to distil off 
as it was formed (over ca. 2 hours). The reaction mixture was allowed to cool to 
room temperature and diluted with DCM (800 cm'). Potassium carbonate was 
removed by filtration and the organic phase was washed with a saturated aqueous 
solution of sodium bicarbonate (400 cm 3) before being dried and concentrated under 
reduced pressure. The residue crystallised on standing and recrystallisation from 
[hexane:EtOAc] provided the title compound (47.3 g, 86%) as colourless needles, mp 
87-88 °C; [aID  +5.2 (c 1.06, EtOH) [lit., 83 ' mp 87-88.5 °C, [a]D +4.9 (c 1.10, EtOH); 
Vm  (CHC13 soln./cm') 3455, 1757, 1604, 1541, 1498; 8H  (200 MHz, CDC1 3) 7.36- 
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7.15 (5H, m, An]), 6.46 (11-1, brs, NH), 4.43-4.32 (1H, m, C4H), 4.12 (1H, dd, J 10.7, 
5.2, C5HAHB), 4.12-4.05 (1H, m, C 5HAHB), 2.90 (1H, dd, J 13.8, 6.0, CHXHYPh) 2.80 
(1H, dd, J 13.8, 6.3, CHxHyPh); & (50MHz) 159.7, 137.8, 128.9 (2C), 128.7 (2C), 
127.0, 69.2, 53.5, 41.0; mlz (El) 178 ([M+H], 100), 117 (18.7). All spectroscopic 




The R-enantiomer was synthesised in an analogous manner to the S-enantiomer. 
Thus, R-phenylalaninol ent-107 (10.0 g, 66.67 mmol), diethylcarbonate (16.4 cm', 
133.34 mmol) and potassium carbonate (0.92 g, 6.67 mmol) provided the title 
compound (9.8 g, 83%) as a colourless solid, mp 86-88 °C; [aID  -4.5 (c 1.2, EtOH) 
[lit.,Error! Bookmark not defined. mp 86-88°C, [a]D  -4.58 (c 1. 1, EtOH)]. 
Benzyl benzyloxyacetate 108 
OBn 
OBn 
To a solution of glycolic acid (3.0 g, 39.5 mmol) in anhydrous acetonitrile (30 cm) 
was added potassium carbonate (21.8 g, 158.0 mmol) and benzyl bromide (11.0 cm 3 , 
92.4 mmol). The reaction mixture was stirred for 16 hours and then diluted with 
water (50 CM)  . The organic phase was separated and the aqueous phase was 
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extracted with DCM (3 x 50 cm 3). The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica gel [hexane:EtOAc (1:1)] to give the title compound (5.25 g, 52%) as a 
colourless oil, Rf [hexane:EtOAc (1:1)] 0.63; Vm, (neat)/cm' 1755, 1603, 1585, 
1496; 8H (200 MHz, CDC1 3) 7.41-7.39 (1011, m, Ark!), 5.24 (2H, s, CO2CH2Ph), 4.67 
(2H, s, COCH2OBn), 4.18 (2H, s, OCH2Ph); E' (50.3 MHz) 169.0, 135.9, 134.2, 
127.4 (4C), 127.2 (4C), 127.1 (2C), 72.0, 65.8, 65.2; mlz (FAB) 257 ([M+H], 
14.6%), 181 (41.2), 137 (22.5), 91(100), 77 (7.3). 




To a solution of benzyloxyacetic acid benzyl ester 108 (256 mg, 1.0 mmol) in MeOH 
(5 cm') was added 10% PdJC (20 mg) and ammonium acetate (45 mg, 0.5 mmol). 
The mixture was exposed to a hydrogen atmosphere (1 atm.) and stirred under 
hydrogen for 30 minutes. The reaction mixture was filtered through a pad of celite 
and concentrated under reduced pressure to give the title compound (160 mg, 95%) 
as a colourless oil, Rf [hexane:EtOAc (2:1)] 0.31; Vm  (neat)/cm' 3450, 1731, 1650, 
1556, 1496, 1455; 6H  (200 MHz, CDC13) 10.5 (111, brs, CO 2H), 7.39-7.25 (511, m, 
Ark!), 4.64 (211, s, COCH2OBn), 4.15 (2H, s, OCH2Ph); 8 (50.3 MHz) 175.4, 136.5, 
128.5 (2C), 128.1, 128.0 (2C), 73.3, 66.4; mlz (El) 166 (M t, 27.9%), 107 (99.3), 91 




To a suspension of sodium hydride (12.96 g, (60% oil dispersion), 322 mmol) in 
THF (200 cm3) at 0 °C was added bromoacetic acid (10.0 g, 71.8 mmol). Benzyl 
alcohol (7.75 g, 71.8 mmol) was added dropwise to the mixture followed by tetra-n-
butylammonium bromide (1. 15 g, 3.60 mmol). The reaction mixture was warmed to 
reflux and held at reflux for 4 hours. The reaction was carefully quenched by addition 
of water at 0 °C and the resulting mixture was concentrated under reduced pressure to 
provide a colourless slurry. This slurry was diluted with diethyl ether (175 cm') and 
extracted with a saturated aqueous solution of sodium bicarbonate (3 x 175 cm 3). The 
combined aqueous extracts were acidified to pH 1 by addition of concentrated sulfuric 
acid and extracted with diethyl ether (3 x 300 cm 3). The combined organic extracts 
were dried and concentrated under reduced pressure. The resulting residue was 
chromatographed on silica gel [hexane:EtOAc (2:1)] to give the title compound (9.83 
g, 82%) as a colourless oil, all spectroscopic data was identical to the acid obtained 
from Method A. 




To a solution of benzyloxyacetic acid 109 (4.95 g, 29.0 mmol) in THF (170 cm 3) at - 
78 °C was added triethylamine (3.96 cm 3, 29.0 mmol) and pivaloyl chloride (3.67 
cm3, 29.0 mmol). The resulting slurry was allowed to warm to 0 °C and stirred at 0°C 
for 20 minutes before being re-cooled to -78 °C. Meanwhile in a separate flask, a 
solution of oxazolidinone 106 (5.40 g, 29.0 mmol) in THF (30 cm3) at -78 °C was 
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treated with n-butyllithium (20.7 cm', 1.6 M in hexanes, 29.0 mmol). The lithiated 
oxazolidinone was then cannulated into the flask containing the mixed anhydride and 
the resulting mixture was stirred for 1 hour. A saturated aqueous solution of 
ammonium chloride (100 cm') was added producing two clear phases. The organic 
phase was separated and the aqueous phase was extracted with DCM (3 x 100 cm'). 
The combined organic extracts were washed sequentially with saturated aqueous 
sodium bicarbonate solution (150 cm') and brine (150 cm 3) then dried and 
concentrated under reduced pressure. The residue was chromatographed on silica gel 
[hexane:EtOAc (1:1)] to give the title compound (9.89 g, 100%) as a colourless 
crystalline solid, Rf [hexane:EtOAc (1:1)] 0.62; mp 69-71 °C; [a]D +57.9 (c 1.14, 
CHC13) [' it-,' 
66 mp 67-69 °C, [aID  +56.0 (c 1.71, CHC13)]; Vm  (CHC13 soln./cm') 
1778,1714,1603, 1584, 1496; 8H (200 MHz, CDC1 3) 7.44-7.19 (10H, m, ArH), 4.71-
4.74-4.59 (5H, m, C2 H2 + OCH2Ph + C4H), 4.28 (1H, t, J 9.0, CSHAHB), 4.22 (1H, 
dd, J 9.0, 3.0, C5HAHB), 3.34 (1H, dd, J 13.2, 2.9, CHXHYPh), 2.82 (1H, dd, J 13.2, 
9.3, CH,jIyPh); ö (50.3 MHz) 170.0, 153.2, 137.0, 134.8, 129.3 (2C), 128.9 (2C), 
128.4 (2C), 128.0 (2C), 127.9, 127.3, 73.4, 69.5, 67.1, 54.7, 37.6; mlz (El) 326 
([M+H], 26.0%), 195 (100), 178 (47.6), 91(18.8); HRMS (El) (C 19H20N04 requires 
326.1392, found 326.1392). All spectroscopic data was in good agreement with that 
of the literature. 
(4R)-3-(2 '-Benzyloxy-1 '-oxoethyl)-4-phenylmethyloxazolidin-2-one ent-1 01 
IANAO I 
BnO tli 
Synthesised in an analogous manner to the S-enantiomer from ent-106. Thus, 
oxazolidin-2-one ent-106 (3.0 g, 16.95 mmol), nBuLi (10.60 cm', 1.6 M in hexanes, 
16.95 mmol), benzyloxyacetic acid (2.83 g, 16.95 mmol), pivaloyl chloride (2.0 cm', 
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16.95 mmol) and triethylamine (2.38 cm 3 , 16.95 mmol) in THF (80 cm) provided 
the title compound (5.4 g, 98%) as a colourless solid, mp 67-69 °C; [aID  -58.3 (c 1.1, 
CHC13) [lit.,bo4a  mp 67-69 °C, [aID  -57.45 (c 2.0, CHC13)]. 
(2 'S,3 'R,4S,4'R)-3-(2'-Benzyloxy-5'-tert-butyldiphenylsilyloxy-4'-N,N-





YN...fL% 5OTBDPS  
To a solution of the glycolate equivalent 101 (3.42 g, 10.56 mmol) in DCM (57 cm) 
at -78 °C was added triethylamine (1.39 g, 1.91 cm 3, 1173 mmol) followed by 
dropwise addition of dibutylboron triflate (12.76 cm', 1.0 M in DCM, 12.76 mmol). 
The solution was stirred at -78 °C for 45 mins and then allowed to warm to 0 °C over 
30 mins and stirred at 0 °C for 1.25 hours. The solution was then recooled to -78 °C 
and a -78 °C solution of aldehyde 73 (1.47 g, 2.89 mmol) in DCM (7.5 cm) was 
added dropwise via cannula. The reaction mixture was stirred at —78 °C for 1 hour 
and allowed to warm to 0 °C over 30 mins and stirred for a further 1 hour at 0 °C. The 
reaction was quenched by the addition of methanol (40 cm) followed by aqueous pH 
7 phosphate buffer solution (25 CM)  . Hydrogen peroxide (30% aqueous solution) (10 
cm 3)  in methanol (10cm) was added dropwise to the solution and the mixture was 
stirred and warmed to room temperature over Ca. 1 hour. The organic phase was 
separated and the aqueous phase was extracted with DCM (3 x 75 cm 3). The 
combined organic extracts were dried and concentrated under reduced pressure. The 
residue was chromatographed on silica gel [hexane:EtOAc (3.5:1)] to give the title 
compound (1.98 g, 82%) as a solid, R f [hexane:EtOAc (1:1)] 0.79; mp 62-63 °C; [a]D 
+14.48 (c 0.87, CHC13); Vm (neat)/cm' 3559, 3062, 3011, 2932, 2857, 1781, 1706; 
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8H(600 MHz, CDC1 3) 7.74-7.13 (30H, m, ArH), 5.41 (1H, d, J2.6, C2.H), 4.47 (1H, 
dddd, J 10. 1, 7.1, 3.2, 2.1, C 4H), 4.26 (1R, d, J 11.0, OCHAHBPh), 4.26-4.24 (1H, m, 
C3.If), 4.11 (1H, dd, J 9.1, 2.1, C5HXHY), 4.08-4.05 (3H, m, CH2OTBDPS + 
C5HXHY), 4.06 (1H, d, J 11.0, OCHAHBPh), 3.86 (2H, d, J 13.8, NCHSHTPh x 2), 3.61 
(2H, d, J 13.8, NCHSHTPh x 2), 3.29 (1H, q, J 5.4, C4 .H), 3.22 (1H, dd, J 13.4, 3.2, 
CHPHQPh), 3.05 (1H, brd, J 8.1, OH), 2.58 (1H, dd, J 13.4, 10.1, CHPHQPh), 1.04 
(9H, s, tBu); E (62.9 MHz) 171.1, 152.9, 139.9 (2C), 13 7.2, 135.7 (3C), 135.6 (3C), 
135.2, 133.0, 132.8, 129.6 (2C), 129.3 (2C), 129.0 (3C), 128.8 (2C), 128.3 (2C), 
128.0 (4C), 127.6 (3C), 127.6 (3C), 127.2, 126.7 (2C), 78.3, 72.5, 72.1, 66.6, 61.3, 
59.6, 55.8, 54.6 (2C), 37.2, 26.7 (3C), 18.9; mlz (FAB) 833 ([M+H], 26%), 478 
(15); HRMS (FAB) (C 52H57N206Si requires 833.3985, found 833.3954). 
(2S,3R,4R)-2-Benzyloxy-5-tert-butyldiphenysilyloxy-4-N,N-dibenzylamino-3-
hydroxypentanoic acid methoxy methyl amide 110 
Me OBn NBn2 
MeO' 'f 
0 OH 
To a suspension of NO-dimethylhydroxylamine.hydrochloride (4.20 g, 43 mmol) in 
anhydrous THF (7.5 cm3) at -30 °C was added trimethylaluminium (21.5 cm3, 2.0 M 
in toluene, 43 mmol). The solution was allowed to warm to room temperature over 
Ca. 15 minutes, after which time a clear solution remained. The solution was recooled 
to -30 °C and a -30°C solution of the aldol adduct 102 (1.43 g, 1.72 mmol) in THF (5 
cm 3)  was added dropwise via cannula. The mixture was warmed to 0 °C and stirred at 
0 °C for 2 hours. The reaction mixture was then cannulated into a rapidly stirred 
biphasic mixture of DCM (50 cm3) and saturated aqueous sodium potassium tartrate 
solution (50 cm3) and stirred for 5 hours when two clear phases were apparent. The 
organic phase was separated and the aqueous phase was extracted with DCM (3 x 50 
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cm3). The combined organic extracts were dried and concentrated under reduced 
pressure. The residue was chromatographed on silica gel [hexane:EtOAc (4:1)] to 
give the title compound (1.23 g, 100%) as a solid, R f [hexane:EtOAc (2:1)] 0.40; mp 
42-43 °C; [a]D  -30.4 (c 1.09, CHC1 3); V m (neat)/cm' 3458, 3059, 3023, 2930, 2854, 
1664, 1425; 8H  (600 MHz, CDC1 3) 7.74-7.16 (25H, m, ArH), 4.62 (1H, brs, C 2H), 
4.36 (11-1, d, J 10.7, OCHAHBPh), 4.20 (1H, td, J7.8, 2.1, C 3FT), 4.10 (1H, dd, J 11.0, 
4.5, C 5HX HY OTBDPS), 4.07 (114, dd, J 11.0, 5.6, C5HXHY OTBDPS), 3.93 (111, d, ' 
10.7, OCHAHBPh), 3.89 (2H, d, J 14.0, NCHSHTPh x 2), 3.72 (21-1, d, J 14.0, 
NCHSHTPhx 2), 3.40 (31-1, s, OMe), 3.20 (1H, ddd,J7.8, 5.6, 4.5, C41]), 3.15 (31-1, s, 
NMe), 2.75 (1H, brd,J6.8, 011), 1.08 (91-1, s, tBu) ;  & (62.9 MHz) 171.4, 140.0 (2C), 
137.5, 135.7 (2C), 135.6 (2C), 133.3, 133.0, 129.6 (2C), 128.7 (4C), 128.1 (4C), 
127.9 (2C), 127.9 (2C), 127.6 (2C), 127.5 (2C), 127.4, 126.7 (2C), 75.2, 71.4, 70.9, 
60.9, 60.8, 59.3, 54.8 (2C), 32.1, 26.7 (3C), 18.9; m/z (FAB) 717 ([M+H], 30%), 
639 (11), 478 (100), 278 (37), 135 (77), 91 (92); HRMS (FAB) (C 44H53N205 Si 
requires 717.3724, found 717.3728). 
110 from aldol adduct 126 
In an analogous manner to that described above aldol adduct 126 (150 mg, 0.18 
mmol), NO-dimethylhydroxylamine.HC1 (440 mg, 4.5 mmol), trimethylaluminium 
(2.25 cm3 , (2.0 M in toluene), 4.5 mmol) in THF (3 cm) gave Weinreb amide 110 
(120 mg, 93%) as a colourless solid. Mixed melting point with authentic 110: 42-43 
°C. All other spectroscopic data was identical with the previously synthesised 
Weirireb amide (vide supra). 
110 from aldol adduct 125 
In an analogous manner to that described above aldol adduct 126 (100 mg, 0.15 
mmol), NO-dimethylhydroxylamine.HC1 (440 mg, 4.5 mmol), trimethylaluminium 
(2.25 cm3, (2.0 M in toluene), 4.5 mmol) in THF (3 cm') gave Weinreb amide 110 
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(102 mg, 91%) as a colourless solid. Mixed melting point with authentic 110: 42-43 
°C. All other spectroscopic data was identical with the previously synthesised 






A solution of the Weinreb amide 110 (1.0 g, 1.4 mmol) and 20% Pd(OH) 2/C (1.0 g) 
in methanol (10 cm') was exposed to a hydrogen atmosphere (1 atm) and stirred 
vigorously for 8 hours. The mixture was then filtered through a pad of celite and 
concentrated under reduced pressure. The residue was chromatographed on silica gel 
[hexane-EtOAc (2:3)] to give the title compound (591 mg, 89%) as a colourless oil, 
Rf [hexane:EtOAc (1:1)] 0.38; [a]D  -30.0 (c 0.6, CH2Cl2); Vm (neat)/cm , 3381, 
1708; 5H (200 MHz, CDC1 3) 7.66-7.10 (15H, m, An]), 5.69 (114, brs, NH), 5.06 (11-1, 
d, .111.7, OCHAHBPh), 4.67 (1H, d, J 12.1, OCHAHBPh), 4.05-3.93 (2H, m, C3H+ 
C51]), 3.74 (111, dd, J 10.2, 4.0, CHXHYOTBDPS), 3.54 (11-1, dd, J 10.3, 7.0, 
CHXHYOTBDPS), 3.45-3.32 (114, m, C 4H), 2.11 (111, brs, OH), 0.98 (911, s, tBu); & 
(50.3 MHz) 172.2, 137.7, 135.5 (2C), 132.5, 130.0 (2C), 128.5 (2C), 128.1 (4C), 
127.9 (4C), 127.8 (2C), 81.8, 75.2, 72.7, 64.6, 57.8, 26.6 (3C), 19.0; m/z (FAB) 476 
([M+H], 41%), 307 (29), 154 (98), 136 (76), 91(100); HRMS (FAB) (C 28H34NO 4 Si 
requires 476.2257, found 476.2258). 
In an analogous manner Weinreb amide 110 (100 mg, 0.14 mmol), Pd/C (100 mg) in 
methanol (1 cm) was stirred under a hydrogen atmosphere for 24 hours to provide 
the title compound (57 mg, 86%) as a colourless oil. Spectroscopic data was 
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A solution of the Weinreb amide 110 (1.0 g, 1.4 mmol) and 20% Pd(OH) 2/C (1.0 g) 
in methanol (10 cm') was exposed to a hydrogen atmosphere (1 atm.) and stirred 
vigorously for 72 hours. The mixture was then filtered through a pad of celite and 
concentrated under reduced pressure. The residue was chromatographed on silica gel 
[hexane:EtOAc (2:3)] to give the title compound (383 mg, 71%) as a colourless 
foam, Rf [hexane:EtOAc (1:1)] 0.11; [aID  +11.52 (c 1.05, CHC13); Vm, (neat)/cm' 
3424, 2931, 2863, 1720; 611 (600 MHz, CDC1 3) 7.61-7.25 (1011, m, ArH), 6.15 (1H, 
brs, NH), 4.67 (1H, brs, 01]), 4.28 (1H, d, J7.7, C31]), 3.98 (1H, t, J7.4, C1]), 3.88 
(1H, dd, J10.7, 3.5, CHAHBOTBDPS), 3.79 (111, brs, OH), 3.61 (1H, dd, J 10.7, 7.3, 
CHAHBOTBDPS), 3.51 (111, dt, J 7.3, 3.5, C5H), 1.03 (9H, s, tBu);  6 (50.3 MHz) 
174.2, 135.5 (4C), 132.6 (2C), 130.0 (2C), 127.9 (4C), 75.7 (2C), 64.4, 58.0, 26.6 
(3C), 19.0; mlz (FAB) 386 ([M+H], 15%), 307 (40), 154 (100), 107 (75), 77 (61); 
HRMS (FAB) (C 2I H28N04Si requires 386.1787, found 386.1776). 
From 113: 
A solution of 113 (591 mg, 1.24 mmol) and 20% Pd(OH) 2 (600 mg) in methanol (10 
cm 3)  was stirred under hydrogen for 48 hours to provide 114 (385 mg, 80%). 
Or: 
A solution of 113 (57 mg, 0.12 mmol) and 10% Pd/C (60 mg) in methanol (0.5 cm) 
was stirred under hydrogen for 48 hours to provide 114 (35 mg, 76%). Spectroscopic 







To a solution of the TBDPS protected lactam 114 (43 mg, 0.112 mmol) in 
MeCN/THF (1:1) (1.5 cm) was added HF (48% aqueous solution) (0.3 cm 3 , 5 eq.). 
The mixture was stirred for 15 minutes. Methoxytrimethylsilane (3.0 cm) was added 
cautiously and the mixture was concentrated. The residue was again treated with 
methoxtrimethylsilane (3 cm 3) and concentrated. This process was repeated once 
more and the remaining residue was chromatographed on silica gel 
[CHC13 :MeOH:NH 3 (28 % aqueous) (5:3:1)] to give the title compound (17 mg, 
100%) as a colourless solid, Rf [CHC13 :MeOH:NH3 (28% aqueous) (5:3:1)] 0.14; mp 
131-133 °C; [a]D+14.2 (c 0.4, ]J20) [lit. 108 mp 130-133, [aI D +14.7 (c 0.58, D20)]; oH 
(250 MHz, D20) 4.31 (1H, d, J 8.0, CA,  4.00 (1H, dd, J 8.0, 7.3, CA,  3.79 (1H, 
dd, J 12.2, 3. 1, CHAHBOH), 3.61 (1H, dd, J 12.2, 4.9, CHAHBOH), 3.45 (111, ddd, J 
7.3, 4.9, 3.1, CA; O (75 MHz) 175.5, 75.5, 74.6, 60.0, 57.9; mlz (FAB) 148 
([M+H], 47.2), 133 (21.9, 105 (32.1), 73 (100); HRMS (FAB) (C 5H, 0N04 requires 
148.0610, found 148.0613). All spectroscopic data was in good agreement with that 












A solution of aldol adduct 102 (200 mg, 0.24 mmol) and 20% Pd(OH) 2/C (200 mg) 
was exposed to a hydrogen atmosphere (1 atm.) and stirred vigorously for 24 hours. 
The mixture was filtered through a pad of celite and concentrated under reduced 
pressure. The residue was chromatographed on silica gel [hexane:EtOAc (2:1)] to 
give 116 (72 mg, 53%) and 113 (48 mg, 42%). Re-exposure of 116 (70 mg, 0.12 
mmol) and 20% Pd(OH) 2/C (100 mg) to a hydrogen atmosphere for 72 hours gave, 
after chromatography on silica gel [hexane:EtOAc (1:1)], lactam 117 (50 mg, 87%). 
Data for 116: 
Obtained as a colourless oil, 
Rf [hexane:EtOAc (1:1)] 0.72; [aID  -2.4 (c 0.50, CHC13); v (neat)/cm' 3374, 1682; 
oH (200 MHz, CDC13) 7.64-6.94 (20H, m, ArII), 5.15 (1H, d, J 12.1, OCHAHBPh), 
4.98 (111, d, J 15.4, NCHXHYPh), 4.86 (111, d, J 12.1, OCHAHBPh), 4.35 (1H, brddd, 
J 10.2, 6.5, 3.5, CA,  4.13 (1H, d, J 7.0, CA,  3.77 (111, dd, J 11.0, 3.7, 
CHSHTOTBDPS), 3.75 (1H, d, J 15.4, NCHXHYPh), 3.67 (1H, dd, J 11.0, 4.6, 
CHSHTOTBDPS), 3.15 (1H, ddd, J 6.2, 4.4, 3.7, C511), 1.05 (9H, s, tBu); O (50.3 
MHz) 171.0, 137.9, 135.7, 135.6 (2C), 135.4 (2C), 132.5 (2C), 130.0, 129.9, 128.6 
(2C), 128.4 (2C), 128.0 (2C), 127.9 (2C), 127.8(2C), 127.8 (2C), 127.5 (2C), 81.8, 
73.3, 72.4, 60.7 (2C), 43.6, 26.7 (3C), 19.0; mlz (FAB) 566 ([M+H], 31%), 386 




Data for 117: 
Obtained as a colourless oil, 
Rf [hexane:EtOAc (1:1)] 0.32; [a]D  -10.8 (c 0.3, CH2C12); Vm (neat)/cm 3357, 
1685; 6H  (250 MHz, CDC13) 7.65-6.91 (15H, m, ArH), 5.03 (1H, d, J 15.3, 
NCHAHBPh), 4.39-4.34 (2H, m, C3H + CHXHYOTBDPS), 3.98 (1H, brt, J 3.9, C41]), 
3.75 (1H, d, J 15.5, NCHAHBPh), 3.74 (1H, dd, J 10.0, 6.5, CHXHYOTBDPS), 3.23 
(1H, dt, J6.7, 3.3, C51]), 1.04 (9H, s, tBu);  8c (62.9 MHz) 172.5, 135.5 (2C), 134.5, 
130.0, 129.9, 129.3, 128.7, 128.6 (2C), 127.9 (2C), 127.8 (3C), 127.6 (3C), 127.5, 
76.1, 74.0, 60.6, 59.7, 43.7, 26.8 (3C), 19.1; mlz (FAB) 476 ([M+H], 14%), 325 
(13), 217 (80), 91(100), 73 (25); HRMS (FAB) (C 28H34NO4Si requires 476.2257, 
found 476.2254). 
Attempted Reduction of Lactam 114 
To a -78 °C solution of lactam 114 (100 mg, 0.26 mmol) in toluene (2 cm') or THF 
(2 cm') was added either diisobutylaluminum hydride (0.26 cm', (1.0 M in toluene), 
0.26 mmol) or lithiumtriethylborohydride (Super Hydride ®) (0.26 cm', (1.0 M in 
TUF), 0.26 mmol). The resulting mixtures were stirred at -78 °C for 1 hour. T.l.c. 
indicated that no reaction had taken place in both cases. As a result the reaction 
mixtures were warmed to room temperature and stirred at room temperature for 3 
hours. T.l.c showed that no reaction had occurred. Further additions of the reducing 





butyldiphenylsilyloxymethyl)-1H-pyrrol-2 (5H)-one 119 
Boc OTBDPS 
0 N I 
CO 
To a solution of the lactam 114 (96 mg, 0.25 mmol) in DCM (1.0 cm') was added 
triethylamine (115 .tl, 0.825 mmol), di-tert-butyldicarbonate (327 mg, 1.5 mmol) and 
dimethylaminopyridine (6 mg, 0.05 mmol). The reaction mixture was stirred for 30 
minutes then diluted with DCM (5.0 cm') and washed with saturated aqueous sodium 
bicarbonate solution (5.0 cm') and brine (5.0 CM)  . The organic phase was 
concentrated under reduced pressure and the remaining residue was chromatographed 
on silica gel [hexane:EtOAc (5:1)] to give the title compound (121 mg, 86%) as a 
colourless oil, Rf [hexane:EtOAc (5:1)] 0.30; Vm  (neat)/cm' 1768 (2 carbonyls, one 
partially obscured) 1719, 1656; 8. (250 MHz, CDC13) 7.63-7.32 (10H, m, An]), 7.05 
(0.2H, d, J 2.5, CA,  7.00 (0.2H, d, J 2.4, C41]), 6.91 (0.6H, d, J 2.4, CA,  4.63 
(0.4H, m, C5H) 4.59 (0.6H, ddd, J 6.2, 3.2, 2.5, CA,  4.38-4.28 (0.4H, m, 
CHAHBOTBDPS), 4.09 (0.6H, dd, J 9.8, 3.3, CHAHBOTBDPS), 4.00-3.88 (0.4H, m, 
CHAHBOTBDPS), 3.83 (0.6H, dd, J 9.8, 6.2, CHAHBOTBDPS), 1.54 (5.411, s, 
OtB u), 1.53 (1.8H, s, OtBu), 1.53 (1.811, s, OtBu),  1.50 (1.811, s, OtBu), 1.49 (1.8H, 
s, otBu),  1.44 (5.4H, s, OtBu),  1.01 (5.4H, s, SitBu), 0.92 (1.8H, s, SitBu), 0.91 
(1.8H, s, SitBu); E (62.9 MHz) 162.6, 149.4, 148.8, 141.9, 135.4 (2C), 135.3 (2C), 
135.0, 132.7, 132.6, 129.8, 127.7 (4C), 127.1, 84.6, 83.3, 62.8, 58.4, 27.9 (3C), 27.4 
(3C), 26.6 (3C), 19.1; mlz (FAB) 590 ([M + Na], 1.1%), 412 (20), 197 (17.1), 91 
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To a solution of the lactam 114 (230 mg, 0.60 mmol) in DCM (5 cm) was added 
2,6-lutidine (150 p.!, 1.32 mmol) followed by tert-butyldimethylsilyltrifluoromethane 
sulfonate (826 p.1, 3.60 mmol). The mixture was stirred at room temperature for 3 
hours. The reaction mixture was diluted with DCM (30 cm') and washed with 
saturated aqueous sodium bicarbonate solution (15 cm 3) and brine (15 CM)  . The 
organic phase was concentrated under reduced pressure and the residue was 
chromatographed on silica gel [hexane:EtOAc (6:1)] to give the title compound (3 10 
mg, 85%) as a colourless foam, Rf [hexane:EtOAc (4:1)] 0.66; [aID  -8.6 (c 0.93, 
CHC13); Vm  (neat)/cm-1 3212, 1720; 8 H (250 MHz, CDC13) 7.64-7.25 (10H, m, ArH), 
5.53 (1H, brs, NH), 4.12 (111, d, J5.8, C3H), 3.87 (111, t, J5.5, CH), 3.76 (111, dd, J 
10.0, 3.4, CHAHBOTBDPS), 3.54 (111, dd, J 10.0, 8.1, CHAHBOTBDPS), 3.41 (1H, 
ddd, J8.1, 5.1, 3.4, C5H), 1.04 (9H, s, tBu), 0.90 (911, s, tBu),  0.89 (9H, s, tBu), 0.18 
(3H, s, Me), 0.12 (3H, s, Me), 0.03 (3H, s, Me), -0.11 (3H, s, Me); 8 (62.9 MHz) 
173.0, 135.4 (2C), 135.3 (2C), 132.8, 132.7, 129.9, 129.8, 127.8 (4C), 77.7, 76.7, 
64.9, 60.0, 26.7 (3C), 25.7 (3C), 25.6 (3C), 19.1, 18.1, 17.7, -3.7, -4.2, -4.3, -4.8, mlz 
(FAB) 614 ([M+H], 62.2%), 556 (25.7), 478 (10.6), 73 (100), HRMS (FAB) 
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To a solution of the lactam 120 (210 mg, 0.343 mmol) in DCM (4 cm) was added 
triethylamine (60 p1, 0.428mmo1) followed by di-tert-butyldicarbonate (100 mg, 
0.457 mmol) and NN-dimethylaminopyridine (9 mg, 0.069 mmol). The resulting 
mixture was stirred at room temperature for 90 minutes. The reaction mixture was 
diluted with EtOAc (10 cm 3) and washed with saturated aqueous sodium bicarbonate 
(10 cm3) and brine (10 CM)  . The organic phase was concentrated under reduced 
pressure and the remaining residue was chromatographed on silica gel 
[hexane:EtOAc (8:1)] to give the title compound (235 mg, 96%) as a colourless oil, 
Rf [hexane:EtOAc (8:1)] 0.56; [aID  -33.1 (c 0.75, dC!3); Vm  (neat)/cm' 1761, 
1719; 8H (250 MHz, CDC1 3) 7.66-7.25 (101-I, m, ArH), 4.31 (111, t, J 1.5, C411), 4.00-
3.96 (1H, d, J 1.6, CA,  3.99 (1H, m, C511), 3.82 (1H, dd, J 9.8, 7.2, 
CHAHBOTBDPS), 3.77 (1H, dd, J 9.8, 5.0, CHAHBOTBDPS) 1.38 (9H, s, otBu), 
1.05 (9H, s, SitBu), 0.88 (9H, s, SitBu), 0.86 (9H, s, SitBu),  0.15 (3H, s, Me), 0.13 
(311, s, Me), 0.12 (31-1, s, Me), 0.10 (311, s, Me); & (62.9 MHz) 172.0, 149.7, 135.4 
(4C), 133.0, 132.9, 129.7 (2C), 127.7 (4C), 82.9, 78.8, 72.0, 66.7, 62.6, 27.8 (3C), 
26.7 (3C), 25.7 (3C), 25.6 (3d), 19.1, 18.0, 17.8, -4.5, -4.6 (2C), -5.2; mlz (FAB) 736 
([M + Na], 29.6%), 636 (100), 614 (85.1); HRMS (FAB) (C38H63NO6Si3Na requires 







To a solution of the lactam 121 (132 mg, 0.185 mmol) in THF (3 cm3) at -78 °C was 
added lithiumtriethylborohydride (Super Hydride ®) (241 tl, 1 .OM in THF, 0.241 
mmol). The mixture was stirred at -78 °C for 15 minutes. The reaction was quenched 
with methanol (0.5 cm3) and a saturated aqueous solution of sodium bicarbonate (2 
cm3). The resulting foamy slurry was warmed to room temperature and vigorously 
extracted with EtOAc (3 x 5 CM)  . The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatograhed on 
silica gel [hexane:EtOAc (6:1)] to give the title compound (127 mg, 96%) as a 
colourless oil, Rf [hexane:EtOAc (4:1)] 0.54; [aID -7.3 (c 1.1, CHC13); Vm  (neat)/cm 
3460, 1701; 8 H (250 MHz, CD30D) 7.78-7.43 (10H, m, ArH), 5.46-5.40 (1H, brm, 
CA, 4.60-4.55 (1H, brm, C311), 4.06 (1H, dd, J 5.0, 2.6, C4H), 4.09-3.95 (1H, brm, 
C511), 3.84-3.81 (2H, brm, CH20TBDPS), 1.42 (9H, brs, OtBu),  1.16 (9H, s, SitB u), 
1.01 (9H, s, SitBu), 0.98 (9H, s, SitBu),  0.23 (6H, s, Me x 2), 0.22 (6H, s, Me x 2); ö 
(62.9 MHz) 155.2, 134.8 (4C), (132.5 (2C), 129.1 (2C), 127.0 (4C), 81.2, 77.4, 75.7, 
66.2, 62.3, 26.8 (3C), 25.7 (3C), 24.7 (3C), 25.7 (3C), 18.1(2C), 17.3, 16.8, -5.9, - 
6.0, -6.3, -6.5; rnlz (FAB) 738 [M + Na]', 29.5%), 698 (34.3), 598 (100), 540 (97.5), 







To a solution of the multi-protected pyrrolidine 122 (115 mg, 0.16 mmol) in THF (3 
cm') was added a solution of 6N HO (1.8 cm') in THF (1 cm 3). The mixture was 
heated to 50 °C and held at this temperature for 2 hours. The reaction mixture was 
concentrated and the remaining residue was chromatographed on silica gel 
[CHC13 :MeOH:NH3 (28% aqueous) (5:3:1)] to give a colourless solid which was 
subjected to a final purification by ion-exchange [Dowex OH -, (prepared by treating 
Dowex 1-X2 with iN aqueous sodium hydroxide and washing with de-ionised water 
until eluent was at pH7)] to give nectrisine (17 mg, 80%) as a colourless oil R f 
[CHC13 :MeOH:NH 3 (28% aqueous) (5:3:1)] 0.25; [()CID  +21.0 (c 0.4, H20) [lit. 78  [aID 
+21.8 (c 0.6, H20)]; SH (600 MHz, D 20) 7.72 (1H, d, J2.4, C21]), 4.75 (1H, dt, J5.2, 
1.0 1  C311), 4.11 (1 H, t, J5.3, C[]), 3.91 (1H, dd, J 11.5, 3.9, CHAHBOH), 3.88 (1H, 
ddddd,J5.3, 4.2, 3.9, 2.3, 1.2, C511), 3.79 (1H, dd,J 11.6, 4.2, CHAHBOH); ö (62.9 
MHz) 170.5, 83.4, 78.2, 76.8, 61.2; mlz (FAB) 131 (M, 38.1%), 91(100); HRMS 
(FAB) (C 5H9NO3 requires 131.0582, found 131.0582). All spectroscopic data was in 
good agreement with that of the literature. 
Methyl benzyloxyacetate 124 
r-1- OMe 
OBn 
To methanol (80 cm3) at 0 °C was added acetyl chloride (13.62 cm 3, 173.5 mmol) 
followed by benzyloxyacetic acid 109 (9.60 g, 57.8). The reaction mixture was 
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warmed to reflux and held at reflux before being concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
(3:1)] to give the title compound (9.86 g, 95%) as a colourless oil, R f [hexane:EtOAc 
(2:1)] 0.62; Vm  (neat)/cni' 1756, 1605, 1557, 1496; 8H (200 MHz, CDC13) 7.37-7.30 
(5H, m, An-f), 4.62 (214, s, COCH2OBn), 4.10 (2H, s, CH2OBn), 3.74 (3H, s, OMe); 
6 (50M1-Iz) 170.5, 136.8, 128.3 (3C). 127.8 (2C), 73.0, 66.8, 51.5; mlz (FAB) 181 
([M+H], 56.7), 91(100). 
Methyl 	 (2S,3R,4R)-2-benzyloxy-5-tert-butyldiphenylsilyloxy-4-N,N- 
dibenzylamino-3-hydroxypentanoate 125 
OBn NBn2 
MeO Lj..2 5OTBDPS  
0 OH 
To a solution of diisopropylethylamine (207 p1, 1.19 mmol) in anhydrous 
diethylether (2.5 cm') at -78 °C was added dibutylboron triflate (1.01 cm 3 , ( 1.0 M in 
DCM), 1.01 mmol). To this cloudy mixture was added ester 124 (178 mg, 0.99 
mmol) in diethylether (1.0 cm) via cannula. The resulting mixture was stirred for 90 
mins at -78 °C before a -78 °C solution of the aldehyde (500 mg, 0.99 mmol) in 
diethylether (1.5 cm') was added via cannula. The resulting mixture was stirred at -78 
°C for 1 hour and 0 °C for 1 hour. The reaction was quenched by addition of aqueous 
pH 7 phosphate buffer solution (0.5 cm') followed by methanol (0.5 cm'). Finally, 
hydrogen peroxide (1.0 cm') in methanol (1.0 cm') was added dropwise and the 
resulting cloudy solution was stirred for 30 minutes at 0 °C and 30 minutes at room 
temperature. The mixture was diluted with DCM (10 cm 3) and the organic phase was 
separated. The aqueous phase was extracted with DCM (3 x 5 cm'). The combined 
organic extracts were washed with a saturated aqueous solution of sodium 
bicarbonate (10 cm 3) and brine (10 cm'), dried and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
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(4:1)] to give the title compound (510 mg, 75 %) as a colourless foam, R f 
[hexane:EtOAc (3:1)] 0.69; [a] D  -32.2 (c 1.94, CIIC1 3); V m (neat)/cm - ' 3546, 1751, 
1601, 1588, 1494; 8H  (250 MHz, CDC13) 7.82-7.15 (25H, m, ArH), 4.40 (1H, d, J 
10.2, OCHAHBPh), 4.38 (1H, d, J 1.4, CA,  4.18 (1H, dd, J 10.7, 5.7, 
CSHAHBOTBDPS), 4.17-4.10 (1H, m, C311), 4.09 (1H, dd, J 10.7, 5.7, 
C5HAHBOTBDPS), 3.91 (2H, d, J 13.5, NCHXHYPh x 2), 3.77 (3H, s, OMe), 3.62 
(2H, d, J 13.5, NCHXHYPh x 2), 3.52 (1H, d, J 10.2, OCHAHBPh), 3.18 (1H, dt, J9.1, 
5.5, CIi), 1.12 (9H, s, tBu); 8c (62.9 MHz) 172.3, 140.0 (2C), 137.4, 135.6 (2C), 
135.5 (2C), 133.1, 132.9, 129.7, 129.6, 129.2 (4C), 128.2 (4C), 127.9 (4C), 127.6 
(4C), 127.5, 126.9 (2C), 77.3, 72.8, 72.1, 61.2, 59.1, 54.8 (2C), 51.8, 26.7 (3C), 18.9; 
mlz (FAB) 688 ([M+H], 62.0%), 599 (25.0), 478 (19.5), 217 (40.8), 91(100); 
HRMS (FAB) (C43H50NO5 Si requires 688.3458, found 688.3458). 
(2 'R,3'S,4R,4'R)-3-(2 '-Benzyloxy-5'-tert-butyldiphenylsilyloxy-4'-N,N-
dibenzylamino-3'-hydroxy-1 '-oxopentyl)-4-phenylmethyloxazolidin-2-one 105 
and 	(2 'S,3 'R,4R,4'R)-3-(2'-Benzyloxy-5'-tert-butyldiphenylsilyloxy-4'-N,N- 
dibenzylamino-3'-hydroxy-1 '-oxopentyl)-4-phenylmethyloxazolidin-2-one 126 
Ph OBn NBn2 
	
Ph OBn NBn2 
01 N 	 OTBDPS 
Synthesised in an analogous manner to 102, from R-imide ent-101 to give a mixture 
of diastereomers 105:126 (9:1 ratio). Thus, the imide ent-101 (590 mg, 1.82 mmol), 
aldehyde 73 (370 mg, 0.729 mmol), dibutylborontriflate (2.18 cm 3 , ( 1.0 M in DCM), 
2.18 mmol), triethylamine (331 p.1, 2.37 mmol) in DCM (17 cm) gave 105 (424 mg, 
70%) and 126 (52 mg, 8.6%) as a colourless oil and a colourless foam respectively, 
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Data for 105: 
Obtained as colourless oil, 
Rf [hexane:EtOAc (3:1)] 0.28; [aID  -29.2 (c 0.9, CHC13); Vm (neat)/cm' 3331, 1773, 
1708; 81 (360 MHz, CDC13) 7.81-7.07 (30H, m, ArH), 5.22 (1H, d, J 2.4, C2.II), 
4.56-4.52 (1H, m, C3 I-I), 4.52 (1H, d, J 11.5, OCHAHBPh), 4.50 (1H, ddt, J9.8, 6.2, 
3.1, C411), 4.27 (1H, d, J 11.5, OCHAHBPh), 4.15-4.11 (1H, m, C 5HXHY), 4.13 (1H, 
dd, J 11.3, 4.4, C5'HMHNOTBDPS) 4.04 (1H, dd, J 11.3, 8.0, C5'HMHNOTBDPS), 
3.93 (2H, d, J 13. 1, NCHSHTPh x 2), 3.86-3.81 (2H, m, NCHSHTPh x 2), 3.84 (1H, 
dd, J 9.5, 2.5, C5HXHY), 3.56 (1H, dt, 8.0, 4.4, C 4.H), 3.30 (1H, dd, J 13.3, 3. 1, 
CHpHQPh), 2.72 (1H, dd, J 13.3, 9.8, CHPHQPh), 1.94 (9H, s, tBu);  E (90.6 MHz) 
170.7, 153.7, 139.5 (2C), 137.7, 136.2 (4C), 135.8, 133.6, 130.3, 130.2, 129.9 (2C), 
129.7 (3C), 129.4 (2C), 129.0, 128.9 (3C), 128.8, 128.7, 128.6 (2C), 128.2 (4C), 
128.1 (2C), 127.9, 127.8, 127.6 (2C), 72.8 (2C), 68.2, 67.2, 62.3 (2C), 60.3, 56.2 
(2C), 38.2, 27.6 (3C), 19.6. 
Data for 126: 
Obtained as a colourless foam, 
Rf [hexane:EtOAc (3:1)] 0.35; OLD-33.6 (c 1.00, CHC13); Vm  (neat)/cm' 3451, 1779, 
1705; 8H(360 MHz, CDC1 3) 7.77-7.19 (30H, m, ArH), 5.46 (1H, d, J 1.7, C2 I]), 4.70 
(1H, dddd, J 10.3, 6.8, 5.2, 3.2, C4H), 4.38 (1H, brd, J 7.6, OR), 4.26 (1H, d, J 10. 7, 
OCHAHBPh), 4.20 (1H, brdd, J 7.2, 2.1, C3J]), 4.19 (1H, dd, J 13.5, 5.1, 
C5'HXHYOTBDPS), 4.22-4.11 (3H, m, C5H2 + C5 'HXHYOTBDPS), 3.99 (1H, d, ' 
10.7, OCHAHBPh), 3.98 (2H, d, J 13.7, NHSHITPh x 2), 3.67 (2H, d, J 13.7, 
NCHSHTPh x 2), 3.41 (1H, dt'-'q, J 5.3, C4 H), 3.30 (1H, dd, J 13.5, 3.2, CHMHNPh), 
2.74 (1H, dd, J 13.5, 9.4, CHMHNPh), 1.10 (9H, s, tBu);  3c (50.3 MHz) 171.7, 153.1, 
140.0 (2C), 137.4, 135.7 (2C), 135.6 (2C), 135.0, 133.1, 133.0, 129.7 (2C), 129.3 
(2C), 129.1 (4C), 128.8 (2C), 128.1 (2C), 128.0 (4C), 127.9 (2C), 127.7 (4C), 127.5, 





hydroxy-pentanoic acid methoxy-methyl-amide 127 




An analogous protocol to that described for the synthesis of Weinreb amide 110 was 
undertaken. Thus, aldol adduct 105 (300 mg, 0.36 mmol), N,O-
dimethylhydroxylamine.HC1 (880 mg, 9.0 mmol), trimethylaluminium (4.5 cm3 , (2.0 
M in toluene), 9.0 mmol) in THF (6 cm) gave, after chromatography on silica gel 
[hexane:EtOAc (1:1)], the title compound (253 mg, 98%) as a colourless oil, Rf 
[hexane:EtOAc (1:1)] 0.56; a D  -14.2 (c 1.25, CHC13), Vm  (neat)/cm' 3424, 1664; 5H 
(360 MHz, CDC13) 7.74-6.97 (25H, m, ArH), 4.59 (1H, d, J2.l, C21-I), 4.36 (1H, brs, 
011), 4.12 (1H, d, J 12.0, OCHAHBPh), 4.13-4.11 (1H, brm, OCHAHBPh), 3.98 (2H, 
d, J 13.2, NCHXHYPh x 2), 3.92 (1H, dd, J 9.3, 2.1, CA,  3.87-3.81 (2H, m, 
C5H20TBDPS), 3.77 (2H, d, J 13.3, NCHXHYPh x 2), 3.45 (1H, brdt, J 10.0, 6.2, 
C411), 3.32 (3H, s, OMe), 3.19 (3H, s, NMe), 1.17 (9H, s, tBu);  S (50.3 MHz) 170.1, 
139.0 (2C), 137.4, 135.7 (4C), 132.9, 132.8, 129.8 (2C), 129.1 (4C), 128.3 (4C), 
128.1 (2C), 127.7 (4C), 127.5 (2C), 127.4, 127.0 (2C), 71.2, 67.5, 61.4, 60.5, 59.3 
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From Weinreb amide 127: 
A solution of the Weinreb amide 127 (200 mg, 0.279 mmol) and 20% Pd(OH) 2/C 
(200 mg) in methanol (5 cm') was exposed to a hydrogen atmosphere and stirred 
under hydrogen for 72 hours. The reaction mixture was filtered through a pad of 
celite and concentrated under reduced pressure. The residue obtained was 
chromatographed on silica gel [hexane:EtOAc (2:3)] to give the title compound (74 
mg, 69%) as a colourless foam, R f [hexane:EtOAc (1:3)] 0.23; [a]D  +40.2 (c 1.25, 
CHC13); v 3305, 1689; 6H  (250 MHz, CDC1 3) 7.67-7.25 (10H, m, An]), 6.52 (1H, 
brs, NI]), 5.00 (1H, brs, OH), 4.42 (1H, brd, J2.7, C3I]), 4.12-3.98 (1H, brm, C4H), 
3.83 (1H, dd, J 10.8, 5.2, CHAHBOTBDPS), 3.72 (111, dd, J 10.8 7.6, 
CHAHBOTBDPS), 3.69-3.61 (1H, brm, C5H), 1.00 (9H, s, tBu); 8c (62.9 MHz) 175.4, 
135.5 (2C), 135.4 (2C), 132.6, 132.4, 129.8, 129.8, 127.8 (4C), 74.9 (2C), 62.6, 55.5, 
26.7 (3C), 18.9. 
From Weinreb amide 157 
Analogous to the above protocol, Weinreb amide 157 (165 mg, 0.263 mmol) and 
20% Pd(OH) 2/C (165 mg) in methanol (4 cm') under a hydrogen atmosphere (1 atm.) 
gave after 24 hours lactam 128 (86 mg, 85%) as a colourless foam. Spectroscopic 
data was identical to the lactam obtainedfrom 127. 
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(4S)-3-(1 '-Oxopropyl)-4-phenylmethyloxazolidin-2-one 137 
Me 
Ph 
To a solution of the oxazolidinone 106 (7.50 g, 43.4 mmol) in THF (100 cm 3) at -78 
°C was added n-butyllithium (1.6 M in hexanes) (29.0 cm', 42.4 mmol). The mixture 
was stirred for 5 minutes and freshly distilled propionyl choride (11.2 cm 3 , 127.2 
mmol) was added slowly via syringe. The resulting mixture was stirred at -78 °C for 
15 mins. The reaction was quenched by addition of a saturated aqueous solution of 
ammonium chloride (50 CM),  producing two clear phases. The organic phase was 
separated and the aqueous phase was extracted with DCM (3 x 100 CM)  . The 
combined organic extracts were washed sequentially with saturated aqueous sodium 
bicarbonate solution (75 cm3) and brine (75 cm') dried and concentrated under 
reduced pressure. The remaining residue was chromatographed on silica gel 
[hexane:EtOAc (3:1)] to give the title compound (9.80 g, 99%) as a colourless 
crystalline solid, R f [hexane:EtOAc (3:1)] 0.46; mp 45-47 °C; [c], +94.7 (c 1. 5, 
EtOI-I) p it., 167 mp 44-46 °C, [a] D  +92.9 (c 1.0 1, EtOH)]; V m  (Nujol mull/cm') 1795, 
1708, 1557; oH  (200 MHz, CHC1 3) 7.38-7.18 (5H, m, ArH), 4.66 (1H, dddd, J 9.9, 
9.6, 6.4, 3.3, C411), 4.18 (2H, m, C5H2), 3.29 (1H, dd, J 13.4 3.3, CHAHBPh), 2.98 
(2H, q, 7.3, C2 'H2), 2.76 (1H, dd, J 13.4, 9.6, CHAHB Ph), 1.19 (3H, t, J7.4, CH3); O 
(50.3 MHz) 174.0, 153.4, 135.2, 129.3 (2C), 128.8 (2C), 127.2, 66.0, 54.9, 37.7, 
28.9, 8.0; mlz (El) 233 (M, 20.4%), 142 (37.4), 91 (50.2), 57 (100). All 









To a solution of imide 137 (3.50 g, 14.8 mmol) in DCM (24 cm 3) at 0 °C was added 
Bu2BOTf (17.8 cm3, ( 1.0 M in DCM), 17.8 mmol). Triethylamine (2.71 cm 3 , 19.3 
mmol) was added to the orange coloured solution and the mixture became bright 
yellow colour in colour. This mixture was stirred at 0 °C for 15 mins before being 
cooled to -78 °C. A -78 °C solution of the aldehyde 73 (2.50 g, 4.39 mmol) was 
introduced via cannula and resulting mixture was stirred at -78 °C for 1 hour then 0 
°C for 30 mins. The reaction was quenched at 0 °C by addition of aqueous pH 7 
phosphate buffer solution (10 cm) followed by methanol (15 CM). 
Methanol:hydrogen peroxide (1:1) (25 cm) was then cautiously added and the 
resulting mixture was stirred at 0 °C for 1 hour. The organic phase was separated and 
the aqueous phase was extracted with EtOAc (3 x 30 CM)  . The combined organic 
extracts were dried and concentrated under reduced pressure. The remaining residue 
was chromatographed on silica gel [hexane:EtOAc (3:1)] to give the title compound 
(3.18 g, 87%) as a colourless solid, R 1 [hexane:EtOAc (3:1)] 0.51; mp 63-65 °C; [aID 
+19.7 (c 0.88, CHC13); Vm  (CHC13 soln.)/cm' 3551, 1782, 1679; 6H  (250 MHz, 
CDC13) 7.81-7.16 (25H, m, ArH), 4.63-4.56 (1H, m, CA,  4.35 (111, qd, J7.1, 1.5, 
C2.II), 4.22 (1H, dd, J 11.1, 3.5, C5'HAHB), 4.20-4.15 (3H, m, C3.H + C5 .H2), 4.06 
(1H, dd, J 11.1, 5.6 C5'HAHB), 3.94 (2H, d, J 13.7, NCHAHBPh x 2), 3.64 (2H, d, J 
13.7, NCHAHBPh x 2), 3.26 (1H, d, J 2.61, 011), 3.19 (1H, dd, J 13.3, 3.3, 
CHXHYPh), 2.80 (1H, td, J5.6, 3.2, C4 HNBn2), 2.71 (1H, dd,J 13.3, 9.5, CH XHYPh), 
1.12 (9H, s, tBu),  0.71 (3H, d, J7.1, Me); 6 (62.9 MHz) 178.7, 152.4, 139.8 (2C), 
135.8 (2C), 135.6 (2C), 135.0, 133.3, 133.0, 129.7 (2C), 129.3 (2C), 129.1 (4C), 
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128.8 (2C) 128.2 (4C), 127.7 (2C), 127.6 (2C), 127.2, 126.8 (2C), 77.1, 69.1, 66.0, 
60.7, 58.1, 55.5 (2C), 54.8, 38.8, 37.6, 26.9 (3C), 19.1, 9.5; mlz (FAB) 741 ([M+H], 
29.8%), 625 (35.1), 479 (46.9), 91 (100); HRMS (FAB) (C 46H53N205Si requires 
741.3725, found 741.3718). 
(2S,3S,4R)-5-tert-Butyldiphenylsilyloxy-4-N,N-dibenzylamino-3-hydroxy-2-
methyl pentanoic acid methoxy-methyl amide 135 
Me Me NBn2 
MeO' NY
' f 
To a suspension of NO-dimethylhydroxylamine.HC1 (7.60 g, 78.0 mmol) in THF 
(15 cm) at -30 °C was carefully added trimethylaluminium (39.0 cm', (2.0 M in 
toluene), 78.0 mmol) over 5 minutes. Vigorous effervescence occurred and the 
mixture was allowed to warm to room temperature over Ca. 15 minutes after which 
time a clear solution remained. This solution was recooled to -30 °C and a -30 °C 
solution of the aldol adduct 136 (1.90 g, 2.62 mmol) in THF (10 cm) was added via 
cannula. The mixture was warmed to 0 °C and stirred at 0 °C for 2.5 hours. The 
reaction mixture was then cannulated into a rapidly stirred biphasic mixture of DCM 
(150 cm3) and saturated aqueous sodium potassium tartrate solution (150 CM),  the 
resulting mixture was stirred at room temperature for 18 hours when two clear phases 
were apparent. The organic phase was separated and the aqueous phase was extracted 
with DCM (3 x 150 CM)  . The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica gel [hexane:EtOAc (3:1)] to give the title compound (1.59 g, 99%) as a 
colourless solid, Rf [hexane:EtOAc (3:1)] 0.31; mp 100-102 °C; [a]D  -8.6 (c 0.93, 
CHC13); Vm (CHC13 soln.)/cm' 3474, 1627; oH  (250 MHz, CDC1 3) 7.82-7.18 (20H, 
m, ArH), 4.23 (1H, dd, J 11.0, 3.2, C 5HAHBOTBDPS), 4.14 (1H, brdd, J9.7 (2d 
coupling obscured), C 3 H), 4.03 (1H, dd, J 11.2, 6.1, C 5HAHBOTBDPS), 3.93 (2H, d, 
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J 13.8, CHXHYPh x 2), 3.75 (2H, d, J 13.8, CHAHBPh x2), 3.54 (3H, s, OMe), 3.48-
3.44 (1H, m, C211), 3.14 (3H, s, Me), 2.78 (1H, ddd, J9.2, 6.1, 3. 1, CA,  1.14 (9H, s, 
tBu), 0.57 (3H, d, J7.0, C2Me); E (62.9 MHz) 178.9, 140.1 (2C), 135.7 (2C), 135.6 
(2C), 133.4, 133.1, 129.6 (2C), 128.9 (4C), 128.0 (4C), 127.6 (2C), 127.5 (2C), 126.8 
(2C), 77.1, 69.1, 61.3, 61.0, 57.9, 55.2 (2C), 35.0, 26.9 (3C), 19.1, 8.7 (1C); mlz 
(FAB) 625 ([M+H], 39.8), 535 (44.2), 478 (39.0), 355 (27.3), 91(100); HRMS 







To a solution of Weinreb amide 135 (254 mg, 0.41 mmol) in methanol (4 cm) was 
added 10 % Pd/C (254 mg). The mixture was exposed to a hydrogen atmosphere and 
stirred under hydrogen for 12 hours. The reaction mixture was filtered through a pad 
of Celite and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (1:3)] to give the title compound (102 
mg, 65%) as a colourless foam, R1 [hexane:EtOAc (2:3)] 0.31; [aID  -6.4 (c 0.95, 
CHC13); Vm  (neat)/cm' 3385, 3272, 1696; 8 H (250 MHz, CDC13) 7.66-7.25 (10H, m, 
ArH), 5.28 (1H, brs, NJ]), 3.80 (1H, dd, J 10.2, 4.4, CHAHBOTBDPS), 3.72 (1H, m, 
CA, 3.63 (1H, dd, J 10.2, 6.6, CHAHBOTBDPS), 3.52 (1H, dt, J6.7, 4.5, C5R), 2.82 
(1H, brs, 01]), 2.38(111, dq-.qn, J7.2, C3H), 1.18 (3H, d, J7.2, CH3), 1.05 (9H, s, 
tBu); ö (62.9 MHz) 176.6, 135.4 (4C), 132.6, 129.9 (2C), 127.8 (4C), 76.9, 65.1, 
61.2 (2C), 44.9, 16.7 (3C), 19.0, 13.0; m/z (FAB) 384 ([M+H], 100%), 306 (35.7), 






Ph r OTBDPS 
c:y 5c 
To a solution of the aldol adduct 136 (90 mg, 0.124 mmol) in methanol (1.5 cm') was 
added 10% PdJC (90 mg). The mixture was exposed to a hydrogen atmosphere and 
stirred under hydrogen for 18 hours. The mixture was filtered through a pad of celite 
and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (1:1)] to give the title compound (30 
mg, 0.063 mmol, 51%) as a colourless foam, along with lactam 134 (21 mg, 0.054 
mmol, 44%) as a colourless foam, R [hexane:EtOAc (1:1)] 0.45; [aID  +14.9 (c 0.41, 
CHC13); v 1 (neat)/cm' 3380, 1667; H  (250MHz, CDC1 3) 7.64-7.18 (1511, m, Ar!]), 
5.00 (111, d, J 15. 1, NCHAHBPh), 4.00 (1H, dd, J7.6, 6.1 CA,  3.80 (1H, dd, J 11. 0, 
3.3, CHXHYOTBDPS), 3.67 (1H, d, J 14.6, NCHAHBPh), 3.65 (111, dd, J 11.0, 5.2, 
CHXHYOTBDPS), 3.19 (1H, ddd, J6.0, 5.2, 3.2, C5H), 2.45 (111, dq-qn, J7.2, C3!]), 
1.29 (3H, d, 7.2, Me) 1.04 (9H, s, tBu);  ö (62.9 MHz) 174.9, 136.0, 135.5 (2C), 
135.4 (2C), 132.5, 132.4, 130.0, 129.9, 128.5 (2C), 127.9 (2C), 127.8 (2C), 127.7 
(2C), 127.3, 75.4, 63.2, 61.5, 44.6, 43.7, 26.7 (3C), 19.0, 13.8; m/z (FAB) 474 
([M+H], 100%), 416 (10.1), 199 (32.6), 91( 83.5); HRMS (FAB) (C 29H36NO3 Si 










To a solution of the lactam 134 (63 mg, 0.164 mmol) in DCM (1.5 cm) was added 
2,6-lutidine (23 j.il, 0.197 mmol) followed by tert-
butyldimethylsilyltrifluoromethanesulfonate (104 tl, 0.452 mmol). The mixture was 
stirred at room temperature for 3 hours. The reaction mixture was then diluted with 
EtOAc (5 cm3) and washed with a saturated aqueous solution of sodium bicarbonate 
(5 cm) and brine (5 cm). The organic phase was dried and concentrated under 
reduced pressure. The remaining residue was chromatographed on silica gel to give 
the title compound (77 mg, 94 %) as a colourless oil, Rf [hexane:EtOAc (3:1)] 0.38; 
[aID +8.1 (c 0.52, CHCI 3); Vm  (neat)/cm' 3203, 1705; oH (250 MHz, CDC13) 7.64-
7.34 (10H, m, ArH), 5.66 (1H, brs, NH), 3.79-3.73 (1H, m, CHAHBOTBDPS), 3.67 
(1H, dd, J 7.2, 5.2, C411), 3.53-3.45 (2H, m, C5H + CHAHBOTBDPS), 2.40 (1H, 
dq-qn, J7.2, C3H), 1.17 (3H, d, J7.2, Me), 1.04 (9H, s, tBu),  0.80 (9H, s, tBu), 0.00 
(3H, s, Me), -0.12 (3H, s, Me); O (62.9 MHz) 176.5, 135.4 (2C), 135.3 (2C), 132.5 
(2C), 129.9 (2C), 127.8 (4C), 76.5, 64.7, 62.0, 45.3, 26.6 (3C), 25.4 (3C), 19.0, 17.6, 
13.4, -4.4, -4.9; mlz (FAB) 498 ([M+H] +, 100%), 440 (24.6), 374 (26.9), 197 (3 7.6), 
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34 
me 	OTBS 
To a solution of the newly TBS protected lactam (vide supra) (50 mg, 0.1 mmol) in 
DCM (1.5 cm) was added triethylamine (18 tl, 0.13 mmol), di-tert-butyldicarbonate 
(31 mg, 0.14 mmol) and NN-dimethylaminopyridine (7 mg, 0.05 mmol). The 
reaction mixture was stirred at room temperature for 18 hours then diluted with 
EtOAc (5 cm3) and washed with saturated aqueous sodium bicarbonate solution (5 
cm3) and brine (5 CM)  . The organic phase was dried and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
(8:1)] to give the title compound (58 mg, 97%) as a colourless oil, R f [hexane:EtOAc 
(3:1)] 0.57; [aID  -30.0 (c 0.2, CHC13); V m (neat)/cm' 1754, 1715 (250 MHz, 
CDC1 3) 7.63-7.33 (10H, m, ArH), 4.14 (111, dd, J 3.7, 2.2, C411), 3.90-3.85 (2H, m, 
C5H+ CHAHB OTBDPS), 3.73 (1H, dd, J 12.4, 4.6, CHAHB OTBDPS), 2.48 (1H, dq, J 
7.2, 3.7, C3H), 1.43 (9H, s, tBu), 1.24 (3H, d, J7.2, Me), 1.04 (9H, s, tBu), 0.85 (911, 
, tBu), 0.56 (3H, s, Me), 0.00 (3H, s, Me); & (50.3 MHz) 175.5, 149.8, 135.5 (4C), 
132.8, 132.5, 129.8 (2C), 127.7 (4C), 82.8, 72.7, 66.8, 62.0, 47.8, 27.8 (3C), 26.8 
(3C), 25.5 (3C), 19.1, 17.7, 14.5, -4.5, -4.7; mlz (FAB) 598 ([M+H], 3.0%), 498 
(19.1), 325 (40.8), 217 (100), 109(83.7), 91(98.6); HRIVIS (FAB) (C 33H52NO5 Si2 






HO ç J 
To a solution of the lactam 139 (48 mg, 0.08 mmol) in THF (1.5 cm') at -78 °C was 
added lithiumtriethylborohydride (Super Hydride ®) (104 .il, (1 .OM in THF), 0.104 
mmol). The mixture was stirred at -78 °C for 15 minutes. The reaction was quenched 
with methanol (0.3 cm) and a saturated aqueous solution of sodium bicarbonate (1 
cm3). The resulting foamy slurry was warmed to room temperature and vigorously 
extracted with EtOAc (3 x 5 Cm)  . The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica gel [hexane:EtOAc (6:1)] to give the title compound (44 mg, 93%) as a 
colourless oil and as an approximately 1:1 mixture of diastereomers (from C 2 proton 
integration), Rf [hexane:EtOAc (3:1)] 0.59; [aID -11.1 (c 0.35, CHC13); v.a, 3467, 
1690; 8H  (250 MHz, CDC13) 7.68-7.24 (1 OH, m, An]), 5.38 (0.5H, brdd, J 7.4, 5.7, 
CA, 5.21 (0.5H, dd, J 8.9, 5. 0, CA,  4.30-3.40 (3H, m, C4H + C5H + 
CHAHBOTBDPS), 3.00 (1H, dd, J 10.9, 8. 1, CHAHBOTBDPS), 1.99-1.95 (1H, brm, 
CA, 1.60-1.30 (12H, m, OtBu  + C3Me), 1.20-0.96 (9H, m, SitBu), 0.90-0.70 (9H, 
m, SitBu), 0.05 (1.5 H, s, SiMe), 0.00 (1.51-1, s, SiMe), -0.12 (1.5H, s, Si/vIe), -0.21 
(1.5H, s, SiMè); & (62.9 MHz) 153.7, 152.9, 135.7 (2C)*,  135.5  (2C)*, 133.0*, 
132.4*, 130.0*, 129.8*, 127.8  (2C)*,  127.6  (2C)*, 88.6*, 80.0*, 67.8*, 66.5, 66.0, 
61.5, 60.4, 46.7, 46.0, 28.3 (3C)*,  26.8  (3C)*,  25.5  (3C)*, 19.0*, 18.9*, 11.7*, .4.5 
(2C)*, (* denotes signals common to both diastereomers); m/z (FAB) no parent ion 
mass, 582 [(M-OH)' 21%), 482 ([M-0 5H9O3] (i.e. —(OH + Boc)) 26%), 404 (21), 
325 (25), 217 (66); HRMS (FAB) for ion at m/z 482 (C 28H42NO2Si2 requires 
482.2911, found 482.2911). 
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Attempted Synthesis of C 3Me Nectrisine Analogue 58 
OH 
M dqO H 
To a solution of the multi-protected pyrrolidine 133 (35 mg, 0.06 mmol) in THF (1 
cm 3)  was added a solution of 6N HC1 (0.7 cm 3) in TI-IF (0.7 CM)  . The mixture was 
heated to 50 °C and held at this temperature for 2 hours. The reaction mixture was 
concentrated and the remaining residue was chromatographed on silica gel 
[CHC1 3 :MeOH:NH 3 (28% aqueous) (5:3:1)1 to give a colourless solid (large 
quantities of salts were present), which was subjected to a final purification by ion-
exchange chromatography (Dowex OH -). No material was recovered from the ion-
exchange resin after eluting with methanol, water and 28% aqueous ammonia. 
(3S,4S,5R)-4-Hydroxy-5-hydroxymethyl-3-methylpyrrolidin-2-one 140 
H OH 
0 	I4 	I 
Md OH 
To a solution of the TBDPS protected lactam 134 (30 mg, 0.078 mmol) in THF (1.0 
cm 3)  was added TBAF (156 p1, 0.156 mmol). The solution immediately turned 
yellow and the mixture was concentrated under reduced pressure. The residue was 
chromatographed on silica gel [EtOAc, followed by methanol] to give the title 
compound (9 mg, 80%) as a colourless amorphous solid, mp 126-128 °C; R 1 
[hexane:EtOAc (1:3)] 0.10; [a]D  +21.5 (c 0.26, MeOH); Vm (neat)/cm 3377, 3280, 
3208, 1643; o (250 MHz, CD30D) 3.86 (1 H, dd, J 7.3, 5.9, CH), 3.83 (1H, dd, J 
11. 6, 3.3, CHAHBOTBDPS), 3.62 (1H, dd, J 11.6, 5.9, CHAHBOTBDPS), 3.47 (1H, 
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td, J5.9, 3.3, C 2H), 2.43 (1H, dq-qn, J7.2, C 31]), 1.27 (3H, d, J7.3, CH3); & (62.9 
MHz) 177.9, 74.8, 61.9, 61.2, 44.8, 11.8; mlz (FAB) 146 ([M+H] 1 , 34.5%), 109 







To a solution of lactam 114 (160 mg, 0.42 mmol) in dry THF (2.0 cm') at 0 °C was 
added BH39THF (6.23 cm3 , ( 1.0 M in THF), 6.23 mmol). After Ca. 10 minutes the 
mixture was heated to reflux and held at reflux for 18 hours. The solution was cooled 
to 0 °C and methanol (Ca. 8 cm) was added to destroy unreacted borane. The solution 
was then concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (1:1)] to give the title compound (157 
mg, 100%) as a solid, R1 [hexane:EtOAc (1:3)] 0.78; mp 150 °C; [a] D  -8.08 (c 0.99, 
MeOH); Vm  (neat)/cm' 3542, 3489, 3350, 3180, 2928, 2845, 1426; oH (600 MHz, 
CD30D) 7.73-7.70 (4H, m, An]), 7.45-7.39 (6H, m, An]), 5.22 (1H, brs, NH), 4.20 
(1H, dt, J5.0, 1.6, CA,  4.08 (1H, dd, J 10.6, 4.8, CHAHBOTBDPS), 4.03 (1H, dt, J 
4.4, 1.8, CA,  3.85 (1H, dd, J 10.6, 2.6, CHAHBOTBDPS), 3.14 (1H, brdd, J 12.5, 
6.4, C 5HXHY), 3.04 (1H, dq, J 12.5, 2.6, C5HXHY), 2.76 (1H, dqn, J 4.9, 2.7, C2ff), 
1.07 (9H, s, tBu); O (50.3 MHz) 134.9 (4C), 132.2 (2C), 129.2 (2C), 127.1 (4C), 
78.5, 75.1, 73.1, 59.8, 59.0, 25.4 (3C), 18.3; m/z (FAB) 372 ([M+H], 100), 198 (4), 







To a solution of the silyl protected compound 141 (19 mg, 0.051 mmol) in 
acetonitrile (0.75 em') was added hydrofluoric acid (0.141 cm' (48% solution in 
water), ca. 5eq). The mixture was stirred for 15 mins before being concentrated under 
reduced pressure and treated with methoxytrimethylsilane (2 CM)  . This mixture was 
then re-concentrated. The residue was treated with methoxytrimethylsilane (2 cm') 
and re-concentrated. The resulting residue obtained was triturated with EtOAc (3 x 
1.0 cm) to give the hydrofluoride salt of the title compound (8 mg, 100%) as a tacky 
solid, [a]D+26.3 (c 0.30, H20) [lit.72c  +27.3 (c 0.47, H20)]; E (600 MHz, D 20) 4.36 
(111, dt, 1 5.0, 2.7, CA,  4.12 (1H, brt, J 3.7, CH), 3.98 (1H, dd, J 12.2, 4.6, 
CHAHBOH), 3.86 (1H, dd, J 12.2, 8.2, CHAHBOH), 3.65 (1H, dt, J 8.2, 4.2, C211), 
3.61 (1H, dd, J 12.6, 5.0, C5HH), 3.38 (1H, dd, J 12.6, 2.7, C5HxHy); E (62.9 
MHz) 75.5, 74.2, 66.6, 58.9, 49.9; m/z (FAB) 134 ([M+H], 30%), 116 (26), 102 
(47), 91(21); HRMS (FAB) (C 5H 12NO3 requires 134.0817, found 134.0817). All 
spectroscopic data was in good agreement with that of the literature. 
The HF salt was subjected to ion-exchange chromatography [Dowex OH] (prepared 
by treating Dowex 1 -X2 with iN aqueous NaOH, followed by water until pH of 
eluent returned to 7) eluting with water to give the free base (quantitative recovery) 
as a sticky oil, Rf [CHC13 :MeOH:28% aq. NH3 (5:3:1)] 0.21; [a] +8.2 (c 0.25, H20) 
[lit . 72b +8.1 (c 0.98, H20)}; 81, (600 MHz, D 20) 4.16 (1H, dt, J 5.8, 3.9, C411), 3.85 
(1H, dd,J5.7, 3.9, C3H), 3.75 (1H, dd,J11.6, 4.8, CHAHBOH), 3.67 (1H, dd,J11.6, 
6.4, CHAHBOH), 3.12 (1H, dd, J 12.2, 5.8, C5HXHY), 2.99 (1H, dt, J6.1, 4.8, CA, 
2.84 (1H, dd, 1 12.2, 3.9, C5HxHy); ö (62.9 MHz) 79.9, 77.4, 65.0, 62.0, 50.4. All 







To a solution of the lactam 134 (103 mg, 0.27 mmol) in THF (2.0 cm 3) at 0 °C was 
added borane.THF (4.05 cm', (1.0 M in THF), 4.05 mmol). After the initial 
effervescence had ceased the mixture was warmed to reflux and held at reflux for 24 
hours. Methanol was cautiously added to the cooled (0 °C) reaction mixture to 
destroy unreacted borane. The resulting mixture was concentrated under reduced 
pressure to a colourless paste. This paste was chromatographed on silica gel 
[hexane:EtOAc (2:3)] to give the title compound (92 mg, 93%) as a colourless oil, R f 
[hexane:EtOAc (6:1)] 0.25; [aID  +17.0 (c 1.26, CHC13); V m  (neat)/cm' 3468, 3255; 
6H (250 MHz, CDC13) 7.66-7.25 (1011, m, ArII), 4.36 (1H, brs, 011), 4.15 (1H, dd, J 
11.3, 3.0, C 5HAHB), 3.76 (1H, dd, J 11.3, 1.9, CSHAHB ), 3.70 (1H, t, J 7.9, C311), 3.26 
(1H, ddd,J8.3, 5.7, CH), 2.87-2.79 (2H, m, CH20TBDPS), 2.23 (1H, dq-.qn, J7.6, 
C411), 1.07 (3H, d, J 6.8, Me), 1.07 (911, s, tBu); 8c (62.9 MHz) 135.4 (4C), 132.3, 
131.9, 130.1 (2C), 127.9 (4C), 77.1, 72.6, 58.6, 58.4, 38.5, 26.8 (3C), 19.1, 15.5; mlz 
(FAB) 370 ([M+H], 40.5), 382(100), 199 (82.2), 135 (50.3); HRMS (FAB) 
(C22H32NO2Si requires 370.2202, found 370.2205). 
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To a solution of the TBDPS protected pyrrolidine 142 (45 mg, 0.122 mmol) in 
acetonitrile (1.5 cm) was added hydrofluoric acid (48% aqueous solution) (0.3 cm', 
—5 eq). The reaction mixture was stirred for 20 minutes. Methoxytrimethylsilane (3.0 
cm 3)  was added cautiously and the mixture was concentrated under reduced pressure. 
The remaining residue was again treated with methoxytrimethylsilane (3.0cm 3) and 
concentrated. This procedure was repeated once more. The remaining residue was 
chromatographed on silica gel [CHC1 3 :MeOH:NH3 (28% aqueous) (5:3:1)] to elute 
the hydrofluoride salt of the title compound (17 mg, 94%) as a colourless oil, R f 
[CHC13 :MeOH:NH3(28% aqueous) (5:3:1)] 0.45. The HF salt was subjected to ion-
exchange chromatography (Dowex 1X2, OH -) using MeOH to elute the free base (16 
mg, 100%) as a colourless oil, 
Data for HF salt: [aID  +6.3 (c 0.4, MeOH); 8. (250 MHz, CD30D) 3.97 (1H, dd, J 
11. 9, 3.5, CHA HBOH), 3.82 (1 H, dd, J 11.9, 6.0, CFIAHBOH), 3.78 (1H, t, J8.3, C3H), 
3.59 (1H, dd, J 11.7, 8.0, CSHAHB ), 3.42 (1H, ddd, J8.0, 6.1, 3.6, C21]), 2.96 (lH, 
dd-1, J 11.5, C,HAHS), 2.25 (1H, m, C41]), 1.23 (3H, d, J6.6, Me); & (75 MHz) 75.2, 
65.3, 57.6, 48.3, 39.2, 12.5. 
Data for free base: [aID  -2.3 (c 0.35, MeOH) H  (250 MHz, CD30D) 3.97 (1H, dd, J 
11.3, 3.9, CHAHHOH), 3.68 (1H, dd, J 11.3, 5.8, CHAHBOH), 3.55 (1H, t, J7.4, C3R), 
3.22 (1H, dd, J 10.9, 7.9, C5HXHY), 3.00 (1H, ddd, J7.3, 5.8, 3.9, C 21]), 2.65 (1H, dd, 
J 10.8, 8.6, C5HH), 2.13 (1H, qn, J 7.4, C41]), 1.16 (3H, d, J 6.8, Me); Ei (62.9 
MHz) 78.3, 65.9, 60.8, 56.1, 41.0, 14.3; mlz (FAB) 132 ([M+H], 44.0%), 322 (100); 






MeOA, 5 OTBDPS 
To a solution of trimethylphosphonoacetate (0.18 cm', 1.47 mmol) in THF/H 20 
(40:1) (20 cm) was added Ba(OFf) 2 (activated)' (240 mg, 1.47 mmol). After 
approximately 30 minutes a white suspension had formed and a solution of the 
aldehyde 73 (386 mg, 0.726 mmol) in THF (3 cm) was added. The resulting mixture 
was stirred for 18 hours. The mixture was then diluted with DCM (150 cm3) and 
washed with a saturated aqueous solution of sodium bicarbonate (150 cm 3) and brine 
(150 cm'). The organic phase was dried and concentrated under reduced pressure. 
The remaining residue was chromatographed on silica gel [hexane:EtOAc (4:1)] to 
give the title compound (320 mg, 78%) as a colourless oil, R f [hexane:EtOAc (4:1)] 
0.57; [aID +61.5 (c 1.06, CHC13); Vm  (neat)/cm' 1724, 1652, 1600, 1566, 1492; oH 
(250 MHz, CDC1 3) 7.53-7.24 (20H, m, ArH), 7.04 (1H, dd, J 15.9, 7.0, C21]), 6.03 
(1H, dd, J15.9, 1.4, C311), 3.93 (1H, dd, J 10.3, 6.3, C 5HAHBOTBDPS), 3.82 (2H, d, 
J —15.6 (obscured), NCHAHBPh x 2), 3.81 (1H, dd, J 10.3, 7.4, C5HAHBOTBDPS), 
3.77 (3H, s, Me), 3.60 (2H, d, J 14.0, NCHAHBPh x 2), 3.52 (1H, ddd, J7.7, 6.3, 1.3, 
C41f), 1.04 (9H, s, tBu);  O (62.9 MHz, CDC13) 166.6, 146.0, 139.6 (2C), 135.5 (4C), 
133.0 (2C), 129.7 (2C), 128.3 (4C), 128.2 (4C), 127.7 (4C), 126.9 (2C), 123.5, 63.7, 
60.3, 54.4(2C), 51.4, 26.6(3C), 18.9; mlz (FAB) 564 ([M+H], 75.6), 294 (100), 197 
(98.8), 135 (60.8), 105 (44.9), 92 (23.3); HRMS (FAB) (C 36H42NO3 Si requires 




dihydroxypentanoate 154 and Methyl (2S,3R,4R)-5-tert-butyldiphenylsilyloxy-4-
N,N-dibenzylamino-2,3-dihydroxypentanoate 143 
OH NBn2 	 OH NBn2 
MeO:4OTBDPS 	MeOJ OTBDPS 
0 OH 	 0 OH 
To a solution of the a,13-unsaturated  ester 144 (850 mg, 1.51 mmol) in acetone/water 
(8:1) (8.5 cm3) was added NMO (534 mg, 4.53 mmol) and osmium tetroxide (4% 
aqueous solution) (1.77 cm3 , 0.266 mmol). The mixture was vigorously stirred for 5 
hours. Saturated aqueous sodium sulfite solution (approx. 5 cm) was added and the 
resulting mixture was stirred for 1 hour, before being partitioned between DCM (25 
cm3) and brine (25 CM)  . The organic phase was separated and the aqueous phase was 
extracted with DCM (3 x 15 CM)  . The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica [hexane:EtOAc (4:1)] to give the title compounds as a 65:35 mixture of 
diastereomers ((2R, 3S, 4R):(2S, 3R, 4R)) (525 mg, 59%), 
Data for (2R,3S,4R) diastereomer 154: obtained (340 mg, 38%) as a colourless 
crystalline solid, Rf [hexane:EtOAc (4:1)] 0.22; mp 112-113 °C; [aID  -32.9 (c 1.4, 
CHC13); Vm  (neat)/cm' 3530, 1747; 6 H (250 MHz, CDC13) 7.73-7.17 (20H, m, ArH), 
4.30 (111, brs, OR), 3.98 (2H, d, J 11.3, NCHAHBPh x 2), 3.97-3.87(411, m, C2H+ 
C3H+ CH20TBDPS), 3.78 (3H, s, OMe), 3.53 (2H, d, J 13. 1, NCHAHBPh x 2), 3.13 
(1H, ddddt, J8.2, 4.0, C4H), 2.85 (1H, brs, 01]), 1.11 (9H, s, tBu); 6 (50.3 MHz) 
173.3, 138.5 (2C), 135.6 (2C), 135.6 (2C), 132.5 (2C), 130.0, 129.9, 129.0 (4C), 
128.4 (4C), 127.8 (4C), 127.3 (2C), 70.5, 68.2, 59.5, 59.0, 54.4 (2C), 52.2, 26.7 (3C), 
18.9; mlz(FAB) 598 ([M+H], 44.1), 478 (48.3), 328 (20.1), 197 (16.4), 135 (15.5, 
' Barium hydroxide was activated by heating in an oven at a temperature of 120°C for 2 hours. 
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91(100); HRMS (FAB) (C 36H44NO 5 Si requires 598.2989, found 598.2989); single 
crystal x-ray diffraction: see appendix. 
Data for (2S,3R,4R) diastereomer 143: obtained (185 mg, 21%) as a colourless oil, R f 
[hexane:EtOAc (4:1)] 0.17; [a]0 -30.6 (c 1.15, CHC13); Vm (neat)/cm -' 3482, 1738; 
H (250 MHz, CDCI3) 7.74-7.20 (20H, m, ArH), 4.66 (1H, brs, OH), 4.12-4.07 (4H, 
MI C2H + C3H + CH20TBDPS), 4.06 (211, d, J 12.9, CHAHBPh x 2), 3.77 (3H, s, 
OMe), 3.53 (2H, d, J 13.4, CHAHBPh x 2), 3.04 (1H, dt, J 9.4, 5.7, CH), 2.75 (111, 
brs, OH), 1.08 (9H, s, tBu); 8c (50 MHz, CDC13) 174.3, 139.3 (2C), 135.6 (2C), 
135.5 (2C), 132.6, 132.5, 129.9 (2C), 128.9 (4C), 128.2 (4C), 127.8 (4C), 127.0 (2C), 
72.4, 70.5, 61.5, 58.7, 54.9 (2C), 52.3, 26.7 (3C), 18.9. 
Synthesis of Diols via AD-mix-a 
To a solution of the a,13-unsaturated  ester 144 (150 mg, 0.266 mmol) in 
acetone/water (3:1) (5 cm) was added AD-mix-a (1.4 g) and methanesulfonamide 
(26 mg, 0.266 mmol). The reaction mixture was stirred vigorously for 7 days. 
Saturated aqueous sodium sulfite solution (approx. 3 cm) was added and the mixture 
was stirred for 1 hour, before being partitioned between DCM (15 cm') and brine (15 
cm3). The organic phase was separated and the aqueous phase was extracted with 
DCM (3 x 10 cm'). The combined organic extracts were dried and concentrated 
under reduced pressure. The remaining residue was chromatographed on silica gel 
[hexane:EtOAc (4:1)] to give unreacted starting material (108 mg, 72%), the 
(2R,3S,4R) diastereomer (19 mg, 43% (based on recovered starting material)) and the 
(2S,3R,4R) diastereomer (10 mg, 22% (based on recovered starting material)). 
Synthesis of Diols via AD-mix- 
The synthesis of the diols using AD-mixP was carried out in an identical manner to 
the synthesis with AD-mix-a. Chromatography provided unreacted starting material 
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(38 mg, 25 %), the (2R,3S,4R) diastereomer (26 mg, 22% (based on recovered 
starting material)) and the (2S,3R,4R) diastereomer (55 mg, 46% (based on recovered 
starting material)). 
(2R,3S,4R)-5-tert-Butyldiphenylsilyloxy-4-N,N-dibenzylamino-2,3-dihydroxy 
pentanoic acid methoxy-methyl-amide 157 
Me OH NBn2 
MeO' 
0 OH 
To a suspension of NO-dimethylhydroxylamine.HC1 (1.15 g, 11.68 mmol) in THF 
(6 cm') at -30 °C was added trimethylaluminium (5.84 cm', (2.0 M in toluene), 11.68 
mmol). The resulting mixture was allowed to warm to room temperature during 
which time vigorous gas evolution was observed. After 20 minutes gas evolution had 
ceased and the clear solution was recooled to -30 °C and a 30 °C solution of methyl 
ester 154 (220 mg, 0.389 mmol) in THF (2 cm') was added via cannula. The 
resulting mixture was allowed to warm to room temperature and stirred at room 
temperature for 24 hours. The reaction mixture was then cannulated into a rapidly 
stirred biphasic solution of DCM (50 cm') and saturated aqueous sodium potassium 
tartrate (50 CM)  . The resulting cloudy mixture was stirred vigorously for 5 hours 
when two clear phases separated. The organic phase was separated and the aqueous 
phase was extracted with DCM (3 x 30 CM)  . The combined organic extracts were 
dried and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (3:1)] to give the title compound (227 
mg, 93%) as a colourless oil, R f [hexane:EtOAc (3:1)] 0.24; [a]D  -21.9 (c 0.98, 
CHC13); Vm  (neat)/cm' 3446, 1664, 1589, 1495; oH  (250 MHz, CDC1 3) 7.78-7.20 
(20H, m, ArH), 4.24 (1H, brs, C211), 4.07 (1H, dd, J 11.4, 6.7, C5HAHBOTBDPS), 
3.96 (2H, d, J 13.2, NCHXHYPh x 2), 3.94 (1H, dd, J 11.4, 4.2, C 5HAHBOTBDPS), 
3.85 (1H, dd, J9.1, 1.0 1  C31]), 3.62 (2H, d, J 13.2, NCHXHYPh x 2), 3.42 (3H, s, 
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OMe), 3.31 (1H, ddd, J 9.1, 6.7, 4.2, C411), 3.20 (311, s, Me), 1.15 (9H, s, tBu); & 
(62.9 MHz) 172.5, 138.7 (2C), 135.6 (4C), 132.9, 132.7, 129.8 (2C), 129.0 (4C), 
128.3 (4C), 127.7 (4C), 127.1 (2C), 77.1, 68.6, 67.4, 60.7, 60.6, 59.9, 54.6 (2C), 26.8 
(3C), 19.1; mlz (FAB) 627 ([M+H], 68.5%), 478 (61.6), 357 (13.0), 135 (51.1), 91 
(100); HRMS (FAB) (C 37H47N205 Si requires 627.3254, found 627.3252). 
(2S,3R,4R)-4-N,N-Dibenzylamino-5-tert-butyldiphenylsiloxy-2,3-dihydroxy 
pentanoic acid methoxy-methyl-amide 142 
Me OH NBn2 
MeO'1' 
0 OH 
The synthesis of the (2S,3R,4R) diastereomer was carried out in an identicle manner 
to the (2R,3S,45) diastereomer. Thus, NO-dimethylhydroxylamine.hydrochloride 
(770 mg, 7.81 mmol), trimethylaluminium (3.91 cm', (2.0 Min toluene), 7.81 mmol) 
and methylester 143 (147 mg, 0.26 mmol) provided the title compound (138 mg, 
85%) as a colourless oil, after chromatography, R f [hexane:EtOAc (3:1)] 0.24; [a]D - 
25.0 (c 0.97, CHC1 3); Vm  (neat)/cm' 3448, 1654, 1493, 1453; 5H(250 MHz, CDC1 3) 
7.77-7.18 (2011, m, ArH), 4.93 (111, brd, J 4.7, OH), 4.27 (111, brd, J 8.8, C2H), 
4.15-4.11 (1H, m, C 5HAHBOTBDPS) 4.11 (1H, dd, J 10.8, 4.5, C5HAHBOTBDPS), 
4.06 (1H, dd, J 7.8, 4.7, C31-f), 4.00 (211, d, J 13.3, NCHXHYPh x 2), 3.64 (2H, d, .' 
13.3, NCHXHYPh x 2), 3.42 (311, s, OMe), 3.24 (311, s, Me), 3.08 (1H, dt, J9.2, 4.7, 
C411), 1.09 (9H, s, tBu); E (75 MHz) 173.5, 139.5 (2C), 135.6 (2C), 135.5 (2C), 
132.9, 132.6, 129.7 (2C), 128.3 (4C), 128.1 (4C), 127.7 (2C), 127.6 (2C), 126.8 (2C), 




hydroxy pentanal 159 
OBn NBn2 
0 OH 
I- - 	d 
To a solution of Weinreb amide 110 (70mg, 0.098 mmol) in toluene (1.5 cm3) at -78 
°C was added diisobutylaluminium hydride (244 tl, 0.244mmol). The resulting 
mixture was stirred at -78 °C for 20 mins and carefully quenched by addition of 
methanol (ca. 0.5 cm') and warmed to room temperature. The resulting mixture was 
diluted with DCM (10 cm3) and saturated aqueous sodium potassium tartrate solution 
(10 cm) was added. The resulting cloudy biphasic mixture was stirred for 3 hours 
after which two clear phases separated. The organic phase was separated and the 
aqueous phase was extracted with DCM (3 x 10 CM)  . The combined organic extracts 
were dried and concentrated under reduced pressure. The remaining residue was 
quickly chromatographed on silica gel [hexane:EtOAc (2:1)] to give the title 
compound (59 mg, 88%) as a colourless oil, Rf [hexane:EtOAc (2:1)] 0.56; [aID - 
38.7 (c 0.3, CH2C12); Vm  (neat)/cm' 3445, 1729; oH (200 MHz, CDC1 3) 9.60 (1H, d, 
J 1. 1, CHO), 7.69-7.04 (25H, m, ArH), 4.10 (111, d, J 11.0, OCHAHBPh), 4.10-3.97 
(4H, m, C2H + C3H +C5H20TBDPS), 3.79 (2H, d, J 13.5, NCHXHYPh x 2), 3.64 
(1H, d,J11.0, OCHAHBPh), 3.45 (2H, d, J 13.5, NCHxHyPh x 2), 3.09 (1H, dt,J9.5, 
5.1, C411), 1.00 (9H, s, tBu);  8c (50.3 MHz) 204.8, 139.7 (2C), 137.3 (2C), 135.7 
(2C), 135.6 (2C), 133.0, 132.7, 129.8 (2C), 129.2 (4C), 128.3 (4C), 128.2 (2C), 128.0 
(2C), 127.8 (4C), 127.1 (2C), 83.3, 72.7, 71.8, 60.9, 59.1, 54.9 (2C), 26.8 (3C), 18.9; 
mlz (FAB) 658 ([M+H], 1.8%), 541 (5), 478 (70), 135 (21.9), 91(100); HRMS 
(FAB) (C 42H48NO4Si requires 658.3353, found 658.3352). 
168 
Experimental 
Debenzylation of 159: Attempted Synthesis of Amino Aldehyde 112 
OH NH2 
H, 5 OTBDPS 
A solution of 159 (50 mg, 0.073 mmol) and 20% Pd(OH) 2/C (50 mg) in methanol (1 
cm') was exposed to a hydrogen atmosphere (1 atm.) and stirred vigorously for 72 
hours. T.l.c. showed that the reaction mixture was composed of several different 
components. As a result the reaction mixture was not purified further. 
p-Methoxybenzyloxyacetic acid 165 
r-11  OH 
OPMB 
To a suspension of sodium hydride (17.60 g (60% oil dispersion), 0.44 mol) in THF 
(400 cm') at 0 °C was added bromoacetic acid (15.0 g, 0.11 mol). p-Methoxybenzyl 
alcohol (15.18 g, 0.11 mol) was added dropwise to the mixture followed by tetra-n-
butyl ammonium bromide (1.76 g, 5.50 mmol). The reaction mixture was heated to 
reflux and held at reflux for 4 hours. The reaction was carefully quenched by addition 
of water at 0 °C and the resulting mixture was concentrated under reduced pressure to 
a slurry. This slurry was diluted with diethyl ether (300 cm 3) and extracted with a 
saturated aqueous solution of sodium bicarbonate (3 x 300 cm'). The combined 
aqueous extracts were acidified to pH 1 by addition of concentrated sulphuric acid 
and extracted with diethyl ether (3 x 500 cm'). The combined organic extracts were 
dried and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (1:1)] to give a pale yellow oil which 
crystallised on standing. Recrystallisation from diethylether provided the title 
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compound (14.3 g, 68%) as a colourless crystalline solid, R f [hexane:EtOAc (1:1)] 
0.42; mp 50-52 °C; Vm (nujol)/cm' 3480, 1713, 1612, 1513 5 1462; 6H  (200 MHz, 
CDC13) 9.78 (1H, brs, COOH), 7.28 (2H, d, J 8.4, ArH(ortho to methoxy)), 6.88 (2H, 
d, J 8.4, ArH (meta to methoxy)), 4.57 (2H, s, CH2COOH), 4.11 (211, s, 
OCH2ArOMe), 3.80 (3H, s, OMe); & (50.3 MHz) 175.1, 159.4, 129.7 (2C), 128.5, 








To a solution of p-methoxybenzyloxyacetic acid 165 (5.54 g, 28.3 mmol) in THF 
(150 cm') at -78 °C was added triethylamine (3.97 cm', 28.3 mmol) and pivaloyl 
chloride (3.32 cm', 28.3 mmol). The resulting slurry was allowed to warm to 0 °C 
and stirred at 0 °C for 20 minutes before being recooled to -78 °C. Meanwhile, in a 
separate flask a solution of the oxazolidinone 106 (5.00 g, 28.3 mmol) in THF (30 
cm3) at -78 °C was treated with n-butyllithium (1.6 M in hexanes) (17.66 cm', 28.3 
mmol). The lithiated oxazolidinone was then cannulated into the flask containing the 
mixed anhydride and the resulting mixture was stirred for 1 hour. A saturated 
solution of ammonium chloride (100 cm) was added producing to clear phases. The 
organic phase was separated and the aqueous phase was extracted with DCM (3 x 
100 CM)  . The combined organics were washed sequentially with saturated aqueous 
sodium bicarbonate (150 cm') and brine (150 cm') then dried and concentrated under 
reduced pressure. The remaining residue was chromatographed on silica gel 
[hexane:EtOAc (1:1)] to give the title compound (10.0 g, 100%) as a colourless solid, 
Rf [hexane:EtOAC (1:1)] 0.56; mp 63-65 °C; [aID +52.0 (c 1.25, CHC13) [lit.,bo4b  for 
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(R)-isomer, mp 67-68 °C, [aID  -69.2 (c 1.32, CH2C12)]; Vm  (nujol)/cm' 1764, 1713, 
1615, 1583, 1515, 1463; H  (200MHz, CDC1 3) 7.37-7.12 (7H, m, An]), 6.89 (2H, dd, 
J 6.6, 1.4, ArH (meta to methoxy), 4.74-4.67 (3H, m, CH20PMB + C 41]), 4.62 (2H, 
s, OCH2ArOMe), 4.24-4.20 (2H, m, C5H2), 3.80 (3H, s, OMe), 3.30 (111, dd, J 13.5, 
3.3, CHHPh), 2.80 (1H, dd, J 13.5, 9.5, CHAHBPh); 8c (50.3 MHz) 170.2, 159.4, 
153.3, 134.9, 129.7 (2C), 129.3, 129.1 (2C), 128.9 (2C), 127.3, 113.8 (2C), 73.0, 
69.2, 67.1, 55.1, 54.6, 37.5; mlz (FAB) 355 (M, 20.0%), 307 (100), 154 (55.4), 121 
(30.3). 




4 "PMBO NBn2 
OU)Nt Lf 5.OTBDPS 
To a -78 °C solution of imide 160 (2.80 g, 7.89 mmol) in toluene (30 cm) was added 
dibutylborontriflate (8.86 cm 3, ( 1.0 M in DCM), 8.86 mmol)), followed by 
triethylamine (1.42 cm3, 9.47 mmol). The resulting mixture was warmed to between - 
50 and -40 °C and stirred for 1 hour before being warmed to -30 °C and stirred for a 
further 1 hour. The mixture was then re-cooled to -78 °C and a -78 °C solution of the 
aldehyde 73 (1.0 g, 1.97 mmol) in toluene (10 cm) was added via cannula. The 
resulting solution was stirred at -78 °C for 1 hour and warmed to 0 °C and stirred for 
a further 45 minutes. The reaction was quenched by addition of methanol (10 cm 3) 
and pH 7 phosphate buffer solution (10 CM)  . Hydrogen peroxide (12 cm') in 
methanol (12 cm) was added cautiously and the resulting cloudy solution was stirred 
at 0 °C for 1 hour. The solution was diluted by addition of DCM (100 CM)  . The 
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organic phase was separated and the aqueous phase was extracted with DCM (3 x 20 
cm'). The combined organic extracts were washed with saturated aqueous sodium 
bicarbonate solution (60 cm') and brine (60cm 3) then dried and concentrated under 
reduced pressure. The remaining residue was chromatographed on silica gel 
[hexane:EtOAc (2:1)] to give the title compound (1.32 g, 78%) as a colourless solid, 
Rf [hexane:EtOAc (1:1)] 0.77; mp 56-58 °C; [a]D  +23.1 (c 0.88, CHC13); Vm 
(neat)/cm' 3534, 1779, 1705, 1609, 1511, 1490; 8H  (600 MHz, CDC1 3) 7.71-7.16 
(25H, m, ArH), 7.10 (2H, dd,J8.5, 1.9, ArHortho to methoxy), 6.76 (2H, dd, J8.8, 
2. 1, ArH meta to methoxy), 5.37 (1H, d, J2.7, C2 II), 4.44 (1H, dddd, J 10. 3, 7.4, 3. 1, 
2.1, CA,  4.22 (1H, td, J 8.2, 2.7, C3 .H), 4.14 (1H, d, J 10.7, CHAHBArOMe), 4.08 
(1H, dd, J 9.0, 2. 1, C5HXHY), 4.06 (1H, d, J 10.9, CHAHBArOMe), 4.06 (2H, m, 
CH20TBDPS), 4.03 (1H, dd, J 8.3, 7.4, C5HXHY), 3.84 (2H, d, J 13.9, NCHSHTPh x 
2), 3.72 (311, s, OMe), 3.62 (2H, d, J 13.9, NCHH2Ph x 2), 3.25 (111, q, J5.7, C4 II), 
3.18 (1H, dd, J 13.4, 3. 1, CHPHQPh), 3.00 (1H, d, J 8.4, 01]), 2.53 (111, dd, J 13.4, 
10.3, CHPHQPh), 1.04 (9H, s, tBu); & (62.9 MHz) 171.2, 159.2, 152.9, 139.9 (2C), 
135.7 (2C), 135.6 (2C), 135.2, 133.0, 132.9, 130.1 (2C), 129.6 (2C), 129.2 (2C), 
129.0 (4C), 128.8 (2C), 128.0 (4C), 127.6 (2C), 127.5 (2C), 127.2 (2C), 126.7 (2C), 
113.4 (2C), 77.9, 72.2, 72.1, 66.6, 61.4, 59.7, 55.7, 55.1, 54.6 (2C), 37.5, 26.7 (3C), 
19.0; m/z (FAB) 863 ([M+H], 20.1%), 593 (6.7), 478 (70.7), 121 (100), 91(91.1); 
HRMS (FAB) (C53H59N207 Si requires 863.4092, found 863.4090). 
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To a solution of aldol adduct 161 (50 mg, 0.058 mmol) in DCM/Water (9:1) (2 cm') 
was added 2,3-dichloro-5,6-dicyano-1,4-benzoquinone (16 mg, 0.0696 mmol). The 
initial dark brown colour changed to a dark green colour over Ca. 20 minutes. Stirring 
was continued for 1 hour. Saturated aqueous sodium bicarbonate (2 cm') was added 
and the organic phase was separated. The aqueous phase was extracted with DCM (3 
x 2 CM)  . The combined organic extracts were dried and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
(1:1)] to provide recovered starting material (34 mg, 68%), oxazolidin-2-one 106 (3 
mg, 91% (based on recovered starting material)) and aldehyde 166 (10 mg, 78% 
(based on recovered starting material)) as a colourless oil, R f [hexane:EtOAc (1:1)] 
0.76; [a]D  -26.3 (c 0.4, CH2C12); Vm  (neat)/cm' 3448, 1728, 1610, 1585, 1512; 8H 
(200 MHz, CDC13) 9.54 (1H, d, J 1. 1, CHO), 7.68-7.12 (20H, m, An]), 7.06 (2H, dd, 
J 8.4, 2.2, ArH ortho to methoxy), 6.73 (2H, dd, J 8.8, 2.2, ArH meta to methoxy), 
4.10-4.04 (3H, m, C2H + C3H + C5HAHBOTBDPS), 4.00 (1H, d, J 10.6, 
CHxHyArOMe), 3.79 (2H, d, J 13.3, NCHSHTPh x 2), 3.70 (3H, s, OMe), 3.70-3.67 
(1H, m, C5HAHBOTBDPS), 3.65 (1H, d, J 10.6, CHHArOMe), 3.47 (2H, d, J 13.3, 
NCHSHTPh x 2), 3.06 (1H, dt, J 9.5, 5.5, CH), 1.00 (9H, s, tBu); ö (50.3 MHz) 
204.9, 159.4, 139.7 (2C), 135.7 (2C), 135.6 (4C), 133.0, 132.8, 129.8 (2C), 129.2 
(4C), 128.3 (4C), 127.7 (4C), 127.1 (2C), 113.6 (2C), 83.0, 72.4, 71.7, 60.9, 59.2, 
55.0, 54.9 (2C), 29.5, 26.8 (3C), 18.9; mlz (FAB) 688 ([M+H], 1.4%), 478 (62), 197 




From Weinreb Amide 167 
To a -78 °C solution of Weinreb amide 167 (100 mg, 0.134 mmol) in toluene (2 cm') 
was added diisobutylaluminium hydride (335 p.!, (1.0 M in toluene), 0.335 mmol). 
The resulting mixture was stirred at -78 °C for 20 mins and carefully quenched by 
addition of methanol (Ca. 0.5 cm') and warmed to room temperature. The resulting 
mixture was diluted with DCM (10 cm 3) and saturated aqueous sodium potassium 
tartrate solution (10 cm') was added. The resulting cloudy biphasic mixture was 
stirred for 3 hours after which time two clear phases separated. The organic phase 
was separated and the aqueous phase was extracted with DCM (3 x 10 cm'). The 
combined organic extracts were dried and concentrated under reduced pressure. The 
remaining residue was quickly chromatographed on silica gel [hexane:EtOAc (2:1)] 
to give the title compound (82 mg, 93%) as a colourless oil, spectroscopic data was 
identical to that from the aldehyde obtainedfrom aldol adduct 161. 
(2S,3R,4R)-5-tert-Butyldiphenysilyloxy-4-N,N-dibenzylamino-3-hydroxy-2-p-
methoxybenzyloxy pentanoic acid methoxy-methyl-amide 167 
Me OPMBNBn2 
MeO (Lj 50ThS 
0 OH 
To a suspension of NO-dimethylhydroxylamine.hydrochloride (1.02 g, 10.44 mmol) 
in anhydrous THF (5 cm) at -30 °C was added trimethylaluminium (5.22 cm3 (2.0 M 
in toluene), 10.44 mmol). The solution was allowed to warm to room temperature 
over ca. 15 minutes, after which time a clear solution remained. The solution was 
recooled to -30 °C and a -30 °C solution of the aldol adduct 161 (300 mg, 0.35 mmol) 
in THF (2 cm') was added dropwise via cannula. The mixture was warmed to 0 °C 
and stirred at 0 °C for 2 hours. The reaction mixture was then cannulated into a 
rapidly stirred biphasic mixture of DCM (30 cm 3) and saturated aqueous sodium 
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potassium tartrate solution (30 cm') and stirred for 5 hours when two clear phases 
were apparent. The organic phase was separated and the aqueous phase was extracted 
with DCM (3 x 50 cm'). The combined organic extracts were dried and concentrated 
under reduced pressure. The residue was chromatographed on silica gel 
[hexane:EtOAc (1:1)] to give the title compound (247 mg, 95%) as a colourless oil, 
Rf [hexane:EtOAc (1:1)] 0.56; [a]D  -20.4 (c 0.68, CHC13); Vm  (neat)/cm' 3443, 
1668, 1611, 1585, 1512; 6H  (200 MHz, CDC13) 7.75-7.09 (22H, m, ArH), 6.79 (2H, 
dd, J6.6, 1.9, ArH meta to methoxy), 4.60 (1H, d, J 1.9, C211), 4.27 (1H, d, J 10.6, 
OCHAHBPh), 4.19 (1H, brdd, J7.7, 2.4, C311), 4.14-4.06 (2H, m, C 5HXHYOTBDPS + 
OCHAHBPh), 3.95-3.90 (1H, m, C5HXHYOTBDPS), 3.89 (2H, d, J 14.3, NCHSHTPh x 
2), 3.79 (3H, s, ArOMe), 3.70 (2H, d, J 14.3, NCHSHTPh x 2), 3.39 (3H, s, NOMe), 
3.21-3.14 (1 H, m, CA,  3.14 (3H, s, NMe), 2.69 (1H, brd, J 7.3, 011), 1.07 (9H, s, 
tBu) ;  8c (50.3 MHz) 171.5, 159.1, 140.1 (2C), 135.7 (3C), 135.6 (2C), 133.4, 133.0, 
129.6 (4C), 128.8 (4C), 128.0 (4C), 127.6 (3C), 126.7 (2C), 113.3 (2C), 75.0, 71.0, 
70.9, 60.9, 59.4, 55.1, 54.7 (2C), 32.2, 26.8 (3C), 18.9; mlz (FAB) 747 ([M+H], 
33%), 657 (4), 478 (15), 325 (11), 217 (91), 121 (42), 91(100), 73 (17); HRMS 






01 2  3N v 
To a solution of the aldol adduct 161 (980 mg, 1.14 mmol) in DCM (10 cm') was 
added 	2,6-lutidine 	(1.7 	cm3 , 	7.13 
	
mmol) 	followed 	by 	tert- 
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butyldimethyltrifluoromethanesulfonate (534 .il, 4.56 mmol). The resulting mixture 
was stirred at room temperature for 3 hours then diluted with EtOAc (50 cm') and 
washed with saturated aqueous sodium bicarbonate solution (30 cm') and brine (30 
cm3). The organic phase was dried and concentrated under reduced pressure. The 
remaining residue was chromatographed on silica gel [hexane:EtOAc (3:1)] to give 
the title compound (1.24 g, 100%) as a colourless sticky foam, R f [hexane:EtOAc 
(3:1)] 0.62; [aID  +31.6 (c 0.94, CHC13); v.. (neat)/cm 1782, 1702, 1611, 1586, 
1513; 8H (250 MHz, CDC13) 7.73 (27H, m, Ark!), 6.78 (2H, dd, J6.7, 2. 1, ArH meta 
to methoxy), 5.24 (1H, d, J6.9, C2.H), 4.43 (1H, d, J 11.4, CHAHBArOMe), 4.38 (1H, 
dd, J 7.0, 2.3, C3.H), 4.14 (1H, d, J 11.4, CHAHBArOMe), 3.97 (1H, m, 
C5'HXHYOTBDPS), 3.97 (2H, d, J 14.6, NCHSHTPh x 2), 3.87 (1H, dd, J 11.6, 3.3, 
CS'HXHYOTBDPS), 3.80 (1H, dd, J 8.6, 1.8, C5HPHQ), 3.70 (3H, s, OMe), 3.63 (2H, 
d, J 14.6, NCHSHTPh x 2), 3.53 (1H, dd, J8.3, 7.6, C 5HHQ), 3.40 (1H, m, C41]), 3.06 
(1H, dt,J9.0, 3.1, C4 IJ),2.72 (1 H, dd, J 13.5, 3. 1, CHMHNPh), 2.11 (1H, dd,J13.8, 
10.5, CFIMHNP1i), 1.15 (9H, s, tBu), 0.61 (9H, s, tBu), -0.02 (3H, s, Me), -0.08 (3H, s, 
Me); Oc  (50.3 MHz) 171.2, 159.3, 152.6, 140.3 (2C), 135.7 (4C), 135.2, 133.4, 133.1, 
130.0 (2C), 129.6 (2C), 129.4 (2C), 129.2 (2C), 128.6 (2C), 128.3 (4C), 128.0 (4C), 
127.5 (2C), 127.1 (2C), 126.3 (2C), 113.4 (2C), 79.1, 73.0 (2C), 66.2, 62.7, 55.0, 
54.9, 53.8 (2C), 37.0, 26.9 (3C), 26.0 (3C), 25.5, 19.1, 18.2, -3.3, -4.8; mlz (FAB) 
977 (MH, 5.7%), 478 (46.2), 197 (11.4), 135 (25.9), 121 (100), 91 (93.1), 73 (31.0); 
HRMS (FAB) (C 59H73N207Si2 requires 977.4956, found 977.4962). 
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ON .f. Lj> 5OTBDPS 
Small traces of this compound could be isolated if the above reaction was left for 
over 3 hours. For example, after 24 hours approximately 5% of the product was 
identified as 170. 
Data for 170: 
Obtained as a colourless solid, 
Rf [hexane:EtOAc (3:1)] 0.35; mp 123-125 °C; [a]D  +33.0 (c 2.7, CHC13); Vm 
(neat)/cm' 3541, 1785, 1695, 1600, 1492; 6H (250 MHz, CDC1 3) 7.80-7.15 (25H, m, 
An]), 5.47 (1H, brs, C2.I]), 4.48 (1H, dddd, J9.9, 7.3, 4.3, 2.9, C 4H), 4.15 (1H, dd, J 
9.2, 2.3, C3 ]]), 4.06 (2H, s, NCHAHBPh x 2), 3.98 (2H, s, NCH AHBPh x 2), 4.11-3.86 
(5H, m, C4.H + C5.H20TBDPS + C5H2) 3.27 (1H, dd, J 13.4, 2.9, CHAHBPh), 2.70 
(1H, dd, J 13.4, 9.9, CHAHBPh), 1.20 (9H, s, tBu),  0.58 (9H, s, tBu),  -0.26 (3H, s, 
Me), -0.45 (3H, s, Me); 8H  (62.9 MHz) 172.7, 152.6, 139.8 (2C), 135.8 (2C), 135.6 
(2C), 135.2 (2C), 133.2, 132.9, 129.7 (2C), 129.6 (3C), 129.4 (2C), 128.9 (2C), 128.0 
(3C), 127.7 (2C), 127.6 (3C), 127.2, 126.7 (2C), 71.6, 70.3, 66.2, 64.3, 61.7, 55.8 
(2C), 55.7, 37.1, 27.0 (3C), 25.7 (3C), 19.0, 17.6, -4.6, -5.0; mlz (FAB) 857 
([M+H], 71%), 587 (4.4), 478 (100), 197 (32), 135 (58), 91(98), 73 (66); HRMS 








To a solution of the aldol adduct 167 (758 mg, 7.76 mmol) in TI-IF (12 cm') at 0 °C 
was added lithium borohydride (854 mg, 38.8 mmol) followed by MeOH (1.58 cm 3 , 
38.8 mmol). The mixture was warmed to room temperature and stirred at room 
temperature for 18 hours. IN aqueous sodium hydroxide (5 cm') was cautiously 
added to destroy unreacted borohydride. The organic phase was separated and the 
aqueous phase was extracted with EtOAc (3 x 10 cm 3). The combined organic 
extracts were dried and concentrated under reduced pressure. The remaining residue 
was chromatographed on silica gel [hexane:EtOAc (4:1)] to give the title compound 
(530 mg, 88%) as a colourless foam, Rf [hexane:EtOAc (2:1)] 0.63; [a] 0 +22.8 (c 
0.58, CHC13); Vma,, (neat)/cm- ' 3446, 1612, 1587, 1513; 8H  (250 MHz, CDC13) 7.74-
7.23 (20H, m, ArH), 7.18 (2H, dd, J7.1, 1.9, ArHortho to methoxy), 6.85 (2H, dd, J 
6.7, 2.0, ArH2 meta to methoxy), 4.35 (1H, d,J11.3, CHAHBArOMe), 4.16 (1H, d, J 
11. 3, CHAHBArOMe), 3.94 (2H, d, J 13.6, NCHXHYPh x 2), 3.95-3.85 (1H, m, 
C5HAHBOTBDPS), 3.87 (1H, q, J 4.3, CA,  3.85-3.75 (1H, m, C 5HAHBOTBDPS), 
3.80 (3H, s, OMe), 3.73 (2H, d, J 13.6, NCHXHYPh x 2), 3.45 (1H, dd, J 7.1, 4. 1, 
CA, 3.36 (1H, m, C41]), 3.36-3.15 (2H, m, CH), 1.15 (9H, s, tBu),  0.65 (911, s, 
tBu), -0.11 (3H, s, Me), -0.17 (3H, s, Me); ö (62.9 MHz) 159.0, 140.3 (2C), 135.7 
(2C), 135.6 (2C), 133.4 (2C), 130.6, 129.6 (4C), 129.1 (4C), 127.9 (4C), 127.6 (4C), 
126.6 (2C), 113.6 (2C), 80.4, 72.3, 71.6, 63.4, 61.3, 59.9, 55.0 (3C), 26.9 (3C), 25.7 
(3C), 19.0, 17.9, -3.7, -4.9; m/z (FAB) 804 ([M+H], 39%), 478 (19.0), 197 (5.0), 





p-methoxybenzyloxy pentan-1-ol 171 
PMBO NH2 
HO 	 OTBDPS 
OTBS 
A solution of the benzyl protected amino alcohol 168 (500 mg, 0.63 5 mmol) and 
20% Pd(OH) 2/C (500mg) in MeOH (10 cm) was exposed to a hydrogen atmosphere 
and stirred under hydrogen for 17 hours. The reaction mixture was filtered through a 
plug of celite and concentrated under reduced pressure. The remaining residue was 
chromatographed on silica gel [hexane:EtOAc (1:1)] to give the title compound (334 
mg, 90%) as a colourless oil, R 1 [hexane:EtOAc (1:1)] 0.44; [a]D  +26.1 (c 1. 14, 
CHCI3); Vm  (neat)/cm' 3567, 3466, 1611, 1587, 1513; 8. (200 MHz, CDC1 3) 7.66-
7.25 (1 OH, m, ArH), 7.08 (2H, d, J 8.4, ArH ortho to methoxy), 6.72 (2H, d, J 8.4, 
ArH meta to methoxy), 4.58 (1H, d, J 11.4, CHAHBArOMe), 4.23 (111, d, J 11.4, 
CHAHBArOMe), 3.94 (1H, dd-t, J 10.1, CH), 3.76 (3H, s, OMe), 3.75-3.62 (3H, m, 
C5H20TBDPS + C2R), 3.48-3.40 (3H, brm, NH2 + CA, 3.20 (2H, m, C 1 H2), 1.06 
(9H, s, tBu), 0.81 (9H, s, tBu), -0.09 (3H, s, Me), -0.10 (311, s, Me); & (50.3 MHz) 
159.1, 135.5 (2C), 133.7, 130.4(2C), 129.6(2C), 129.1 (4C), 127.6(4C), 113.6(2C), 
80.7, 72.7, 70.1, 65.1, 57.0, 56.3, 54.8, 26.7 (3C), 25.5 (3C), 19.0, 17.7, -4.5, -5.0; 
mlz (FAB) 624 ([M+H]-, 0.7%), 325 (11.3), 217 (62.6), 91 (84.8), 45 (100); HRMS 








A suspension of IBX (65.2 mg, 0.233 mmol) in DMSO (0.5 cm 3) was stirred 
vigorously for approximately 20 minutes by which time a clear solution was 
apparent. At this point the amino alcohol 170 (145 mg, 0.233 mmol) in THF (3.5 
cm') was added via syringe. The resulting mixture was stirred at room temperature 
for 15 minutes. Water (1.5 cm) was added and the mixture was diluted with EtOAc 
(5 CM)  . The organic phase was separated and the aqueous phase was extracted with 
EtOAc (3 x 5 cm'). The combined organic extracts were dried and concentrated 
under reduced pressure. The residue remaining was chromatographed on silica gel 
[hexane:EtOAc (4:1)] to give the title compound (138 mg, 96%) as a colourless oil, 
Rf [hexane:EtOAc (4:1)] 0.44; [a]D  +7.1 (c 0.05, CH2C12); Vm  (neat)/cm' 3399, 
1611, 1587, 1512; 8H  (600 MHz, CDC13) 7.73-7.30 (10H, m, ArH), 7.23 (0.8H, dd, J 
8.5, 2. 1, Arffortho to methoxy), 7.12 (1.2H, dd, J8.5, 2.2, ArHortho to methoxy), 
6.86 (0.8H, dd, J 8.5, 2.1, ArH meta to methoxy), 6.81 (1.2H, dd, J 8.5, 2.0, ArH 
meta to methoxy), 4.50 (0.4H, d, J 11.5, CHAHBArOMe), 4.45 (0.4H, d, J 11.5, 
CHAHBArOMe), 4.36 (0.611, d, J 11.3, CHAHBArOMe), 4.34 (0.6H, d, J 11.3, 
CHAHBArOMe), 4.08 (0.6H, d, J2.4, CA,  4.05 (1.OH, dd, J9.7, 5.2, C5HXHY), 3.98 
(0.4H, d,J3.2, CA,  3.90 (0.6H, dt,J5.1, 2.5, 2.5, CA,  3.83-3.79 (0.4H, m, C41]), 
3.79 (1.21-1, s, OMe), 3.79 (1.8H, s, OMe), 3.81-3.77 (0.4H, m, CHSHTOTBDPS), 
3.76 (0.4H, d, J 10.7, CHSHTOTBDPS), 3.70 (0.6H, d, J 10.3, CHSHTOTBDPS), 3.67 
(0.611, d,J10.3, CH SHTOTBDPS), 3.62 (1.OH, dd,J9.8, 2.8, C 5HXHY), 1.06 (3.6H, s, 
tBu), 1.05 (5.4H, s, tBu),  0.88 (5.4H, s, tBu),  0.70 (3.6H, s, tBu), 0.08 (1.8H, s, Me), 
0.08 (1.811, s, Me), -0.03 (1.2H, s, Me), -0.10 (1.2H, s, Me); & (62.9MHz) 159.0*, 
135.6* (2C), 135.5* (2C), 133.3, 133.1, 129.8*, 129.7*, 129.5*, 129.4, 129.1, 129.0* 
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(2C), 127.5*  (4C), 113.7 (2C), 113.6 (2C), 95.2, 94.2, 84.9, 84.3, 80.5, 76.4, 71.2*, 
70.1, 68.7, 66.8, 66.7, 55.2*,  26.8  (3C)*,  25.6 (3C)*, 19.1*, 17.9, 17.7, -4.8, -4.9, - 
5.0, -5.3 (*denotes  signals common to both diastereomers); mlz (FAB) 622 
([M+H], 5.9%), 564 (1.8), 383 (2.5), 121 (100), 73 (23.8); FIRMS (FAB) 
(C35H52NO5Si2 requires 622.3384, found 622.3385). 
(2R,3S,4R)-2-tert-butyldiphenylsilyloxymethyl-3-tert-butyldimethylsilyloxy-4-p-




To a solution of the mixture of anomeric amines 176a (2.4 mg, 3.86 mo1) in THF 
(0.5 cm) was added phenyl isocyanate (1 pi,  9.1 pmo1). The resulting mixture was 
stirred for 18 hours before being concentrated under reduced pressure. The remaining 
residue was chromatographed on silica gel [hexane:EtOAc (4:1)] to provide the title 
compound (1.2 mg, 42%) as a colourless oil, Rf [hexane:EtOAc (4:1)] 0.41; Vm 
(neat)/cm' 3686, 1678; 8H(600 MHz, CDC1 3) 7.71 (1H, brs, NHPh), 7.65 (2H, dd, J 
7.9, 1.4, ArH ortho to silicon), 7.60 (2H, dd, J 7.9, 1.4, ArH ortho to silicon), 7.42-
7.07 (12H, m, ArH), 6.96 (1H, tt, J7.3, 1.3, ArHparato NH of urea), 6.88 (2H, dd, J 
6.6, 2.0, ArHmetato methoxy), 5.17 (1H, brs, NH (at anomeric centre)), 4.63 (111, d, 
J 5.5, CA,  4.52 (1H, d, .1 11.5, CHAHBArOMe), 4.37 (1H, d, J 11.5, 
CHAHBArOMe), 4.06 (1H, ddd, J 6.7, 5.5, 4.4, CI]), 4.02 (1H, dd, J 9.2, 6.7, 
C5HXHY), 3.93 (1H, d, J 11.5, CHSHTOTBDPS), 3.81 (3H, s, OMe), 3.77 (1H, dd, J 
9.2, 4.4, C5HXHY ), 3.65 (1H, d,J11.5, CHSHTOTBDPS), 1.04 (9H, s, tBu),  0.90(9H, 
, tBu), 0.13 (3H, s, SiMe), 0.06 (3H, s, SiMe); nOe experiments: irradiation of the 
signal at 3.65 ppm caused enhancement of the signals at 3.93 ppm (15%) and 4.63 
ppm (2.5%), irradiation at 3.93 ppm caused enhancement of signal at 3.65 ppm 
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(13%), irradiation at 4.37 ppm caused enhancement of signal at 4.52 ppm (17%), 
irradiation of signal at 4.52 ppm caused enhancement of signal at 4.37 ppm (12%); 
mlz (FAB) 741 ([M+H], 5.3%), 683 (14.2), 383 (15.9), 121 (100) ; HRMS (FAB) 
(C42H57N206Si2 requires 741.3755, found 741.3758) 
(2'S,3'S,4S,4'R)-3-(3'-tert-Butyldimethylsilyloxy-5'-tert-butyldiphenylsilyloxy-
4'-N,N-dibenzyl-2 '-methyl-i '-oxopentyl)-4-phenylmethyloxazolidin-2-one 178 
Ph 
Me NBn2 
03N ij% 5 OTBDPS 
o 0 OTBS 
To a solution of the aldol adduct 136 (373 mg, 0.50mmol) in DCM (6 cm) was 
added 2,6-lutidine (147 p1, 1.25 mmol) followed by tert-
butyldimethylsilyltrifluoromethanesulphonate (292 p1, 1.25 mmol). The mixture was 
stirred at room temperature for 1.5 hours then diluted with EtOAc (40 cm 3) and 
washed with a saturated aqueous solution of sodium bicarbonate (20 cm 3) and brine 
(20 CM)  . The organic phase was dried and concentrated under reduced pressure. The 
remaining residue was chromatographed on silica gel [hexane:EtOAc (8:1)] to give 
the title compound (394 mg, 92%) as a colourless solid, R f [hexane:EtOAc (3:1)] 
0.71; mp 56-57 °C; [aID  +31.3 (c 0.88, CHC13); 8H  (250 MHz, CDC1 3) 7.81-7.13 
(25H, m, Ark!), 4.46 (1H, dddd, J 9.9, 9.6, 6.6, 3.3, C411), 4.33 (1H, dq, J 7.2, 2.0, 
C2 H), 4.12 (1H, dd, J 10.9, 4.1, C S 'HAHB OTBDPS), 4.10 (3H, m, C5H2 + 
C5 'HAHBOTBDPS), 4.06 (2H, d, J 13.8, NCHX HY Ph x 2), 3.96 (1H, dd, J 8.5, 2.0, 
C3 H), 3.90 (2H, d, J 13.4, NCHXHY Ph x 2), 3.14 (1H, dd, J 13.3, 3.3, CHSHTPh), 
3.10 (1 H, dt, J9.9, 4.1, C4.I]), 2.65 (1 H, dd, J 13.3, 9.6, CHSHTPh), 1.20 (9H, s, tBu), 
0.75 (3H,d,J7.2, C2.Me), 0.59 (9H, s, tBu),  -0.13 (3H, s, SiIvfe), -0.27 (3H, s, SiMe); 
E (62.9 MHz) 175.6, 152.4, 140.2 (2C), 135.6 (2C), 135.4 (2C), 135.1, 133.1 (2C), 
182 
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129.5, 129.3, 129.1 (4C), 128.6 (4C), 127.8 (4C), 127.4 (4C), 126.9, 126.3 (2C), 
71.1, 65.6, 64.8, 60.8, 55.4 (2C), 54.8, 41.0, 37.6, 26.8 (3C), 25.7 (3C), 18.9, 18.0, 
10.2, -4.1, -5.1; mlz (FAB) 854 (M, 59.9%), 797 (31.2), 678 (24.7), 585 (27.4), 478 
(100); FIRMS (FAB) (C 52H67N205Si2 ([M+H]) requires 855.4589, found 855.4573). 
(2R,3S,4R)-3-tert-Butyldimethylsilyloxy-5-tert-butyldiphenylsilyloxy-4-N,N-




To a solution of the aldol adduct 177 (320 mg, 0.37 mmol) in uHF (5 cm') was 
added lithium borohydride (0.925 cm3, 1.85 mmol (2.0 M in THF)) followed by 
methanol (40 tl). The reaction mixture was stirred for 30 minutes at room 
temperature. The reaction was quenched by addition of a iN sodium hydroxide 
solution (ca. 1 cm 3) and partitioned between water (10 cm') and EtOAc (10 cm'). The 
organic phase was separated and the aqueous phase was extracted with EtOAc (3 x 
10 cm'). The combined organic extracts were dried and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane:EtOAc 
(6:1)] to give the title compound (252 mg, 99%) as a colourless oil, R f 
[hexane:EtOAc (3:1)] 0.69; [aID  -17.4 (c 1.9, CHC13); Vmi,, (neat)/cm' 3445, 1615, 
1590, 1521; 8H  (250 MHz, CDC1 3) 7.83-7.21 (20H, m, Ark!), 4.00 (2H, d, J 13.3, 
NCHAHBPh x 2), 4.00 (2H, m, C5H20TBDPS), 3.86 (2H, d, J 13.3, NCHAHBPh x 2), 
3.60 (1H, dd, J8.3, 1.4, C3H), 3.27 (2H, d, J7.5, CH20H), 3.17 (1H, td, J-9.5, 4.8, 
CA, 2.15 (1H, ddd, J7.5, 6.6, 1.3, C2H), 1.23 (9H, s, 'Bu), 0.62 (9H, s, 'Bu), 0.25 
(3H, d, J6.6, C2Me), -0.11 (3H, s, Si/vIe), -0.31 (3H, s, Si/vIe); E (62.9 MHz) 140.6 
(2C), 135.7 (2C), 135.6 (2C), 133.4, 133.3, 129.6 (2C), 129.4 (4C), 128.0 (4C), 127.6 
(2C), 127.6 (2C), 126.7 (2C), 71.5, 65.2, 65.1, 59.8, 55.4 (2C), 38.1, 27.0 (3C), 25.7 
(3C), 19.0, 17.9, 9.2, -4.2, -4.4; mlz (FAB) 682 ([M+H], 50.1%), 478 (62.6), 197 
183 
Experimental 
(31.2), 135 (83.8), 91 (60.7), 73 (100); HRMS (FAB) (C 42H6ONO3 Si2 requires 





To a solution of NN-dibenzylamino alcohol 178 (114 mg, 0.167 mmol) in methanol 
(2.0 cm'), was added 20% Pd(OH) 2/C (114 mg). The reaction mixture was exposed to 
a hydrogen atmosphere (1 atm.) and stirred under hydrogen for 18 hours. The 
reaction mixture was filtered through a pad of Celite and concentrated under reduced 
pressure. The remaining residue was chromatographed on silica gel [hexane: EtOAc 
(1:1) + 5% EtN) to give the title compound (35 mg, 42%) as a colourless oil, Rf 
[hexane: EtOAc (3:1)] 0.11; 8H  (200 MHz, CDC1 3) 7.68-7.27 (10H, m, An]), 3.80-
3.57 (4H, m, CH20TBDPS + C3H + C I HAHBOH), 3.31 (1H, dd, J 11.4, 5.4, 
C I HAHBOH), 3.18 (1H, dt, J9.1, 4.5, CI]), 2.62 (2H, brs, NH2), 1.83-1.79 (1H, brm, 
C4H), 1.08 (9H, s, tBu), 0.90 (3H, d, J 7.3, C2Me), 0.83 (9H, s, tBu), 0.00 (3H, 5, 
Si/vIe), -0.06 (3H, s, SiMe); ö (50.3 MHz) 135.5 (4C), 129.7 (2C), 127.7 (4C), 75.8, 




butyldimethylsilyloxy-4-methyl furan 181 
OTBDPS 
c H2  
Me 	OTBS 
A suspension of IBX (17 mg, 0.06 mmol) in DMSO (0.1 cm) was stirred vigorously 
for approximately 20 minutes by which time a clear solution was apparent. At this 
point the amino alcohol 179 (30 mg, 0.06 mmol) in THF (0.3 cm) was added via 
syringe. The resulting mixture was stirred at room temperature for 2 minutes. Water 
(1.5 cm') was added and the mixture was diluted with EtOAc (2 CM)  . The organic 
phase was separated and the aqueous phase was extracted with EtOAc (3 x 2 cm). 
The combined organic extracts were dried and concentrated under reduced pressure. 
The residue remaining was chromatographed on silica gel [hexane:EtOAc (5:1)] to 
give the title compound (29 mg, 100%) as a colourless oil, R f [hexane:EtOAc (1:1)] 
0.93; 8H (200 MHz, CDCI3) 7.78-7.27 (10H, m, ArH), 4.07 (03H, dd-t, J 8.2, 
C5HAHB), 3.92 (03H, dd-t, J8.4, C 5HAHB), 3.86 (1H, d, J7.0, C311), 3.74 (03H, d, J 
10.3, CHAHBOTBDPS), 3.64 (03H, d, J 10.6, CHAHBOTBDPS), 3.55 (1.4H, s, 
CHAHBOTBDPS), 3.49 (03H, dd-t, J 8.4, C5HAHB), 3.32 (03H, dd-t, J 8.6, 
C5HAHB), 2.40 (1H, dqn, J8.4, 7.0, C411), 1.84 (2H, brs, NH2), 1.08 (9H, s, tBu), 1.06 
(3H, d, J7.0, C4Me), 0.90 (63H, s, tBu), 0.80 (23H, s, tBu), 0.10 (2.1H, s, SiMe), 
0.05 (0.9H, s, SiMe), 0.03 (0.9H, s, SiMe), 0.02 (2.1H, s, SiMe); ö (50.3 MHz) 
135.7 (2C), 135.3 (2C), 133.3 (2C), 129.6 (2C), 127.6 (4C), 92.8, 78.7, 70.3, 67.4, 
40.8, 26.7 (3C), 25.6 (3C), 19.1, 17.5, 15.4, -4.5, -5.0. 
185 
Experimental 
(4S)-3-(2 '-Bromo-2 '-methyl-i '-oxopropyl)-4-phenylmethyloxazolidifl-2-OflC 187 
Ph 
01 3N 	2' Br 
0 0 
To a solution of the oxazolidinone 106 (2.0 g, 11.3 mmol) in THF (50 cm') at -78 °C 
was added '2BuLi (7.1 cm3 , ( 1.6 M in hexanes), 11.3 mmol) followed by 2-bromo-2-
methylpropionylbromide (3.38 g, 2.42 cm3 , 14.7 mmol). The mixture was stirred at - 
78 °C for 1 hour. The reaction was quenched by addition of a saturated aqueous 
solution of ammonium chloride (Ca. 40 cm 3). The organic phase was separated and 
the aqueous phase was extracted with DCM (3 x 50 
CM)  . The combined organic 
extracts were dried and concentrated under reduced pressure. The residue was 
chromatographed on silica gel [hexane:EtOAc (4:1)] to give the title compound (3.38 
g, 92%) as a colourless crystalline solid, R f [hexane:EtOAc (3:1)] 0.56; mp 68-70 °C; 
[a]0 +28.9 (c 1.07, CHC13); Vm  (neat)/cm' 1789, 1681, 1603, 1583, 1546; 6 (200 
MHz, CDC1 3) 7.39-7.21 (5H, m, ArH), 4.73 (1H, tdd, J9.8, 3.6, 2.9, C4H), 4.26 (1H, 
dd-t, J 9. 1, C5HAHB), 4.17 (1H, dd, J 9.1, 3.0, C 5HAHB), 3.24 (1H, dd, J 13.3. 3.6, 
CHHPh), 2.82 (1H, dd, J 13.3, 9.5, CHXHYPh), 2.14 (3H, s, Me), 2.09 (3H, s, Me); 
ö (50.3 MHz) 171.1, 151.1, 135.1, 129.4 (2C), 128.9 (2C), 127.3, 66.0, 57.5, 56.7, 
37.4, 31.3, 30.2; mlz (FAB) 328 (M, 81 Br 99%) 326 (Mt, "Br 100%), 247 (45), 178 




dimethyl-3'-hydroxy-1 'oxopenty1)-4-pheny1methyIoxazo1idin-2-Ofle 186 
Ph 
NBn2 
01 N 	 1.5.O1BDPS 
To a solution of 186 (321 mg, 0.985 mmol) and aldehyde 73 (200 mg, 0.394 mmol) 
in THF (3 cm) was added Lii (5 mg, 0.0394 mmol) and CrCl 2 (241 mg, 1.97 mmol) 
(Note: all manipulations involving CrC1 2  were performed in a glove bag under an 
atmosphere of argon). A slight exotherm occurred on addition of the CrC1 2 and the 
mixture was stirred at room temperature for 90 minutes. Saturated aqueous sodium 
chloride solution (1 cm) was added to the green solution and the resulting mixture 
was stirred for 15 minutes. The organic phase was separated and the aqueous phase 
was extracted with EtOAc (3 x 2 cm'). The combined organic extracts were dried and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica gel [hexane:EtOAc (4:1)] to give the title compound (190 mg, 64%) as a 
colourless oil, Rf [hexane:EtOAc (3:1)] 0.52; [aID -22.4 (c 0.4, CHC13); V m  
(neat)/cm' 3508, 1778, 1684; 8H  (200 MHz, CDC1 3) 7.82-7.18 (25H, m, An]), 4.98-
4.94 (1H, brm, C 3.H), 4.71 (1H, tdd, J9.9, 7.0, 3.3, C411), 4.14 (1H, dd, J 11.4, 7.3, 
CHAHBOTBDPS), 4.24-4.00 (3H, m, C5H2 + CHAHBOTBDPS), 3.86 (2H, d, J 13.9, 
NCHXHYPIL x 2), 3.60 (2H, d, J 13.9, NCHXHYPh x 2), 3.19 (1H, dd, J 13.2, 2.9, 
CHsH1Ph), 3.00 (1H, brdt-q, J5.l, C 4H), 2.66 (1H, dd, J 13.2, 9.9, CHSHTPh), 1.23 
(3H, s, Me), 1.12 (9H, s, tBu),  1.07 (3H, s, Me); & (62.9 MHz) 177.4, 152.6, 139.7 
(2C), 135.7 (3C), 135.5, 132.5, 129.3 (3C), 129.1 (3C), 128.8, 128.7 (2C), 128.0 
(3C), 127.8 (3C), 127.7 (3C), 127.2 (2C), 127.1, 126.7 (2C), 74.6, 66.1, 66.0, 62.4, 
57.6, 54.5 (2C), 51.5, 37.8, 26.8 (3C), 20.1, 19.4, 18.9; m/z (FAB) 755 ([M+H], 
9.1%), 665 (3.2), 325 (14), 217 (96), 91(100); HRMS (FAB) (C 47H55N205Si requires 
755.3880, found 755.3876). 
187 
Experimental 
(1 'S,l ' 'R,6R)-6-(2' '-tert-Butyldiphenylsilyloxy-1 ' '-N,N-dibenzylamino)-3-(2'-






To a suspension of NO-dimethylhydroxylamine.HC1 (194 mg, 1.98 mmol) in THF 
(1.5 cm3) at -30 °C was added trimethylaluminium (0.99 cm', (2.0 Min toluene), 1.98 
mmol). The solution was warmed to room temperature and stirred for Ca. 15 minutes 
when a clear solution remained. The solution was re-cooled to -30 °C and a -30 °C 
solution of aldol adduct 185 (50 mg, 0.066 mmol) in THF (1.0 cm) was added via 
cannula. The resulting mixture was stirred at -30 °C for 30 minutes and slowly 
warmed to 0 °C and stirred at 0 °C for 1.25 hours. The reaction was quenched by 
addition of MeOH (ca. 1.0 cm3) and allowed to warm to room temperature. The 
resulting cloudy solution was diluted with DCM (10 cm') and a saturated aqueous 
solution of sodium potassium tartrate (10 cm') was added. The mixture was stirred 
vigorously for 2 hours by which time two clear phases remained. The organic phase 
was separated and the aqueous phase was extracted with DCM (3 x 10 cm'). The 
combined organic extracts were dried and concentrated under reduced pressure. The 
remaining residue was chromatographed on silica gel [hexane:EtOAc (4:1)] to give 
the title compound (41 mg, 100%) as a colourless oil, R 1 [hexane:EtOAc (3:1)] 0.38; 
[a]D -13.9 (c 0.71, CHC13); Vm  (neat)/cm' 3446, 1755, 1697; oH (250 MHz, CDC1 3) 
7.87-7.11 (25H, m, An]), 5.06 (1H, tdd, J 11.2, 6.8, 3.8, C 1 ,HBn), 4.12 (1H, dd, J 
11.7, 7.9, C 2,,HAHBOTBDPS), 3.99 (1H, dd, J 11.7, 7.2, C2,'HAHBOTBDPS), 3.83 
(2H, d,J14.0,NCHHyPhx2), 3.81 (1H, dd,J11.8, 3.8, C 2,HH1OH), 3.70 (1R, dd, 
188 
Experimental 
J 11.8, 3.8, C 2,HSHTOH), 3.65 (1H, m, CA,  3.48 (2H, d, J 14.0, NCHXHYPh x 2), 
3.16 (1H, dd, J 13.9, 11.2, CHPHQPh), 3.05-2.96 (2H, m, CH PHQPh + C 1 .HNBn2), 
1.09 (9H, s, tBu), 0.56 (3H, s, Me), 0.53 (3H, s, Me); & (62.9 MHz) 174.5, 150.8, 
139.1 (2C), 137.3, 135.6 (2C), 135.5 (2C), 133.1, 132.7, 129.8, 129.7, 128.9 (2C), 
128.7 (4C), 128.4 (2C), 128.1 (4C), 127.7 (2C), 127.6 (2C), 127.0 (2C), 126.7, 81.5, 
63.4, 60.9, 57.6, 55.6, 54.1 (2C), 41.5, 33.2, 26.8 (3C), 20.4, 19.0, 17.8; mlz (FAB) 
755 ([M+H], 48.0%), 478 (27.5), 197 (25.1), 135 (36.8), 91(100); HRMS (FAB) 







A solution of aldol adduct 185 (50 mg, 0.066 mmol) and 20% Pd(OH) 2/C (50 mg) in 
methanol (2 cm) was exposed to a hydrogen atmosphere (1 atm.) and stirred under 
hydrogen for 18 hours. The reaction mixture was filtered through a pad of celite and 
concentrated under reduced pressure. The remaining residue was chromatographed 
on silica gel [hexane:EtOAc (3:1)] to give the title compound (19 mg, 73%) as a 
colourless oil, Rf [hexane:EtOAc (3:1)] 0.27; [aID -15.6 (c 0.36, CHC13); Vmax  
(neat)/cm' 3390, 1666; 8H(250 MHz, CDC1 3) 7.65-6.93 (15H, m, ArE), 5.04 (1H, d, 
J 15.0, NCHAHBPh), 4.02 (1H, brdd, J 7.3, 4.7, CA,  3.82 (1H, dd, J 11.0, 3.0, 
CHXHYOTBDPS), 3.69 (1H, dd, J 11.0, 4.7, CHAHBOTBDPS), 3.62 (1H, d, J 15.0, 
NCHAHBPh), 3.06 (1H, ddd, J7.3, 4.7, 3.0, C5R), 1.24 (3H, s, Me), 1.07 (3H, s, Me), 
1.05 (9H, s, tBu); 8c (62.9 MHz) 178.1, 136.1, 135.6 (2C), 135.4 (2C), 132.5, 130.0, 
129.9, 128.5 (3C), 127.9 (3C), 127.7 (3C), 127.3, 76.2, 61.0, 60.9, 43.7, 43.3, 26.8 
(3C), 22.9, 19.1, 17.6; mlz (FAB) 488 ([M+H], 53%), 325 (6), 217 (43), 91(100), 
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X-ray Crystal Structure of 154 
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Table 1 Crystal data and structure refinement for 154 
Part A: Crystal Data 
Empirical formula C3617143N05Si 
Formula weight 597.80 
Wavelength 1.54184 A 
Temperature 150 (2) K 
Crystal system Monoclinic 
Space group P21 
Unit cell dimensions a = 10.4970 (6) A alpha = 90 deg. 
b= 14.4596 (9) A beta = 113.316 (4) deg. 
c= 11.7189(7)A gamma =9odeg. 
Volume 1633.46 (17) A3 
Number of reflections for cell 82 (20 <theta <22 deg.) 
Z 2 
Density (calculated) 1.215 Mg 7M3 
Absorption coefficient 0.971 mm 
F (000) 640 
Part B: Data Collection 
Crystal description Colourless Plate 
Crystal size 0.58 x 0.31 x 0.12 mm 
Theta range for data collection 4.11 to 70.23 deg. 
Index ranges -12<=h<=11, -3<k<16, 0<1<14 
Reflections collected 4051 
Independent reflections 3867 [R (int) = 0.0314] 
Scan type Omega-theta 
Absorption correction Optimised numerical (T min  = 0.597, Tmax = 
0.906 
Part C: Solution and 
Refinement 
Solution Patterson (DIRDIF) 
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Refinement type Full-matrix least squares on F2 
Program used for refinement SHELXL-97 
Hydrogen atom placement Geometric/difference map 
Hydrogen atom treatment Riding/rotating group 
Data/restraints/parameters 3867/1/396 
Goodness of fit on F2 1.037 
Conventional R [F>4sigma 
(F)]  
RI = 0.0322 [3674 data] 
Weighted R (F 2 and all data) wR2 = 0.0873 
Absolute structure parameter 0.01(4) 
Extinction coefficient 0.0017(3) 
Final maximum delta/sigma 0.021 
Weighting scheme calc 
w= 1 /[\s"2'(Fo"2")+(0.061 1 p)A2A+o 1997 
P] where P(Fo"2"+2Fc"2'')/3 
Largest duff. Peak and hole 0.436 and —0.301 e.A3 
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Table 2 Atomic coordinates (x 1O) and equivalent isotropic displacement 
parameters (A2 x 1 0) for 154. U(eq) is defined as one third of the trace of the 
orthogonalized U/ tensor 
X y z U(eq) 
C(1) -3866(2) -866(2) -1760(2) 24(l) 
o (1) -5037(2) -657 (2) -2348(2) 41(1) 
0(1M) -3214(2) -1559(2) -2053(2) 37(1) 
C (1M) -4058 (3) -2087(3) -3132(3) 54(l) 
C (2) -2937(2) -395 (2) -566 (2) 25 (l) 
o (2) -3726(2) 232 (2) -189(2) 40(l) 
C (3) -1708(2) 75 (2) -722(2) 22(l) 
o (3) -2271(2) 672 (2) -1764(2) 36(l) 
 -824(2) 633 (2) 447 (2) 20(l) 
N(4) 2(2) 1325(l) 103(2) 20(1) 
C(41) 342(2) 2148(2) 919(2) 24(1) 
C (42) 1256 (2) 933 (2) 21(2) 26(l) 
C (41A) -920(2) 2706 (2) 792 (2) 23(l) 
C(42A) -1733(2) 3112(2) -343(2) 27(1) 
C(43A) -2849(3) 3666 (2) -456(3) 32(l) 
C(44A) -3193(3) 3819(2) 557(3) 37(1) 
C (45A) -2415(3) 3405 (2) 1679 (3) 37(l) 
C(46A) -1293(3) 2846 (2) 1789 (2) 32(1) 
C(41B) 1979(2) 1590(2) -529(2) 25(1) 
C(42B) 1252(2) 2165(2) -1533(2) 27(1) 
C (43B) 1962 (3) 2760 (2) -2009(2) 29(l) 
C (44B) 3401 (3) 2777 (2) -1505 (2) 34(l) 
C(45B) 4128(3) 2195(2) -1533(2) 27(1) 
C(46B) 3416 (2) 1614 (2) -42(2) 30(1) 
 -12(2) -29(2) 1498 (2) 22(l) 
0(6) 674(2) 474(1) 2632(1) 22(1) 
Si (7) 950(1) 44(1) 4017(1) 18(1) 
C(71A) 1756(2) -1127(2) 4129(2) 20(1) 
C(72A) 1412 (2) -1899(2) 4662 (2) 27(1) 
C (73A) 2007 (3) -2758(2) 4681 (3) 33(l) 
C(74A) 2975 (2) -2872(2) 4156(2) 30(1) 
C (75A) 3343 (3) -2124(2) 3633 (2) 29(l) 
C(76A) 2746(2) -1262(2) 3615(2) 25(1) 
C (71B) -766(2) -59(2) 4170 (2) 24(l) 
C (72B) -1993(2) 207 (2) 3194 (2) 32(l) 
C(73B) -3269(2) 116(3) 3286 (3) 44(1) 
C (74B) -3340(3) -221(2) 4359 (3) 49(l) 
C (75B) -2145(3) -473(2) 5340 (3) 45(l) 
C (76B) -873(3) -401(2) 5246 (2) 31 (1) 
C (71C) 2154 (2) 888 (2) 5161 (2) 21(1) 
C (72C) 2266 (3) 652 (2) 6479 (2) 27(l) 
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C(73C) 1594(3) 1873 (2) 4840 (2) 27(1) 
C (74C) 3606 (2) 833 (2) 5140 (2) 30(l) 
Table 3 bond lengths Afor 154 




o (1M)-C (1M) 1.442(3) 
C(2)-O(2) 1.411(3) 
C (2)-C (3) 1.532(3) 
C (3)-0 (3) 1.419(3) 
C (3)-C (4) 1.542 (3) 
C (4)-N (4) 1.481(3) 
C (4)-C (5) 1.526(3) 
N (4)-C (42) 1.472(3) 
N (4)-C 41) 1.478(3) 
C(41)-C(41A) 1.507(3) 
C (42)-C (41B) 1.510(3) 
C (41A)-C (46A) 1.386(3) 
C (41A)-C (42A) 1.394(3) 
C (42A)-C (43A) 1.381(4) 
C (43A)-C (44A) 1.389(4) 
C (44A)-C (45A) 1.380(4) 
C (45A)-C (46A) 1.393(4) 
C (4113)-C (46B) 1.386(3) 
C (4113)-C (4213) 1.395(4) 
C (42B)-C (4313) 1.391(4) 
C (43B)-C (4413) 1.387(4) 
C (44B)-C (4513) 1.381(4) 
C (45B)-C (4613) 1.390(3) 
C (5)-0 (6) 1.434(3) 
O (6)-Si (7) 1.6538 (16) 
Si (7)-C (71A) 1.874(3) 
Si (7)-C (71C) 1.882(2) 
Si (7)-C (7113) 1.885(2) 
C (71A)-C (72A) 1.395(4) 
C (71A)-C (76A) 1.406(3) 
C (72A)-C (73A) 1.387(4) 
C (73A)-C (74A) 1.391(4) 
C (74A)-C (75A) 1.371(4) 
C (75A)-C (76A) 1.392(4) 
C (7113)-C (7213) 1.396(3) 
C (71B)-C (7613) 1.400(3) 
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C (72B)-C (7313) 1.392(3) 
C (73B)-C (7413) 1.377 (5) 
C (75B)-C (7613) 1.373 (5) 
C (75B)-C (76B) 1.386(3) 
C (71C)-C (73C) 1.530(3) 
C (71C)-C (74C) 1.537(3) 
C (71C)-C (72C) 1.540(3) 
Table 4 Bond angles (degrees) for 154 
Bond Angle (degrees) 
O (1)-C (1)-0 (1M) 124.2(2) 
O (1)-C (1)-C (2) 124.1(2) 
o (1M)-C (1)-C (2) 111.60 (19) 
C (1)-0 (1M)-C (1M) 115.1(2) 
o (2)- C(2)-C (1) 109.60 (18) 
O (2)-C (2)-C (3) 112.3(2) 
C (1)-C (2)-C (3) 110.72 (17) 
O (3)-C (3)-C (2) 106.77 (17) 
O (3)-C (3)-C (4) 110.2(2) 
C(2)-C(3)-C(4) 111.41 (16) 
N (4)-C (4)-C (5) 116.33 (17) 
N (4)-C (4)-C (3) 108.86 (17) 
C (5)-C (4)-C (3) 109.7(2) 
C (42)-N (4)-C (41) 111.07 (18) 
C (42)-N (4)-C (4) 113.09 (19) 
C (41)-N (4)-C (4) 112.70 (17) 
• (4)-C (41)-C (41A) 112.90 (18) 
• (4)-C (42)-C (41B) 113.5 (2) 
C (46A)-C (41A)-C (42A) 118.2(2) 
C (46A)-C (41A)-C (41) 121.7(2) 
C (42A)-C (41A)-C (41) 120.1(2) 
C (43A)-C (42A)-C (41A) 120.7(2) 
C (42A)-C (43A)-C (44A) 120.5(2) 
C (45A)-C (44A)-C (43A) 119.3(2) 
C (44A)-C (45A)-C (46A) 120.0(2) 
C (41A)-C (46A)-C (45A) 121.2(2) 
C (46B)-C (41B)-C (42B) 118.3(2) 
C (46B)-C (41B)-C (42) 119.2(2) 
C (42B)-C (41B)-C (42) 122.4(2) 
C (43B)-C (42B)-C (41B) 120.4(2) 
C (44B)-C (43B)-C (42B) 120.4(2) 
C (45B)-C (44B)-C (4313) 119.6(2) 
C (44B)-C (45B)-C (46B) 119.8(2) 
C (41B)-C (46B)-C (45B) 121.4(2) 
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O (6)-C (5)-C (4) 110.2(2) 
C (5)-0 (6)-Si (7) 123.19 (15) 
O (6)-Si (7)-C (71A) 107.88 (10) 
O (6)-Si (7)-C (71C) 105.25 (10) 
C (71A)-Si (7)-C (71C) 112.27 (10) 
O (6)-Si (7)-C (71B) 108.67(9) 
C (71A)-Si (7)-C (71B) 110.10(12) 
C (71C)-Si (7)-C (71B) 112.40 (10) 
C (72A)-C (71A)-C (76A) 116.6(2) 
C (72A)-C (71A)-Si (7) 124.40 (17) 
C (76A)-C (71A)-Si (7) 119.01(19) 
C (73A)-C (72A)-C (71A) 122.0(2) 
C (72A)-C (73A)-C (74A) 120.2(3) 
C (75A)-C (74A)-C (73A) 119.2(3) 
C (74A)-C (75A)-C (76A) 120.6(2) 
C (75A)-C (76A)-C (71A) 121.5(2) 
C (72B)-C (71B)-C (76B) 117.3(2) 
C (72B)-C (71B)-Si (7) 120.48 (18) 
C (76B)-C (71B)-Si (7) 122.23 (18) 
C (73B)-C (72B)-C (71B) 121.0(3) 
C (74B)-C (73B)-C (72B) 120.3(3) 
C (75B)-C (74B)-C (73B) 119.8 (2) 
C (74B)-C (75B)-C (76B) 120.2(3) 
C (75B)-C (76B)-C (71B) 121.4(3) 
C (73C)-C (71C)-C (74C) 109.3(2) 
C (73C)-C (71C)-C (72C) 108.8(2) 
C (74C)-C (71C)-C (72C) 108.82 (18) 
C (73C)-C (71C)-Si (7) 110.13 (15) 
C (74C)-C (71C)-Si (7) 110.24 (16) 
C (72C)-C (71C)-Si (7) 109.52 (17) 
Symmetry transformations used to generate equivalent atoms: 
Table 5 Anisotropic displacement parameters (A"2 x ]o"3) for 154. The anisotropic 
displacement factor exponent takes the form: -2pi"2 [h''2 a*2  U]] + ... +2 h k a* 
b* U]2] 
Ui! U22 U33 U23 U13 U12 
C (1) 25(l) 19 (1) 28(l) 4 (1) 10 (1) -2(1) 
0(1) 26(1) 40(1) 44(1) 1(1) 0(1) 4(1) 
O (1M) 29(l) 28(l) 44(l) -14(l) 3 (1) 2 (1) 
C (1M) 45(2) 52(2) 57(2) -32(2) 12(1) -11 (1) 
C(2) 28(1) 21(1) 26(1) 0(1) 11 (1) -1(1) 
0(2) 35(l) 42(1) 49(1) -15 (1) 22(1) -3(1) 
C(3) 26(1) 19(1) 19(1) 1(1) 7(1) -2(1) 
0(3) 46(1) 26(1) 25(1) 8(1) 3(1) -13(1) 
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C(4) 24(1) 15(1) 22(1) 1(1) 8(1) -1(1) 
N(4) 24(1) 12(1) 24(1) 0(1) 9(1) 0(1) 
C (41) 28(l) 15(l) 25 (l) 8 (1) 3 (1) -13(l) 
C(42) 28(1) 21(1) 31(1) 3(1) 12(1) 4(1) 
C (41A) 24(1) 15(l) 29(1) -2(1) 9(1) -3(1) 
C (42A) 30(l) 21(1) 33 (1) 6 (1) 14(l) 0(i) 
C(43A) 29(1) 24(2) 41(1) 10(1) 11 (1) 2(1) 
C(44A) 29(1) 20(1) 48(2) -2(1) 15(1) 1(1) 
C (45A) 37(l) 37 (2) 37(l) -13(l) 15(l) 0(i) 
C(46A) 35 (1) 28(2) 28(1) -3(1) 8(1) 4(1) 
C (41B) 30(l) 17(l) 29(l) -4(1) 13(l) -1(1) 
C(42B) 29(1) 24(1) 28(1) -2(1) 11 (1) -2(1) 
C (43B) 42(l) 18(l) 32(l) 0(1) 18(l) 1(1) 
C (44B) 44(l) 22 (2) 42(l) -6(1) 24(l) -9(1) 
C (45B) 29(l) 31(2) 45(l) -5 (1) 14(1) -7(1) 
C(46B) 27(1) 26(2) 32(1) 0(1) 9(1) 0(1) 
C(S) 28(1) 17(1) 21(1) 0(1) 7(1) -2(1) 
0(6) 27(1) 16(1) 19(1) 0(1) 6(1) -2(1) 
Si (7) 20(1) 14(1) 20(1) 0(1) 7(1) 0(1) 
C (71A) 20(l) 16(l) 20(l) -3(1) 4 (1) -2(1) 
C (72A) 26(l) 20(l) 38(l) (1) 15(l) -1(1) 
C(73A) 35 (1) 17(2) 49(2) 6(1) 17(1) 1(1) 
C(74A) 32(1) 17(1) 38(1) -4(1) 9(1) 6(1) 
C(75A) 29(1) 28(2) 32(1) -2(1) 14(1) 10(1) 
C(76A) 29(1) 19(1) 29(1) 1(1) 13(1) 4(1) 
C (71B) 25(l) 16(l) 33(l) -7(1) 12(l) -3(1) 
C(72B) 25(1) 30(2) 39(1) -8(1) 10(1) 3(1) 
C(73B) 27(1) 42(2) 60(2) -14(2) 12(1) 2(1) 
C(74B) 34(1) 42(2) 84(2) -17(2) 37(2) -10(1) 
C (75B) 51(2) 34 (2) 64 (2) -8(2) 40 (2) -8(2) 
C (76B) 38(l) 22(l) 42(l) -3 (1) 25(l) -2(1) 
C(71C) 23 (1) 16(1) 22(1) -1(1) 7(1) 1(1) 
C (72C) 35(l) 22(l) 22(l) -1(1) 10 (1) -1(1) 
C(73C) 34(1) 15(1) 28(1) -2(1) 8(1) 3(1) 
C (74C) 25(1) 26(2) 37(1) -4(1) 11 (1) -4(1) 
Table 6 Hydrogen coordinates (x 1O'4) and isotropic displacement parameters (AA2 
x 1O'3) for 154 
X y z U(eq) 
H(1M1) -4906 -2288 -3044 81 
H(1M2) -3538 -2630 -3208 81 
H(1M3) -4303 -1702 -3877 81 
H(2) -2563 -879 92 29 
H(2A) -4367 452 -819 61 
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H(3) -1116 -404 -887 26 
H(3A) -1764 1141 -1651 54 
H(4) -1481 981 715 25 
H(41A) 990 2546 715 28 
H(41B) 820 1946 1793 28 
H(42A) 999 366 -494 31 
H(42B) 1913 752 864 31 
H(42C) -1517 3006 -1047 33 
H(43A) -3384 3945 -1233 38 
H(44A) -3956 4204 478 39 
H(45A) -2644 3502 2377 44 
H(46A) -773 2555 2561 38 
H(42D) 267 2151 -1893 32 
H(43B) 1458 3156 -2683 35 
H(44B) 3882 3188 -1828 40 
H(45B) 5114 2191 -195 42 
H(46B) 3924 1226 640 35 
H(5A) -653 -488 1611 27 
H (SB) 683 -367 1283 27 
H(72A) 750 -1835 5023 32 
H(73A) 1954 -3270 5055 40 
H(74A) 3377 -3461 158 36 
H(75A) 4011 -2195 3280 35 
H(76A) 3015 -752 3248 30 
H(72B) -1957 453 2456 38 
H(73B) -4095 288 2606 53 
H(74B) -4212 -280 4420 59 
H(75B) -2190 -697 6058 54 
H(76B) -56 -587 5927 37 
H(72C) 2974 1044 7085 41 
H(72D) 2526 0 6660 41 
H(72E) 1369 760 6532 41 
H(73C) 2203 2303 5464 41 
H(73D) 657 1905 4830 41 
H(73E) 1563 2041 4020 41 
H(74C) 3531 905 4284 45 
H(74D) 4024 232 5464 45 














DDQ 2,3-dichloro-5,6-dicyano- 1 ,4-benzoquinone 
DIBAL-I-iT diisobutylaluminium hydride 






e.e. enantiomeric excess (i.e. % of major enantiomer - % of minor 
enantiomer) 
El electron impact ionisation 
Et ethyl 
Ether diethyl ether 
FAB fast atom bombardment 
Fmoc fluorenylmethylcarbonyl 
HPLC high performance liquid chromatography 
HRMS high resolution mass spectrum 
Hz Hertz 
IBX iodoxybenzoic acid 
JR infra red 
L unspecified ligand 
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M unspecified metal 
M moldm 3 





NMO N-methylmorpholine N-oxide 
NMR nuclear magnetic resonance 
Nu unspecified nucleophile 




ppm parts per million 
py pyridine 
Rt retention time for HPLC 
Tf, triflate trifluoromethanesulfonate 
TBAF tetrabutylammonium fluoride 
TB S tert-butyldimethylsilyl 
TBDPS tert-butyldiphenylsilyl 
THF tetrahydrofuran 
t.l.c. thin layer chromatography 
TMS trimethylsilyl 
TPAP tetra-n-propyl ammonium perruthenate 
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